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INTRODUCTION

Sepsis continues to be a clinical problem with metabolic and
cardiovascular complications (232).

Mortality from septic shock has

remained near 50% for the last 20 years in spite of the use of
antibiotics and advances in critical care medicine (250,278,290).
Gram-negative bacteria are responsible for the vast majority of septic
shock cases in adults (437).

Endotoxin derived from the outer cell

wall of Gram-negative bacilli produces symptoms similar to those
observed in septic shock when it is injected into animals (232,437).
These symptoms include fever, reduced blood pressure and altered
levels of plasma metabolites (232,250).

However, the onset of these

symptoms is generally earlier and the magnitude and duration of
symptoms may vary from those observed in a clinical situation (419).
In this study, a bacteremic model of sepsis was adopted which produces
symptoms of septic shock over a longer interval of time than
endotoxin.

Although the bacteremic model may not completely duplicate

the conditions found in humans,

it provides another animal model that

can be used to investigate the spectrum of problems which develop
during sepsis and septic shock.
Metabolic changes observed during sepsis include alterations in
carbohydrate, protein and lipid metabolism (232,290).

A common

feature of most animal models of septic shock is an initial hyperglycemia followed by hypoglycemia and accompanied by increased glucose

1

2
utilization (101,429).

However, septic patients challenged with an

oral glucose load are unable to respond to the glucose challenge with
adequate stimulation of peripheral glucose utilization (175,235).
Alterations in skeletal muscle metabolism during sepsis could
contribute significantly to changes in total peripheral glucose
utilization.

To date, studies have shown that though basal muscle

glucose utilization is increased (420), insulin-stimulated muscle
glucose utilization is often depressed in the septic state (324,325).
Alterations in glucose utilization may be due to changes in the ratelimiting steps of glycolysis, viz.

glucose transport, hexokinase,

phosphofructokinase and pyruvate dehydrogenase (PDH).

Previous

studies have shown alterations in basal and insulin-dependent PDH
activity during sepsis (337,397).

Changes in the membrane sugar

carrier could also account for sepsis-induced alterations in glucose
utilization.

A major objective of this dissertation was to determine

whether basal and insulin-mediated glucose transport were altered in
skeletal muscles from bacteremic and endotoxic rats.
The intracellular signals responsible for modulating glucose
transport remain unresolved.

Several investigators have proposed that

elevation of intracellular ca2+ plays a role in mobilizing the glucose
carrier from the cytosol into the plasma membrane (28,85,196,369).
Therefore, the altered cellular ca2+ regulation observed during
endotoxic shock (122,272,348,350) and presumably in septic shock, may
contribute to changes in glucose transport.

Hepatocytes from

endotoxic animals have elevations in both free and exchangeable
intracellular Ca 2 + (348,350).

In addition, agonist-stimulated ca2+

3
release from the endoplasmic reticulum (ER) was attenuated in these
Cellular exchangeable (ca2+] increased in skeletal

hepatocytes (272) ·

muscle from rats exposed to endotoxin (122).

The increased

intracellular ca2+ in muscle may result from alterations in ca2+
movements across the sarcolemmal membrane, sarcoplasmic reticulum (SR)
and/or mitochondria.

Thus, a second objective of this study was to

determine whether Ca 2 + regulation is altered in skeletal muscles from
bacteremic rats.
The increased cytoplasmic (ca2+] and attenuated release of ca2+
from ER in hepatocytes were prevented by administering ca2+ channel
antagonists along with the endotoxin (272,350).

Increased exchange-

able (Ca2+] observed in skeletal muscles from endotoxic rats also was
reduced when ca2+ blockers were coadministered with endotoxin (122).
These data suggest that ca2+ channels in liver and skeletal muscle
plasma membranes may contribute to the changes in cellular (Ca2+).

In

this study, experiments were done to determine whether these ca2+
antagonists could prevent alterations in basal and insulin-mediated
glucose transport and ca2+ regulation in skeletal muscles from
bacteremic rats.

An additional portion of this study assessed the

ability of ca+ modifying agents to reproduce the changes in glucose
transport observed in bacteremic rats.

These two approaches provided

evidence that altered ca2+ regulation contributed to changes in
skeletal muscle glucose transport during bacteremia.
A review of the literature concerning the various topics of this
dissertation as well as the results of the experimental studies and
their discussions are presented in chapters 1 through 7.

The studies

4
which characterized the changes in basal and insulin-mediated glucose
transport in skeletal muscle during bacteremia are presented in
chapters 2 and 3.

Skeletal muscle ca 2 + regulation was assessed in the

study presented in chapter 4.

Experiments described in chapters 5 and

6 were designed to determine whether addition of ca 2 +-modifying agents
to control muscles could reproduce the changes in glucose transport
observed in muscles from bacteremic rats.

The ability of ca2+ channel

antagonists to prevent the changes in skeletal muscle glucose
transport during bacteremia was examined in chapter 7.

Chapter 8

contains the overall conclusions drawn from the experimental data.
Chapter 9, the event(s) leading up to altered glucose transport and
the subsequent ramifications of changes in skeletal muscle
carbohydr~te

metabolism during septic shock are discussed.

In

CHAPTER I

LITERATURE REVIEW

A.

ANIMAL MODELS OF SEPTIC SHOCK

Sepsis in humans may progress into shock which is characterized
by: 1) the development of an inadequate utilization of metabolic
substrates and 2) a diminished supply of blood to peripheral tissues
(290).

Several animal models have been developed to study the

metabolism and cardiovascular changes found in sepsis and septic
shock.

Early studies indicated that bacterial infections could

produce a shock state when bacteria were destroyed and components of
the bacteria were subsequently released into the bloodstream where
they acted as antigens to stimulate the reticule-endothelial system
(RES)

(232).

The resulting "hypersensitivity'' response was believed

to account for the clinical symptoms of shock (232).

Investigators

eventually established that many of the symptoms associated with
septic shock could be reproduced by injecting endotoxin (192,232,295).
Endotoxin is composed of lipopolysaccharide (LPS) and associated
protein from the bacterial cell wall of Gram-negative bacteria (295).
Lipopolysaccharide is composed of a lipid A region containing
pyrophosphate plus long chain fatty acids which are linked to
diglucosamine; an R core region of short chain sugars connected to
diheptose and 2-keto-3-deoxyoctonoic acid (KDO); and an 0 side chain
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which also is composed of sugars (295,376).

Although the outer side

chain polysaccharide provides antigenic specificity, many of the
actions of endotoxin can be reproduced with the lipid A moiety of the
LPS molecule (295,376).

When injected into animals, endotoxin

initiates rapid metabolic and cardiovascular changes (192,232,256,429)
with a rapid onset of the hypodynamic and hypometabolic state and
thus, is considered an acute model of septic shock.
Studies of sepsis have established that many changes may not
result directly from endotoxin (419).

Instead, increased production

of some hormones and the release of immunomodulatory mediators from
the RES are responsible for many of the metabolic and hemodynamic
alterations (192).

In addition, investigators realized that sepsis is

characterized by an initial hyper-hemodynamic (hyperdynamic) and
hypermetabolic interval which may progress into a hypodynamic and
hypometabolic state of shock.

As a result there has been a need for

animal models which more closely mimic this biphasic effect and
subsequently, several models have been developed.

One of these animal

models is the injection of live Gram-negative bacteria into animals.
Generally, the Gram-negative bacteria used in live bacterial models
are Escherichia coli or Pseudomonas (97,168,319,364,437).

Bacteria

can be administered intravenously (iv), intraperitoneally (ip) or
subcutaneously (sc)(419).

Intravenous administration results in the

acute onset of shock whereas ip and sc injections provide a focus of
infection and sepsis develops over a more prolonged time period (419).
However, the onset of shock in live bacteria models tends to be acute
in comparison to the development of shock during human sepsis (419).
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Clinical sepsis is often characterized by a focus of infection
containing obligate anaerobes such as Bacteroides, as well as
facultative anaerobes such as~- coli (422).

Many times, the gut

flora appear to be involved in the development of an infection.

The

animal models developed to more closely mimic these conditions include
cecal ligation and subsequent puncture, followed by expression of the
feces into the abdominal cavity (CLP); and implanted pellets
containing known quantities of bacteria along with sterilized fecal
material to act as an adjuvant to infection (419).

An abdominal

peritonitis develops in both of these models, and a chronic septic
state is produced (419).

Implanted pellets offer the advantage of

using a known species and quantity of bacteria.

In CLP, the bacterial

load is not as easily quantitated but it is a less complicated way of
inducing sepsis with a focus of infection.

Although each model can be

advantageous for specific research questions, the relevance and
importance of a specific alteration depends on its presence in human
sepsis and its contribution to the understanding of the septic process
itself.
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B.

CARBOHYDRATE METABOLISM DURING SEPSIS AND SEPTIC SHOCK

1)

Plasma levels of sugars and related metabolites.

Alterations in plasma sugar were documented as early as 1877 when
Bernard observed increased blood sugar during hemorrhage (422).

More

recently, investigators have reported hyperglycemia followed by a
progressive hypoglycemia in various models of sepsis and endotoxic
shock (131,133).

The time course and magnitude of change in plasma

glucose depends on several factors including the model of sepsis
studied (419), dietary state (134), and severity of the septic or
endotoxic insult (256).

Plasma lactate generally increases in both

clinical and experimental sepsis and the severity of the septic insult
often correlates with the magnitude of increase in plasma lactate
(256).

Hormones which regulate plasma glucose and carbohydrate

metabolic processes also change with sepsis.

In the initial stages of

sepsis, plasma insulin increases or remains unchanged but as septic
shock develops, insulin falls to very low values (97,133,168).
Whether insulin alterations follow changes in plasma glucose levels or
vice versa remains unclear (48).

Macrophage derived mediators, which

appear to have insulin-like effects are also released in response to
injury and/or infection.

Counterregulatory hormones such as glucagon

(105), catecholamines (97,105,168,220) and glucocorticoids (105) and
growth hormone (97) generally increase and remain elevated throughout
the septic insult.
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Early investigators utilized glucose and insulin tolerance tests
to assess metabolic changes in plasma sugar levels and the associated
metabolic hormones.

Howard (199) studied Korean war casualties and

reported findings from several critically injured patients including
one septic patient.

These patients exhibited elevated blood glucose

levels compared to controls.

They also developed much higher glucose

values over a longer period of time when given an oral glucose
tolerance test compared to control patients.

An intravenous (iv)

insulin injection (0.1 U/kg) resulted in a large decrease in blood
glucose in control subjects and this decrease was attenuated in the
severely injured patients which was attributed to insulin resistance
in peripheral tissues (199).

Ross et al.

(333) interpreted these

results as an indication of increased hepatic glycogenolysis and
gluconeogenesis since glucose assimilation was not different in their
own patients before and after surgery.

Other earlier investigators

(183) concluded that peripheral glucose utilization was decreased in
some instances and unaltered in others although direct experimental
evidence was not available.
Clinical studies have focused more specifically on post-surgical
septic patients (105).

Blood glucose, hepatic glucose production and

forearm glucose utilization were increased in septic patients compared
to controls (175).

An iv glucose injection produced results similar

to those observed by Howard (175,199).

In addition, Gump et al.

(175)

reported that iv glucose did not inhibit hepatic gluconeogenesis and
did not adequately stimulate peripheral glucose utilization.

Howard

(199) had previously noted the similarity to diabetic states and
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observed that the metabolic alterations could not be explained by
decreased insulin production.

Insulin secretion in response to the

glucose was actually elevated in septic patients compared to controls
(l75).

In addition, subsequent studies in rats have shown that there

is insulin hypersecretion during endotoxic shock (133,433).
More recent clinical studies indicate that most septic patients
are glucose intolerant but the metabolic profile may differ among
patients.

Dahn et al.

(103) described one subset of patients which

have elevated levels of glucagon, epinephrine, and growth hormone.
This group responded appropriately to iv glucose with increased
insulin and growth hormone as well as a tendency for glucagon to
decrease or remain unchanged.

A second subgroup responded to iv

glucose with little or no change in insulin, glucagon or growth
hormone despite elevated glucagon and epinephrine prior to glucose
infusion.

The later group exhibited elevated glucose clearance per

unit of plasma insulin and increased hepatic glucose production under
resting conditions (105,106) indicating alterations in both basal and
insulin-mediated metabolism.

These studies indicate that the changes

in carbohydrate metabolism during sepsis are complex and the
contribution of various organs and metabolic hormones to a particular
plasma glucose level cannot be assessed from the experimental and
clinical studies that have been reported to date.
2)

Kinetics of plasma glucose and related metabolites.

Investigators have quantified production and utilization of glucose
and other metabolites in vivo using slow constant infusions of
radioisotope-labelled glucose in various models of sepsis and septic
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shock.

The rate of glucose appearance (Ra), rate of glucose

disappearance (Rd), and the metabolic clearance rate (MCR) which
normalizes Rd for changes in plasma glucose were calculated.

Fasted

dogs given a lethal dose of Escherichia coli endotoxin developed
hyperglycemia during the first 60 min which progressed to hypoglycemia
by 120 min (429,430).

During hyperglycemia, Ra and Rd increased

significantly but Rd exceeded Ra (430).

Both Rd and Ra progressively

decreased back near control levels by 180 min although Rd still
exceeded Ra (429,430).

The metabolic clearance rate remained elevated

throughout the experiment (429,430) and the magnitude of the MCR
increase appeared to be greater in nonsurviving dogs than in surviving
dogs (430).

Plasma lactate, lactate production and utilization also

increased with this model (430).

Much of the lactate utilized was

found in the form of glucose indicating its use in gluconeogenesis.
Similar results were observed in rats given lethal or sublethal doses
of~.

coli endotoxin (255,256).

In addition, decreased insulin and a

sustained increase in plasma glucagon were observed.

These studies

indicated that both increased hepatic gluconeogenesis and peripheral
glucose utilization, independent of plasma glucose concentrations
occurred with endotoxic shock.

Other models of sepsis (361) as well

as septic shock (428) have produced qualitatively similar results to
those observed with endotoxin.

Twenty four hrs after dogs were given

a nonlethal dose of live ~. coli (1010 organisms) bacteria, they
developed increased glucose clearance although plasma glucose and
glucose production were unaltered (361).

Guinea pigs given the same

amount of bacteria (LD50) developed changes similar to those found in

12
rats and dogs given endotoxin (428).

The hypoglycemia and progressive

· Ra were not as severe in survivors compared to
decrease in
nonsurvivors.

In addition, the increase in glucose disappearance did

not translate into increased glucose oxidation in survivors or
nonsurvivors.

Rats receiving a nonlethal intraperitoneal (ip)

injection of ~. coli (total of 10 11 organisms in 3 ip injections) and
those exposed to cecal ligation and puncture (CLP) developed similar
profiles (179,256).

From these studies, the overall conclusion is

that alterations in both glucose utilization and production occur
during sepsis.

However, the alterations depend on the length and

magnitude of the insult and plasma glucose does not always indicate
the presence of changes in its production or utilization.
3)

Skeletal muscle carbohydrate metabolism.

Skeletal muscle

could contribute significantly to the increased peripheral glucose
utilization observed during sepsis.

Normally, muscle consumes fatty

acids but circulating hormones, mediators or ischemic related
reductions in 02 utilization may cause muscle to switch to glucose for
its energy needs (89,336).

Furr et al.

(147) examined the effect of

endotoxin on glucose uptake in isolated forelimb of the dog.

They

were unable to observe any major increase in glucose uptake in
denervated and innervated forelimb,

in situ, in fasted dogs up to 4

hrs after iv injection of 3 mg/kg ~. coli endotoxin despite increased
vascular resistance and decreased arterial glucose delivery.

However,

diaphragms removed from fasted rats exhibited a 60-70% increase in
basal glucose oxidation 3 hrs after Salmonella enteritidis endotoxin
(iv) (132).

Similar results were obtained in soleus muscles from
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faste d

subJ"ected to cecal ligation and puncture 16 to 24 hrs
r a~s
~

prior to glucose uptake measurements, in vitro (420).

Rats given b·

£._oli (iv) endotoxin developed increased MCR and also showed increased
glycolysis and glycogen synthesis in isolated epitrochlearis muscles
at a time when cardiovascular and plasma metabolite changes were
evident (13,256).
Romanosky et al.

(332) reported increased glucose uptake in the

isolated, perfused hindlimbs of fasted, anesthetized dogs given 0.4
mg/kg b· coli endotoxin.

The increase in glucose utilization occurred

at a time when hypoglycemia and hypoinsulinemia were present.
Skeletal muscle blood flow was significantly diminished but oxygen
consumption was unchanged so that 02 availability was not a cause of
increased glucose utilization.

Romanosky and coworkers (332) also

reported increased lactate production by muscle in spite of the
unchanged 02 consumption.

Meszaros et al.

(285) reported increased

uptake and phosphorylation of 2-deoxyglucose (2DG) in gastrocnemius,
quadriceps, abdominal muscle and diaphragm, in vivo, 3 hrs after b·
coli endotoxin administration to conscious, fasted rats.

The

elevation persisted in quadriceps, abdominal muscle and diaphragm 24
and 48 hrs after endotoxin administration.

Basal glucose utilization

in isolated epitrochlearis muscles, in vitro, increased 3 hrs after
endotoxin was given as was total peripheral glucose utilization (285).
Raymond et al.

(326,327) did not find any changes in gracilis muscle

glucose uptake in dogs given t. coli endotoxin (2 mg/kg) over 6 hrs
when muscle blood flow was constant.

However, they observed increased

glucose uptake in the same muscle 4 to 6 hrs after infusion of live t.
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nder constant flow conditions (326).

Furthermore, endotoxin

.
tl y into the muscle circulation for 5 min increased
perfused d irec
glucose uptake without changing 02 uptake, pH or temperature
( 32 6,327).

The authors concluded that the discrepancy in models was

due to the rapid clearance of the iv endotoxin from the circulation
and a constant release of endotoxin with the injection of bacteria
(326,327).

These studies indicated an increase in muscle glucose

utilization independent of plasma glucose at a time when muscle oxygen
consumption was unaltered.

Although decreased blood flow may

contribute to the elevation of glucose uptake, the studies of Raymond
et al.

(326) showed an elevation even when blood flow was maintained

at control values.

Moreover, Meszaros et al.

(285,287) indicated that

glucose metabolic changes occurred even when endotoxic animal
mortality was low.
Insulin-mediated glucose uptake in skeletal muscle also was
reported to change in various models of septic shock.
al.

~ichterman

et

(420) performed in vitro studies on soleus muscles from CLP-

treated rats and reported similar responses in glucose utilization
compared to controls.

Insulin-mediated increases in glycolysis and

glycogen synthesis were enhanced in epitrochlearis muscles from
endotoxic rats compared to controls (13).

The enhanced in vitro

carbohydrate metabolic response to insulin in skeletal muscle is
different from that observed in perfused gracilis muscle studies
(324,325).

Raymond et al.

(324,325) reported a complete absence of

glucose uptake response to insulin in pentobarbital anesthetized
endotoxic and bacteremic dog gracilis muscles maintained under
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cons ta
(

324

nt flow conditions.

Although the results of Raymond et al.

,325) support previous studies on glucose and insulin tolerance in

. nts and in intact animals, the ~
in vitro
work suggests either that
patie
~~the surrounding milieu of nutrients caused the effect observed in vivo
or that both enhanced and attenuated insulin-mediated glucose
utilization can occur during the course of septic shock depending on
the severity and time course of the model.
4)

Effectors of altered carbohydrate metabolism.

Events and

factors leading to the altered skeletal muscle carbohydrate metabolism
remain controversial.

Wichterman et al.

(420) postulated that hypoxia

or ischemia leading to hypoxia caused an increase in muscle glucose
utilization presumably due to the shift in energy production from
glucose oxidation to glycolysis.

However other investigators

(326,332) indicated that elevated glucose utilization occurred even
when

Oz

consumption was unchanged from control values.

The study of

diaphragms from endotoxic rats indicated that glucose oxidation might
be elevated rather than depressed (132).

The idea that there may be

an uncoupling of electron transport and ATP formation has yet to be
ruled out.

Increased body temperature also has been correlated with

increased basal carbohydrate metabolism (191,256) but this was
attributed to parallel or common events (256).

In addition, several

studies have shown alterations without observing changes in body and
muscle temperature (326).

Other investigators found that endotoxin

directly activates glucose uptake (326) although similar changes in
skeletal muscle metabolism occur with burn (301) or trauma (383) not
associated with sepsis.
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The alterations in circulating hormone levels have also been
explain changes in skeletal muscle carbohydrate metabolism in
use d t o
septic states (47,48).
•

seps 1. 5 ,

Increased circulating levels of insulin during

may explain an increase in the apparent basal carbohydrate

metabolism but not the attenuated response to glucose or insulin
challenge.

In addition, increased basal glucose metabolism has been

observed in the absence of insulin (420).

Elevations in

counterregulatory hormones (20,103) such as catecholamines, glucagon
and growth hormone have been used to explain altered metabolic states
during sepsis.

Bessey et al.

(20,21) reported increased basal glucose

utilization and attenuated glucose utilization during a euglycemic
insulin clamp experiment in individuals given 25-30 ng/kg/min of
epinephrine.
Q

However, Hargrove et al.

(179) demonstrated that neither

or fil adrenergic blockade prevented changes in glucose Rd, Ra or MCR

in bacteremic rats.

Glucagon alters carbohydrate metabolism but its

primary site of action is on the liver and glucagon infusion has no
effect on peripheral carbohydrate metabolism (21,320).
Bessey et al.

Instead,

(21) have shown that infusion of epinephrine and

cortisol can mimic many of the metabolic effects observed in septic
patients.

Glucocorticoid and growth hormone levels increase during

sepsis (103,104) but their role in altering peripheral glucose
metabolism is not known.

Dahn et al.

(104) found a lower mortality in

septic patients which responded to a glucose challenge with increased
growth hormone compared to nonresponding patients, suggesting that
growth hormone may be important.
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Sepsis activates the release of macrophage-derived mediators
such as monokines and these mediators have been shown to have
meta bol

ic effects (258,339,386).

Glucose clearance time was reduced

in rats given a glucose challenge along with 50-100 Units of IL-1
( 33 9).

Tumor necrosis factor (TNF) also has been shown to have

effects on metabolic hormones and plasma carbohydrate metabolite
levels (286,386).

However, other investigators (14,286) were unable

to show that human rTNF (-10 7 units) altered peripheral glucose
utilization after 3 hrs of TNF infusion in conscious rats.

Lee et al.

(258) examined the role of monokines in muscle carbohydrate
metabolism.

They found that murine rIL-la had no effect on 2-

deoxyglucose (2DG) transport while human rTNF increased 2DG transport
(EC 5 o=36 nM) in the L6 muscle cell line after 19 hrs.

When cells were

incubated with a crude monokine preparation, glucose transport was
stimulated within 3 hrs.

The experimental evidence indicates that

monokines may mediate carbohydrate metabolism although their
contribution to changes observed during septic shock are complex and
not completely understood.
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C.

1)

STUDIES OF SKELETAL MUSCLE SUGAR TRANSPORT

Introduction.

Membrane sugar transport has been studied

since the early 1900s but it was not until the 1940's that
investigators realized the importance of facilitated diffusion in
metabolism (259).

Early observations of the facilitated diffusion

process indicated

stereospecificity for sugars, saturability,

temperature-sensitivity, and inhibitor specificity of facilitated
transport (259).

Facilitated diffusion is found in red blood cells

(RBCs), placenta. liver, adipose tissue, as well as in cardiac and
skeletal muscle (259).

Much information about the facilitated glucose

carrier protein has been obtained from studies on RBCs (218,259).

It

is now established that the glucose carrier consists of a 55 kDa
glycoprotein found in electrophoretic band 4.5 of the RBC proteins
(218).

More recently, the glucose transporter gene has been localized

to a -15 Kb fragment on fibroblast chromosome 1 (365).

The transfer

of sugar across the membrane through the carrier appears to conform to
first order kinetics (421).

The carrier transfers sugar in both

directions although glucose is rapidly metabolized upon entering the
cell so little if any moves out under physiological conditions
(259,421).

Although sugar transport in adipose tissue, cardiac and

skeletal muscle is a facilitated carrier-mediated system, it is unlike
the RBC carrier because it is insulin sensitive (233,259).
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Skeletal muscle is considered to be metabolically important
since it is the primary metabolic fuel consumer (304).

Under

physiological conditions, skeletal muscle utilizes fatty acids for
most of its energy needs but carbohydrates become a primary energy
source during stressful conditions (304).

Skeletal muscle sugar

transport is the rate-limiting step in glucose utilization (233) and
insulin acts as the primary regulator of glucose transport and
subsequent steps in glucose utilization (233,259).

Thus, more recent

studies have focused on factors regulating muscle sugar transport with
major emphasis on mechanisms involved in insulin activation of sugar
transport.

Adipocyte sugar transport is similar to that of muscle

(83,87,259) and many of the steps involved in insulin-activation of
sugar transport have been determined in adipocytes and extrapolated to
skeletal muscle.
2)

Techniques for sugar transport measurements.

techniques are available to measure sugar transport.

Several

Since glucose is

rapidly metabolized after being transported, most techniques
capitalize on glucose analogs which are readily transported but not
metabolized (259).

Early studies (248,259) utilized the slowly

metabolized sugar galactose but recent investigators have used nonmetabolizable 3-0-methylglucose (3MG), xylose, and 2-deoxy-D-glucose
(2DG).

3MG is transported but not further metabolized and xylose is

transported but poorly metabolized (259).

When 2DG is transported it

is phosphorylated to form 2-deoxy-glucose-6-phosphate (2DG6P) and
under conditions where transport is rate-limiting, it can be measured
to assess transport.

In addition, cytochalasin b specifically
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inhibits facilitated glucose transport (79,366).

Transport kinetics

e 3MG and 2DG appear to be similar (60,189,233,246,298)
for g lucos '
'
although in some cases 2DG appeared to be metabolized (60).

Recently

D'Amore and Lo (102) proposed that 2DG and 3MG use two different
glucose transport systems.

The authors proposed that glucose and 2DG

used two transport systems while 3MG used only one system.

The system

used by 2DG was affected by conditions which did not affect the 3MG
system.

Glucose controls were not performed to determine whether

agents also altered glucose utilization.

In addition, the agents

which did not alter 3MG transport in the D'Amore and Lo study (102)
have been shown to alter skeletal muscle 3MG transport in previous
studies (80,85,245,246).

The Ki reported for glucose and 3MG were

similar to those reported in earlier studies on skeletal muscle
(61,298).

The results do not support the hypothesis that 2DG (not

3MG) is the only analog which reflects changes in skeletal muscle
glucose transport.
The analog 2DG is most widely used to measure muscle sugar
transport under in vivo conditions.

Basal sugar transport can be

obtained from fasted subjects when insulin is low and insulin
stimulation of transport is measured after a bolus injection or during
a constant infusion of insulin or glucose (197,198).

The main

advantage in using 2DG is that a unidirectional transport can be
calculated from the rate of 2DG disappearance, the rate of 2DG6P
appearance or the rate coefficient for the disappearance or
appearance.

However, care must be taken that degradation of 2DG6P by

phosphatases does not enter into the measurement (368).

Other
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nonme t
cell .

abolizable glucose analogs such as 3MG are not trapped in the
However, net uptake of 3MG into tissues in vivo was measurable

. g radioisotopically labelled 3MG (297).
us in

In vivo accumulation

within the cell is a measurement of the net flux.

The Km for the

transport of 3MG was 2.4 rnM in frog sartorius muscle (298) and 4.6 mM
in barnacle muscle (60) with an apparent Km of 35 rnM for glucose
uptake in rat soleus muscle (67).

The EC50 of the glucose transport

response for insulin is approximately 1-4 nM (162,262).
The environment surrounding muscle tissue is better controlled
under in vitro conditions.

Therefore, much information about the

regulation of glucose transport has come from in vitro studies.
Recent studies have focused on isolated muscle groups such as soleus
or epitrochlearis in which there are no torn fibers (13,67,245,246).
Apparently, sugar transport in freshly isolated skeletal muscle cells
has not been widely successful.

Instead, cultured muscle cell lines

such as the L6 or BC3H-l lines have been used to study transport
(240,241).

Uptake and efflux of hexose sugars have been studied in

isolated muscles and cultured cell lines (62,124,240,245).

The

greatest success in measuring influx has been obtained with 2DG since
it is transported and phosphorylated which prevents it from being
transported out of cells and thus, linear uptake rates can be measured
for a reasonable time period (233).

Other analogs such as 3MG move

out of cells such that a net uptake rate (using the radioisotopic
method) is measured rather than a unidirectional influx (245,298).
general problem in studies of sugar influx into isolated, intact
muscles has been that the time required for equilibration of sugar

A
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the media and interstitial space may be too long to permit

between

. ·al influx measurements (246).
in1t1
transp Or

In order to measure unidirectional

t without the inclusion of a phosphorylation step and to

eliminate the problems with extracellular equilibration, investigators
have used efflux of radiolabelled sugar from preloaded muscles (246).
The appearance of radioactivity in the media can then be used to
calculate the rate and rate coefficient for the transport process.

In

addition, this technique offers the advantage of being able to measure
basal and stimulated transport in the same muscle.

Carruthers (60)

found that transport was symmetrical in single barnacle muscle cells
while Narahara and Ozand (298) found that transport was asymmetric in
frog sartorius muscle.

In rat skeletal muscle, the initial uptake and

release of 3MG (uptake= 0.12 µmol/kg wet wt/rnM; efflux= 0.16 µmol/kg
wet wt/mM) were similar indicating that transport was approximately
symmetrical (245).
3)

Modulation of basal sugar transport.

Basal sugar transport

in skeletal muscle can be affected by physiological, pharmacological,
and pathophysiological conditions.

Physiological conditions which are

known to alter basal sugar transport include dietary state, exercise
and aging.

Exercise (107,209,214,335,402) and contractile activity

(317) are associated with increased basal glucose transport in
skeletal muscle as measured in perfused hindlimb preparations
(209,317) or in vitro (107,401).
Dietary state has less of an effect on basal sugar transport but
may modulate changes in transport in conjunction with other factors.
Diet has been manipulated either with starvation or by changing the

23
ratio of fat to carbohydrate consumption.

Starvation caused reduced

glucose Ut ilization in human forearm (310) but had little effect on
glucose utilization in perfused hindlimbs (19,42,163,335).
ZDG uptake was markedly reduced in working muscles (208).

In vivo
In contrast

starvation (42) increased basal glucose transport in isolated muscle.
The decreased glucose utilization observed in vivo was possibly due to
increased use of fatty acids and not glucose to meet energy demands
(208) and related to changes in hormonal regulation of metabolism
(304).

Diets high in fat had little effect on glucose uptake in

perfused rat hindlimbs (289) and had no detectable effect on glucose
transport in isolated muscles or membranes (169,172).

Glucose

utilization appeared to decrease in isolated soleus muscles from rats
given a high fat diet (172).

Exercise-induced increases in glucose

utilization and glucose transport were reduced moderately by a high
fat diet and completely prevented with a high carbohydrate diet (436).
High carbohydrate diets allow more rapid glycogen repletion than high
fat diets but glycogen alone could not account for the dietary effect.
Instead, diet appears to modulate recycling and membrane availability
of glucose transporters (436).
Skeletal muscle glucose utilization and transport activities
change during growth and development and during the aging process.
Basal glucose transport and utilization are at peak levels in juvenile
rats (162,208) and decrease with aging in rats and elderly humans
(135,163).

The age-associated changes in skeletal muscle sugar

transport and the effects of diet and exercise on transport suggest
that several cellular modulators may regulate glucose transport.
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Several studies have determined how glucose transport is
reg Ul

ated within cells.

In these studies, agents which modify sugar

transport are added to isolated muscles before or during transport
measurements (24-27,29,245,246).

Since skeletal muscle and adipocyte

glucose transport are similar, studies on isolated adipocytes have
provided information relevant to muscle sugar transport.

Hormones or

mediators which affect cell metabolism have been used to determine
whether they modulate glucose transport (29,126,245).

Several

investigators have focused on the effect of transmembrane Na+ and K+
gradients on sugar transport (25,27,28,246).

Agents known to modify

specific intracellular ions, metabolites or enzyme activities have
been used to determine whether a coupling exists between cellular
metabolic energy or metabolic pathways and sugar transport (80,248).
Counterregulatory hormones may influence skeletal muscle glucose
transport.

Glucagon has no effect on skeletal muscle glucose

utilization (320) and did not influence glucose transport in barnacle
muscle fibers (15).

Epinephrine is known to reduce peripheral glucose

utilization in vivo (251).

In perfused hindlimbs, epinephrine alone

stimulated glucose uptake in a dose-dependent manner (75).

Several

investigators also have examined the effect of epinephrine on glucose
transport.

Bihler et al.

(29) reported that low doses of epinephrine

reduced basal glucose transport in rat hemidiaphragms while high doses
stimulated transport.

The low dose effects were blocked by the ~l

antagonist practolol while the high dose effects were blocked with the
~2 antagonist butoxamine.

However, epinephrine inhibited glucose

transport in rat soleus muscle (29).

Other investigators found that
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activated hexokinase via a ~-adrenergic signal (15,75,213)
epinephrine

but did no t

affect skeletal muscle glucose transport.

A third group

of investigators (86,323) found that ~-adrenergic stimulation of
soleus muscle actually stimulated basal glucose transport.
Epinephrine stimulated glucose transport in frog sartorius muscles
( 391 ).

These studies indicate that the

~-adrenergic

signal initiated

by epinephrine may have multiple actions which may depend on the
length of exposure to epinephrine.

Initial application of epinephrine

may stimulate hexokinase to a point where glucose transport is no
longer rate-limiting, and thus the increased transport observed by
some investigators results from activation of hexokinase.

Direct

addition of cAMP to muscle inhibits glucose transport (15) which
indicates that the inhibitory effects of epinephrine may be due to
direct effects of cAMP-dependent protein kinase on glucose transport.
Investigators also have shown that the second messenger cGMP stimulate
glucose transport although the mechanism(s) involved and the
physiological importance are unknown (15).
Growth hormone and its associated mediators, insulin-like growth
factors (IGF-1, IGF-II) also stimulate glucose transport in a manner
similar to insulin and bind to specific receptors which activate many
of the same cellular processes as does insulin.

Although growth

hormone has little direct effect on glucose transport (126), IGF-I
(62,126) and IGF-II (126) stimulate skeletal muscle glucose transport
via specific but separate receptors.

IGF-I activates a membrane

receptor with tyrosine kinase activity and appears to share an
intracellular messenger system with insulin for activation of glucose
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transport (126,438,440).

Although IGF-I and insulin can bind to each

other's membrane receptors in some organ systems (212), investigators
have found that IGF-I and insulin do not work via binding to the
other's membrane receptor in skeletal muscle (62,299,318).

IGF-II

also activates glucose transport although the receptor and cellular
messenger system are unrelated to those of insulin and IGF-I (202).
The transmembrane Na+ and K+ gradients can affect basal sugar
transport in several skeletal muscles including soleus, diaphragm and
extensor digitorum longus (EDL) (28,83,246).

Reduction of the

transmembrane Na+ gradient by equimolar substitution of extracellular
Na+ ([Na+J

0

)

with Li+ (77,246) stimulates basal sugar transport.

Reduction of [Na+] 0 by equimolar substitution with extracellular [K+]
([K+] 0

)

stimulates glucose transport not only due to a low [Na+]

0 -

mediated increase carrier mediated transport, but also due to a
nonspecific increase for glucose transport that was due to high [K+] 0
induced swelling.

-

The Na+;K+ ATPase inhibitor ouabain also reduces

transmembrane [Na+] gradients and is known to stimulate glucose
transport (24,78,369).

This effect is not immediate but may require

up to 90 min of incubation before an increase in transport is
detectable (245).

Reduction of the Na+ gradient also can be achieved

with the Na+ ionophore monensin (28) or with veratrine (369).

When

added to skeletal muscle, monensin and veratrine stimulate glucose
transport immediately (28,369).

However, Bihler and coworkers (28)

observed that the transmembrane Na+ gradient did not directly
influence glucose transport.

Instead, accumulation of Na+ in the

cellular compartment is thought to reduce Na+/ca2+ exchange across the
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sarcolemma and intracellular organelles, which in turn results in
increased intracellular Ca 2 + ([Ca 2 +Ji) (28).

According to this

hypothesis, glucose transport is stimulated as [Ca 2 +Ji accumulates
which may account for the delayed increase in transport observed with
agents such as ouabain.

The cellular processes activated by a rise in

[Ca2+li and which in turn activate glucose transport are not known.
In contrast to the above studies, Kitasato and Marunaka (237) found
that a portion of skeletal muscle glucose transport is Na+-dependent
but its contribution to overall glucose transport was small.
Addition of [K+] 0 is known to depolarize muscle cells and
increase cellular respiration (227,307,395).
equimolar substitution of [Na+]

0

As indicated above,

with high [K+]

0

skeletal muscle glucose transport (246,391,444).

led to an increase in
Although this

increase was attributed partly to high [K+] 0 -induced cellular swelling
by Kohn and Clausen (246), Valant and Erlij

(391) reported that K+-

induced increases in glucose transport were blocked by cytochalasin b
(a specific blocker of glucose transport) which suggested a K+mediated increase in carrier-mediated transport.

Valant and Erlij

(391) also found that the enhanced glucose transport was prevented
with dantrolene (an excitation-contraction coupling antagonist) which
indicates that ca2+ release from the sarcoplasmic reticulum (SR) may
be involved in the K+-induced stimulation of glucose transport.

The

increased respiration also is dependent on the depolarization induced
release of ca2+ from the sarcoplasmic reticulum (SR) (395).

In

addition, the direct release of SR ca2+ by ryanodine stimulates
cellular respiration (216,418).

Other investigators have observed
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that

·ncreased (K+] 0 diminished basal glucose transport in skeletal

i

muse le

and the return of muscles to a low [K+]

0

media stimulated the

transport process (24,27,79).
Several investigators have attempted to correlate ca 2 + movements
with changes in glucose transport (28,85,369), since changes in
cellular (Ca2+] appear to mediate changes in glucose transport similar
to those observed when transmembrane ion gradients (i.e. Na+,K+) are
altered.

Holloszy and Narahara (196) were first to propose that ca 2 +

may cause changes in skeletal muscle glucose transport.

They found

that 3MG transport in frog sartorius muscles progressively increased
as extracellular (ca 2 +]
muscles.

([Ca 2 +]

0 )

was increased in K+-depolarized

Addition of [Ca 2 +) 0 also enhanced the effects of cGMP on

glucose transport (15).

Other investigators have since expanded on

these observation by measuring the effect of various agents on soleus
muscle 3MG transport and 4 5ca2+ efflux or uptake (28,85,369).

The

agents tested include 2,4-dinitrophenol, hyperosmolar mannitol media,
caffeine, A23187, insulin, vanadate, veratrine, trypsin, and pchloromercuribenzoic acid (PCMB) as well as electrical stimulation and
sudden increases in temperature subsequent to a previous cooling
(80,85,369).

In these experiments, hexose transport and 4 5ca2+ efflux

were stimulated within a similar time interval.

Bihler and coworkers

(28) found that monensin stimulated skeletal muscle glucose transport
along with an increase in 4 5ca2+ uptake.

These investigators

(28,80,369) postulated that elevation of (Ca 2 +Ji enhanced glucose
transport.

However, in these studies the magnitude of 45ca2+ flux did
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not always

correlate with the magnitude of change in glucose

transport.
Other investigators attempted to change [Ca 2 +Ji directly to
determine whether glucose transport was altered.

When [Ca 2 +Ji was

increased in dialyzed barnacle muscle fibers, glucose transport also
was stimulated (15).

Addition of the ca2+ chelator EDTA to media

containing no added Ca 2 + resulted in decreased basal glucose transport

in soleus muscles when the incubation period extended beyond 30 min
(164,439).

Basal sugar transport was transiently stimulated during

shorter exposure periods to EDTA (439) and EGTA had no effect on
transport.

The results of these experiments could not be explained by

changed in cellular [Ca 2 +].

Instead, the stimulatory effect was

attributed to the chelation of Mg 2 + while the subsequent inhibitory
effect was due to a decrease in ATP (439).
Calcium ionophores also have produced variable effects on
skeletal muscle glucose transport.

The ionophore A23187 stimulated

skeletal muscle 3MG efflux and increased [Ca2+] 0 enhanced the
ionophore effect on transport (80).
high [A23187]

Bihler et al.

(26) observed that

(6-20 µM) stimulated glucose transport and 45ca2+

uptake, but smaller concentrations inhibited transport and 4 5ca2+
uptake in rat atria and hemidiaphragms.

These results led the authors

to conclude that A23187 may act on additional cellular processes.
Other investigators either have observed no effect of A23187 on
glucose transport (171,178,240) or a decrease in glucose transport
(240).

In addition, Hall et al.

(178) observed that A23187 inhibited

glucose transport when ca2+ and Mg2+ were not added to the incubation
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·a and this effect was reversed when Mg2+, but not Ca 2 + was added
me d i
2
back to t h e me dl.· a . These results suggest that the ca + ionophore
A
37 may affect other cellular processes and ions which can modulate
231
glucose transport.
The ionophores A23187 and ionomycin do have nonspecific effects
(l 7 0).

Both A23187 (296) and ionomycin (291) cause cytoplasmic

alkalinization and data from Klip et al.

(242) suggests that

alkalinization increases basal sugar transport.

However, in

fibroblasts ionophore-induced alkalinization results from ca 2 +dependent protein kinase C activation of Na+;H+ exchange (296).

An

increase in [Ca 2 +Ji could act independently to activate glucose
transport and cause cellular alkalinization.

Both ionophores also

have been shown to uncouple mitochondrial oxidative phosphorylation
(149) which could deplete cellular ATP and perhaps stimulate glucose
utilization.

Baker and Carruthers (15) and Smith et al.

(367)

initially proposed that decreased [ATP] could increase basal sugar
transport but Clausen (80) has cited several examples of elevated
basal transport with maintenance of energy stores.

Clausen (80)

pointed out that A23187 affects Mg2+ transport and intracellular [K+]
([K+]i), and Hall et al.

(178) suggested that the primary effect of

A23187 on sugar transport was related to Mg2+.

Ionophore effects have

also been attributed to the activation of other cellular processes.
Recently, Drummond et al.

(120) found A23187 increased protein

synthesis in hamster fibroblasts without a change cytoplasmic free
2
[Ca +J.

Instead, A23187 depletion of [ca2+li stores was crucial to

the effects on gene expression (120).

SR (18) and mitochondria (226)
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leted of ca2+ by both ionophores and these changes could
can be dep
modulate sugar transport.
Although experiments with ionophores have not provided
unequivocal evidence that Ca 2 +i may be involved in regulating glucose
transport, recent studies in adipocytes have provided somewhat more
concrete evidence that changes in [Ca 2 +]i affect glucose transport.
Pershadsingh et al.

(312) found that glucose transport was stimulated

by vanadate, phorbolester and concanavalin A.

This stimulation was

prevented in cells loaded with Quin-2AM, which presumably quenched the
transient increase in [Ca 2 +li·

In addition, insulin and sulfonylureas

both increase cytosolic free [Ca 2 +] in isolated adipocytes (117) and
stimulate glucose transport (330).

In addition, studies in

fibroblasts (2,431), adipocytes (236) and cultured skeletal muscle
(129,374) have shown that phorbol esters stimulate basal glucose
transport.

Phorbol esters activate protein kinase C activity (63) and

this enzyme may be involved in modulating basal glucose transport
activity (129).

In one recent study, phorbol esters had minimal

effects on glucose transport in half-solei and hemidiaphragms (370).
However, the authors did not rule out the possibility that
physiological activators of protein kinase C may stimulate glucose
transport (370).
Several types of stresses and pathophysiological conditions are
associated with changes in skeletal muscle metabolism which can partly
he attributed to alterations in basal glucose transport.

Diabetes is

associated with decreased skeletal muscle glucose transport (403,404)
and transport can be restored to control values by administration of
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·n to diabetic animals (225,404).

inSU l 1

transp

A decrease in muscle glucose

ort also is observed in genetic (96) and chemically-induced

(Z0 3 ) obesity despite increases in plasma glucose and insulin levels
(96,311).
Removal of neuromuscular stimulation via limb immobilization,
muscle unloading or denervation results in a decrease in basal glucose
utilization and transport (50,184,363).

When limbs are subsequently

allowed to move freely or are reloaded, these metabolic changes are
quickly reversed (184,363).

Other forms of limb immobilization are

associated with increased basal glucose transport (363) which
indicates that more than one cellular process may be affected.
Exposure of animals to cold or to stresses such as anoxia, endotoxin,
or burn injury may result in increased transport (67,248,285,388,392,
442).

However, in vivo measurements were made in some of these

studies (285,388) and therefore, the changes in glucose transport may
be due to alterations in insulin sensitivity.

The signal(s) which

stimulate glucose transport during anoxia and endotoxic shock require
further investigation.

The mechanism responsible for increased

transport following burn injury also has not been elucidated although
similar changes in burn and denervation suggest that interruption of
nerve stimulation may contribute to these changes (388,389).
4)
transport.

Coupling between insulin binding and activation of glucose
In recent studies, investigators have examined the

mechanisms which couple insulin binding to its receptor and the
subsequent stimulation of glucose transport.

Insulin binding to the

Q-subunit (Mr 135 kDa) of the receptor stimulates tyrosine kinase
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. i·ty located on the ~-subunit (Mr 95 kDa)
activ

(315).

The tyrosine

kinase autophosphorylates other tyrosine residues on the ~-subunit and
further enhances tyrosine kinase activity.

In addition, the ~-subunit

tyrosine kinase phosphorylates cellular proteins including histone 2B
and angiotensin II (51,309,315).

The subsequent actions of the

phosphorylated proteins/enzymes and their targets are not understood.
Other cellular factors also are capable of modulating insulin receptor
activity.
on the

Protein kinase C appears to phosphorylate serine residues

~-subunit

and this results in attenuation of insulin-activated

tyrosine kinase activity (33,380).

Activation of cAMP-dependent

protein kinase also phosphorylates serine residues on the insulin
receptor which are believed to attenuate insulin receptor binding
(66,315).

In addition, cAMP-dependent protein kinase attenuates

tyrosine kinase activity although the mechanism is not known
(315,381).

Vanadate activates the insulin receptor tyrosine kinase

activity which is thought to occur via phosphorylation of serine
residues on the

~-subunit

(121,288,315,384).

Recently, it has been

shown that the receptor contains a calmodulin binding site (160,165).
When insulin binds to its receptor, calmodulin dissociates from the
plasma membrane ca2+_ATPase and binds to the ~-subunit of the insulin
receptor (65,280,313,340).

As a consequence of the calmodulin

dissociation from the ATPase, ca2+ movement to the extracellular
compartment decreases, resulting in a localized increase of cellular
2
Ca +, which in turn is postulated to mediate some of insulin's actions
(280).

In addition to tyrosine kinase activity and the localized

increase in [ca2+]i, insulin has recently been shown to stimulate the
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synt h e

sis of a novel glycophospholipid (230,275,341,342) which is

. ved to mediate some of insulin's intracellular actions.

be 1 1e

comp Oun

ds containing thioesters have also been proposed as mediators

of insulin's actions (176).

In addition, recent reports suggest that

thiol groups are important for insulin receptor kinase activity (423).
Insulin is believed to mobilize intracellular glucose
transporters into the membrane which increases the Vmax for glucose
transport (366,410).

However, some investigators report that insulin

also modifies the Km for glucose transport by modifying the transport
protein (79).

The cellular messengers which stimulate insulin-

mediated glucose transport have not been elucidated.

The time course

of phospholipid synthesis indicates that it is not involved in
mediating insulin stimulation of glucose transport (228).

However,

the actions of insulin tyrosine kinase (76,115,261) and/or increased
localized (Ca 2 +Ji (280) may be involved in stimulating glucose
transport.

Experimental regimens which modify insulin tyrosine kinase

activity also alter insulin-mediated glucose transport (54,76,96,210,
261) but the phosphorylated intermediate(s) which mobilizes glucose
transporters into the membrane has not been isolated.

These

modifications may have parallel effects on tyrosine kinase and glucose
transport which may not be a direct cause-effect relationship.

The

idea that insulin stimulates glucose transport via changes in (Ca2+li
also has been subject to criticism.

Insulin stimulates endoplasmic

reticulum (ER)/SR 45ca2+ uptake (293) and the action of the ca2+ pump
should reduce (ca2+li which indeed was observed by Baker and
Carruthers in barnacle muscle fibers (15).

Recent studies in
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. cytes indicate that insulin transiently stimulates [ca 2 +Ji when
a d ipo
cellular ca2+ is measured directly (118).
In addition, [Ca 2 +Ji within

a specified range appears to be required for optimal stimulation of
glucose transport by insulin (15,117).

The transient change in

[Ca2+Ji in response to insulin may not have been detectable using
45ca2+ flux measurements.

In addition, insulin may act to locally

increase a change in [Ca 2 +Ji or may activate a ca2+_dependent protein
or flux required for the stimulation of glucose transport.
5)

Modulation of insulin-mediated

~lucose

transport.

As with

basal glucose transport, the insulin-mediated glucose transport
response can be influenced by physiological, pharmacological and
pathophysiological events within the muscle cell.

Kahn (222)

categorized the changes that can occur in insulin-mediated transport
as those affecting insulin sensitivity or responsiveness.

Sensitivity

and responsiveness are determined using cellular responses (e.g.
glucose transport) over a wide range of insulin concentrations, such
that the maximal response has reached a plateau.

Insulin sensitivity

refers to the concentrations of insulin required to give a half
maximal cellular response.

Changes in sensitivity reflect changes in

insulin receptor affinity (222).

Responsiveness indicates the maximal

response obtained with the higher concentrations of insulin and postinsulin-receptor binding events are responsible for changes in
responsiveness.

Alterations in sensitivity and responsiveness can be

attributed to binding and post-binding defects, respectively because
insulin binding studies indicate that maximum insulin action occurs
when only 10-20% of the receptors are occupied, the rest being "spare
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receptors" (139).

A decrease in the number of insulin receptors would

affect sensitivity long before maximum responsiveness and when insulin
responsiveness is affected, there are not necessarily changes in
insulin receptor number (222).
Exercise and diet, as well as the aging process have been shown
to influence skeletal muscle insulin-mediated glucose transport.
Exercise enhances the insulin response although the exercise effect is
transient and returns to control levels between 24 and 48 hrs after
the last bout of exercise (210).

Several investigators report that

skeletal muscle glucose uptake and glucose transport sensitivity to
insulin are improved (34,115,411) which can be attributed to the
increased insulin binding to skeletal muscle during exercise
(34,115,411).

In addition, the maximal responsiveness of glucose

transport to insulin increases in response to exercise (107,317,402)
indicating that post-insulin receptor binding events also may be
altered by exercise.

Cold exposure is a condition similar to exercise

since it increases thermogenesis via muscle shivering (392) .

Skeletal

muscle from cold exposed rats develops an increased maximal insulin
transport response which was postulated to result from a post-insulin
binding effect (392).
Dietary changes also influence insulin responsiveness and
sensitivity.

During starvation, the sensitivity and responsiveness of

glucose uptake to insulin increases (42,163,335).

In contrast, high

fat diets have been shown to decrease the maximum insulin-mediated
glucose transport response in skeletal muscle (169,172,271,289).
Although the number of high affinity sites for insulin binding were
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reduced, maximum insulin binding was not affected (169).

In

adipocytes, the reduced responsiveness has been attributed to a
reduction in the number of glucose transporters (195).
Goodman et al.

(162) reported that the sensitivity and

responsiveness of skeletal muscle glucose transport to insulin peaked
in 4 week old rats and subsequently decreased with age.

They

postulated that the decrease in sensitivity resulted from a decrease
in the number of receptors while the decreased responsiveness was
attributed to a reduction in the total number of glucose transporters.
In humans, glucose utilization also decreases and Fink et al.

(135)

have shown that Vmax decreases in adipocytes from elderly patients
which indicates the number of glucose transporters is reduced.
Many investigators have used a pharmacological approach to
dissect and understand the cellular events involved between insulin
binding and the stimulation of glucose transport (24,86,240,439).
This type of approach also is helpful in determining whether
circulating hormones, mediators, or factors may be responsible for
alterations in insulin-mediated transport during physiological
situations.

As with studies on basal transport, the effect of ion

gradients on glucose transport has been studied to determine whether
Na+, K+, or ca2+ may be involved in the transduction process (15,24,
79,86,118,237,246,439,444).

More recent studies have focused on the

role of cellular enzymes in transducing the insulin signal into an
increase in glucose transport (68,236,370,380).

Perhaps the most

difficult problem in the area of insulin-mediated glucose transport
has been to distinguish between agents which interrupt or accelerate
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specific steps in the insulin signaling pathway and agents which act
on cellular mechanisms that modulate specific steps in the pathway.
Cori and Cori (93) were the first to observe that epinephrine
decreased glucose clearance.

Studies in perfused hindlimbs

subsequently demonstrated that the effect of epinephrine in vivo was
due to its ability to suppress insulin-mediated glucose uptake
(20,75,213).

In skeletal muscle, epinephrine attenuates insulin-

mediated glucose transport by decreasing the sensitivity of the
glucose transport response for insulin (49).

These results are

similar to those observed in adipocytes (366) and more recent studies
in adipocytes indicate that epinephrine acts on a

~-adrenergic

receptor to stimulate cAMP-dependent protein kinase (66,366).

The

protein kinase inhibits insulin binding to plasma membranes which
reduces insulin sensitivity (315).

However, the mechanism may be

different in muscle since Webster et al.

(411) found that epinephrine

enhanced insulin binding to soleus muscle.

Instead, epinephrine may

reduce insulin-mediated glucose transport by decreasing insulin
receptor tyrosine kinase activity (381).

The glucocorticoid

dexamethasone also decreased the response of glucose transport (299)
and glycogen synthesis to insulin but had no effect on insulin binding
(260,299).

Leighton et al.

(260) postulated that the glucocorticoid

acted on a cellular event required for insulin activation of glucose
transport.

Glucose itself has been shown to modulate insulin-mediated

glucose transport (156,436).

Glucose also modulates an insulin-

mediated increase in [Ca2+li in adipocytes (117).

Although the
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mechanism involved is not known, it is possible that glucose affects
insulin-mediated transport via its enhancement of the ca 2 + signal.
Several studies have examined the role of transmembrane ion
gradients in modulating or acting as a signal for insulin stimulation
of glucose transport.

Clausen and coworkers (86,246) have found that

replacement of Na+ with Li+, Tris or choline has no effect on insulinmediated glucose transport in skeletal muscle.

In contrast, Bihler

(24,25) observed that addition of ouabain or small reductions in
extracellular [Na+]

([Na+]

glucose transport.

Larger reductions in [Na+] 0 attenuated insulin-

mediated transport (25).

0 )

enhanced insulin-stimulated (0.2 mU/ml)

Since Kohn and Clausen (246) measured

transport immediately after Na+ substitution and Bihler (25) measured
transport several minutes after exposure of muscle to low [Na+]

or

0

ouabain, it seems that the transmembrane [Na+] gradient effect on
insulin-mediated glucose transport takes time to develop.

Bihler (25)

has suggested that the Na+ effects on insulin-mediated transport are
mediated via changes in [Ca2+li·

As with basal glucose transport,

Kitasato and Marunaka (237) have proposed that a portion of insulinstimulated glucose transport is dependent on the Na+ gradient.

They

observed that as [Na+] 0 was reduced, a component of insulin-mediated
3MG transport also was reduced in frog sartorius muscles.
Other investigators have proposed that K+ or its effect on
membrane potential modulates insulin stimulation of glucose transport
(444).

Clausen and Flatman (86) as well as Stark and O'Doherty (377)

have challenged this hypothesis and found that insulin effects on
glucose transport are unrelated to K+-induced changes in membrane
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potential.

In addition, attenuated insulin-mediated transport has

been observed when [K+]

0

is substituted for [Na+J 0 but this effect

results from cellular swelling and can be prevented with hyperosmolar
media (246).

Potassium appears to be an unlikely candidate to mediate

the actions of insulin on glucose transport.
As with studies concerned with regulation of basal glucose
transport, many investigators have focused on the role that Ca 2 + or
ca2+_dependent activities may play in insulin stimulation of glucose
transport.

Removal of [Ca 2 +] 0 or chelation of [Ca 2 +]

absence of [Ca 2 +J

0

0

by EDTA in the

resulted in an attenuation of insulin-mediated

sugar transport (15,25,164,439).

As with basal transport, EDTA also

transiently stimulates insulin-mediated xylose transport in soleus
muscles which is followed by an attenuation of insulin-mediated
transport (439).

Insulin-mediated 2DG transport in L6 muscle cells

also was stimulated by EGTA (240).

The inhibitory effect of EDTA was

partially due to a reduction in insulin receptor binding and was
attributed to ATP depletion (439).

Clausen et al.

(80) measured

45 ca2+ efflux during insulin stimulation of glucose transport and
found that ca2+ efflux increased but other investigators have been
unable to detect an increase in cytosolic free [Ca2+] during insulin
stimulation in various muscle preparations (15,240).

An increase in

[Ca 2 +Ji in response to insulin has been detected in isolated
adipocytes (118).

McDonald and Pershadsingh (280) have suggested that

insulin may cause localized increases in [Ca2+li which were not
detected with the earlier techniques.

Other studies also suggest that

2
Ca + may modulate the action of insulin on glucose transport (118).
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The

·onophore A23187, which increases ca2+ permeability, attenuated

l

insulin stimulation of glucose transport in rat hemidiaphragms (26).
caffeine had a similar effect on insulin stimulation of glucose
transport in rat soleus muscles (80,171).

The ionophore and caffeine

ave increased [Ca 2 +li beyond the physiological range and thus,
may h
prevented the generation of an intracellular ca2+ transient to
modulate insulin stimulation of transport.
Some reports suggest that activation of ca2+_dependent protein
kinase C may modulate insulin-stimulation of glucose transport (236).
Protein kinase C phosphorylates the insulin receptor on

~-subunit

serine residues and reduces insulin-stimulated tyrosine kinase
activity (33,380).

This leads to an attenuation of insulin-stimulated

glucose transport (68,236,370).

In this manner, protein kinase C

alters insulin responsiveness and not sensitivity (68).

Overall,

experiments with protein kinase C suggest that it modulates the
actions of insulin but is not required for insulin stimulation of
glucose transport.

ca2+_calmodulin-dependent processes also have been

proposed to mediate the action of insulin on glucose transport
(166,280) but there is no experimental evidence to support this
concept.
Pathophysiological conditions such as leprechaunism, limb
denervation or immobilization, obesity, diabetes, and shock are
associated with altered insulin-mediated glucose transport.

The steps

involved in insulin activation of glucose transport have been
elucidated from skeletal muscle and adipocyte alterations which
develop during some of these disease processes.

Leprechaunism is a
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· disorder in which patients exhibit severe glucose intolerance
genetic
( 2441 354).

Submaximal (244) and supramaximal (354) insulin are unable

to stimulate 2DG uptake in fibroblasts from these patients.

Insulin

binding is altered in some patients (54,354) although in other cases
insulin binding was not affected (54,244) which suggests post-receptor
alterations occur also.
Disruption of nerve-muscle communication via limb immobilization
or denervation also blunts insulin stimulation of glucose transport
(50,140,306,363).

Although complete dose-response curves have not

been done in most of these studies, the results consistently suggest
that insulin responsiveness is attenuated (50,140,306,363) while
sensitivity is not affected (140,306).

Insulin binding studies

support this hypothesis since there are no changes in insulin binding
(306).

Thus, nerve stimulation appears to modulate one or more post-

insulin binding activities.
In contrast, studies on obesity have shown effects on skeletal
muscle sensitivity and responsiveness to insulin (59,96,203,311).

In

soleus muscles from genetically obese mice and mice rendered obese
after gold-thioglucose injections, insulin binding decreased (203) and
the sensitivity and responsiveness of 2DG uptake to insulin were
decreased.

Similar results have been obtained in genetically obese

rats (96,311) and in humans (59).

Subsequent studies have shown that

maximal tyrosine kinase phosphorylation of the ~-subunit and of
exogenous substrates (4 glutamate:l tyrosine copolymers) are reduced
in obese mice (261) and humans (8,59).

A recent study observed

alterations in the insulin receptor ATP binding site (182) which could
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reduce tyrosine kinase activity.

Draznin et al.

(119) also have shown

that cytosolic free [Ca 2 +] is elevated in adipocytes from obese
patients and unlike controls, it is not transiently elevated in
response to insulin.

These results suggest that post-insulin receptor

effects also occur in insulin-responsive tissues from obese
individuals.

A decrease in glucose utilization in response to a

euglycemic clamp in obese humans also has been attributed to changes
in capillary density and muscle fiber type (265).
factors may also influence insulin responses.

Thus extracellular

Noninsulin-dependent

diabetes is often associated with obesity (139) but insulin binding
does not appear to decrease in skeletal muscles from type II diabetic
mice (360) or from humans (8,59).

Instead, studies show that there is

a decrease in $-subunit tyrosine kinase activity (8,59,360).
Tyrosine kinase activity in type I or insulin-dependent diabetes
also is reportedly decreased in livers from genetically diabetic rats
and from rats given a streptozotocin injection 5 weeks earlier (309).
In addition, hepatic insulin binding was decreased.
et al.

However, Burant

(51) reported that there was an increased number of insulin

receptors in hindlimbs from streptozotocin-injected (7 days), diabetic
rats.

The length of diabetes (5 wk vs 7 days) and the tissues used to

measure insulin binding (liver vs muscle) may account for the
differing results.

In type I diabetes, maximum insulin-stimulated

glucose transport is attenuated in skeletal muscle (402,403) and this
information coupled with the diminished skeletal muscle tyrosine
kinase activity suggests that type I diabetes results from postinsulin binding defects.
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Maximum insulin-mediated glucose transport also is reportedly
attenuated in muscles from burned hindlimbs (388), muscles from uremic
rats (276), muscles exposed to anoxia (442) and hindlimbs from
pregnant rats (181).

The mechanism(s) responsible for the diminished

responsiveness has not been elucidated although in burned hindlimbs it
is hypothesized that a functional denervation occurs which leads to
altered insulin responsiveness (389).

In addition, studies of anoxia

have shown that both insulin receptor and post-receptor alterations
are responsible for the resulting decrease in insulin-mediated glucose
transport (442).
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1)

CONTROL AND REGULATION OF CELLULAR ca 2 +

Introduction.

Calcium plays a role in cellular metabolic,

mechanical and electrical activities (35,322).

Cytosolic free Ca 2 + is

responsible for many actions attributed to ca2+, although the
cytosolic concentration (10- 7 M) in resting cells is very low (35) in
comparison to total cellular ca 2 + (-1.5-2.0 mmoles/kg wet wt)
(35,122,125,322).

Other cellular compartments, such as the

sarcoplasmic reticulum (SR) and mitochondria buffer and store ca2+
(44).

Along with the plasma membrane, these cellular compartments

allow the cell to maintain a low resting level of cytosolic Ca 2 +
(Ca2+i) until a stimulus mobilizes ca2+ from these compartments into
the cytosol.

About 60% of total cellular ca2+ in skeletal muscle is

exchangeable while 40% is nonexchangeable (35,94,122).

Most of the

exchangeable ca2+ is sequestered in the mitochondrial and SR
compartments with only 10% left in the cytosol (35).

In recent years,

the regulation of [ca2+li by these compartments and their associated
membranes has been the focus of many studies since it is important for
maintenance of cellular function and integrity.
2)

Methods for the measurement of cellular ca2+ regulation.

Several experimental techniques assess cellular ca2+ regulation.
Total cellular ca2+ content measurements could provide information
about gross alterations in the sum of extracellular and cellular Ca 2 +
content without indicating changes in ca2+ movements between
individual compartments (35).

This technique is not always a reliable
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indicator of altered ca 2 + regulation since changes in any one or more
compartment(s) though significant may be small in comparison to total
cell ca2+ (35).

Measurements of radiolabeled ca2+ ( 45 ca 2 +) movements

and the use of compartmental analyses have been used to estimate
changes within the cellular compartments (35,39,390).

Overall

cellular ca 2 + regulation can also be assessed using 45 ca 2 + uptake or
efflux measurements in isolated whole organs, tissues and cells
(35,38,394).

4 5 ca 2 + uptake or efflux measurements assess cellular

exchangeable ca 2 + excluding extracellular Ca 2 + and thus are indicators
of ca2+ content changes within the cell rather than the total ca 2 +
content (35-37,394).

Mathematical models have been developed so that

ca2+ movements within a cellular compartment can be determined from
45ca2+ uptake or efflux curves (390).

In addition, uptake and efflux

measurements are used to determine changes in ca2+ movements in
response to stimuli.

Borle (35,39) concluded that 45 ca2+ uptake or

efflux are relatively easy to perform but they often are not performed
properly or the results are interpreted beyond the sensitivity of the
method.
More recently, techniques have emerged which directly assess
cytosolic free ca2+.

In one of these techniques a ca2+_sensitive,

fluorescent dye (aequorin, Quin-2, Fura-2, Indo-1) is introduced into
isolated cells, cells are then excited at a certain wavelength of
light which results in a fluorescence emission of an intensity that is
proportional to the cytosolic free (ca2+]

(173).

Both cytosolic free

2
Ca 2+ as well as transient changes in [Ca 2 +Ji resulting from Ca+
movements across the plasma membrane or organelles can be detected
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which provides information about Ca 2 + regulation in the cell and in
individual compartments within the cell under basal conditions and in
the presence of various stimuli.

This technique is not applicable to

whole tissue or organs in vitro or in vivo (243,263).

Recent advances

in fluorinated ( 19 F) Ca 2 + chelators may allow investigators to measure
cytosolic free ca 2 + in perfused organs and possibly experimental
animals using nuclear magnetic resonance (NMR) spectral detection
methods (263).

Another method to measure cytosolic free ca2+ involves

the use of Ca 2 +-sensitive microelectrodes (264).

Intracellular ca 2 +

has been measured in several tissues following the development of
ca2+_sensitive liquid ion exchange microelectrodes (190).

Some

investigators found that the microelectrode responds too slowly to
ca2+i transients but Levy and Tillotson (264) observed rapid responses
to transient changes in cytosolic [ca 2 +li·

Other investigators have

found ca2+_sensitive electrodes are not reliable (190) although new
ca2+_sensitive agents which improve the reproducibility of electrode
measurements have been described (190,264).

In the future, these

microelectrodes may allow investigators to measure transient,
localized changes in (Ca2+li which cannot be detected with other
techniques (264).
3)

Cellular ca 2 + movements which regulate ca2+i·

Cytosolic

free Ca 2 + can change in response to physiological signals or
pathophysiological changes which affect influx or efflux of ca2+
across the sarcolemmal, SR, or mitochondrial membranes (56,305,322).
Sarcolemmal calcium movements, which may influence cellular ca2+,
include influx via leak and voltage or agonist-sensitive ca2+
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channels, as well as efflux via Na+;ca2+ exchange plus an ATPase pump
for ca2+ (35).

In the SR, Ca 2 + is actively pumped into the SR lumen

by a SR ATPase and released from SR through a passive ca 2 +-release
channel in response to various stimuli (274,283,334).

Mitochondria

pump ca2+ across the inner mitochondrial membrane into the matrix
using a uniporter that derives its energy from the transmembrane
potential difference generated by respiration (35,305).

Mitochondria

allow ca2+ to move out via a Na+/ca 2 + exchange mechanism also believed
to be within the mitochondrial inner membrane.

Regulation of these

individual processes are apparently important for the maintenance of
overall [Ca2+li regulation and if the activity of one or more of these
processes is disturbed, the result may be an alteration in overall
cellular ca 2 + regulation.
Calcium movements across the sarcolemma depend on whether the
muscle cell is in a resting or stimulated state.

Under resting

conditions, ca2+ influx occurs via a saturable, carrier-mediated
process referred to as a leak channel (35).

An average Km for [Ca 2 +J 0

of 0.5 mM and Vmax of 170 pmol/mg protein/min has been measured in
excitable and nonexcitable cells although specific measurements are
not available for skeletal muscle (35).

ca2+ movements through this

channel can be altered by changes in the transmembrane ca2+ gradient
or by changes in ca2+ permeability across the plasma membrane.
[Ca 2+] 0 increases,

As

[ca2+li may also increase (35,215) although the

increase may be rapidly buffered so that an increase in [ca2+li may be
transient (38,84).

ca2+ movements across the sarcolemma can also be

increased with the ca2+ ionophores A23187 and ionomycin (26,215,240,

49

266).

These ionophores increase overall sarcolemmal Ca 2 + permeability

which results in a rise in [ca 2 +li (215) as well as increased ca2+
release from the SR and mictochondria (18,120,149,226).
When skeletal muscle is electrically stimulated or depolarized,
Caz+ movements occur through the voltage-sensitive channels as well as
the leak channels.

A slow inward sarcolemmal ca2+ channel (Ica,s or L

channel) is activated during stimulation although its contribution to
the action potential is minimal unless the muscle is repeatedly
stimulated (4,17,116,161,229,375).

Unlike cardiac muscle, Ica,s is

not required for stimulation of skeletal muscle SR ca2+ release and
the subsequent contraction (161).

Another ca2+ current (transient,

Ica,f or T channel) also has been observed in skeletal muscle but its
functional significance is unknown (95,154).

Movements across the

sarcolemma under basal and stimulated conditions can be manipulated.
When extracellular [Ca 2 +]

([Ca 2 +] 0

)

is depleted and muscle is

depolarized, a decrease in [Ca 2 +]i occurs but does not significantly
affect the threshold for action potentials (74) although there is an
increased mechanical threshold and a reduction of maximum contractile
force development (11,269) indicative of effects on excitationcontraction coupling.

Direct stimulation of SR ca2+ release and the

resulting contracture were not affected by the reduction in [ca2+] 0
(74,371).

These results led investigators to conclude that [Ca2+] 0

was required for a localized electric field, which in turn, allowed
charge movement to occur within the membrane following an electrical
stimulus (74).

A portion of charge movement is believed to control SR

2
Ca + release (253,355).

When [ca2+] 0 is replaced with Mg2+,
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excitability of stimulated skeletal muscle is not markedly altered
( 7 4,269).

Absence of (Ca 2 +J 0 without Mg2+ replacement, leads to

depolarization (98,143) which is attributed to loss of plasma membrane
ion selectivity or increased charge density on the external
sarcolemmal surface (74,269).

Thus, the removal of (Ca 2 +J 0 may alter

cellular functions (98,143) but the effects are not necessarily
mediated via alterations in (Ca 2 +li·

As [ca 2 +)

0

is elevated, a

proportional increase in Ica,s occurs (116) although its contribution
to cytosolic ca2+ is probably minimal in comparison to the effect of
SR ca2+ release on [Ca 2 +li·
The slow inward ca 2 + current (Ica s or L channel) in skeletal

'
muscle was first described by Beaty and Stefani (17) in frog skeletal
muscle and more recently in rat (73,116) and rabbit (406) skeletal
muscle.

The Ica f also has been observed in frog skeletal muscle (95)
'
although this may be a tetrodotoxin-insensitive Na+ channel capable of
carrying divalent cations (177).

Specific ca2+ channel agonists and

antagonists have been developed to probe the L channel but not the Ttype channel.

Among the selective ca 2 + channel blockers of Ica,s are

3 families of compounds which act on voltage- and agonist-sensitive
Ca 2 + channels in a variety of tissues (159).

The major families of

Ca 2+ antagonists are the phenylalkylamines (verapamil), dihydropyridines (nifedipine) and benzothiazepines (diltiazem) (159).

The

cations Cd2+, Mn2+, co2+, and Ni2+ also block ca2+ movements through
this channel (73,116,167,177).

Other compounds with less specificity

also reduce channel activity including phenytoin, tricyclic
antidepressants, local anesthetics, catecholamine receptor
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antagonists, opiate antagonists, barbiturates, indomethacin,
reserpine, tamoxifen and antineoplastic anthracyclines (159,167).
ca2+_ ATPase and Na+;ca2+ exchange are believed to constitute
the major efflux processes (35,56,58).
also occurs in skeletal muscle (35).

ca2+ efflux via leak channels
However, its contribution to

total ca2+ efflux is minimal in comparison to ca2+ ATPase and Na+;ca 2 +
exchange (0.5 %/min) and thus contributes little to the regulation of
ca2+i (35).

The characteristics of the ca2+_ATPase have been

characterized in red blood cell and this carrier is part of the E1-E2
family of ATPases which undergo a transient phosphorylation and
subsequent conformational change as part of pump activity (353).
Similar characteristics of the Ca 2 +-ATPase have been reported in other
tissues (38,58,114).

A few studies have reported slightly different

ca2+_ATPase proteins on the sarcolernrna (377) and t-tubules (43).

The

pump functions with a stoichiometry for ca2+/ATP of 1:1 and 2 protons
are exchanged for 1 ca2+ as ca2+ is pumped out of the cell (353).

The

protein responsible for ca2+_ATPase (Mr 138 kDa) activity is
associated with the plasma membrane and ATP plus Mg2+ are necessary
for activity (57,58,353,378).

Calmodulin activates ca2+_ATPase

activity by increasing the affinity of the protein for ca2+ as well as
the Vmax and thus, calcium serves as both an activator and a substrate
(35,57,353).

Other activators of the ca2+ pump include acidic

phospholipids, long chain polyunsaturated fatty acids (58) and cyclic
nucleotide phosphodiesterases (35).

This pump functions as a high

affinity (Km for ca2+ = -1 µMin RBC) (353), low capacity (Vmax = 10
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runol/mg protein in RBCs) system which appears to be responsible for
·
ca2+ when [Ca2+){L is relatively low (35).
pumping
As [Ca2+li increases in most tissues, Na+/ca2+ exchange moves
more ca2+ out of the cell (32,35,257) and some investigators believe
the exchange mechanism is capable of operating in the reverse
direction (i.e. increased intracellular [Na+)) (321).

Most skeletal

muscle Na+/Ca 2 + exchange studies have been performed in frog (55,94)
and barnacle (32,112,257,406) muscle preparations with a few studies
in mammalian skeletal muscle (157,432).

Regulation and

characteristics of the exchanges appear to be similar in these
preparations.

Exchange operates as an electrogenic mechanism with a

stoichiometry of 3Na+/lca2+ and overall it is believed to be a low
affinity (Km for Ca 2 +

=

2-10 µM), high capacity (Vmax > 15 nmol/mg

protein) enzyme that is activated when [Ca 2 +Ji is elevated (58).
Investigators are uncertain about the importance of Na+/ca2+
exchange in vertebrate skeletal muscle (157,432).

A portion of the

uncertainty stems from the complexity of the exchange mechanism itself
and from the numerous cellular processes which regulate exchange
activity (55).

Caputo and Bolanos (55) observed that one component of

Ca 2 + efflux depended on [Ca2+]i, another relied on intracellular
[Na+] ([Na+Ji) and a third component was independent of [ca2+] 0 and
[Na+]i·

In addition, Na+/Na+ exchange also has been observed in

isolated rabbit skeletal muscle sarcolemmal vesicles (157).
Alterations in extracellular [Na+)

([Na+] 0

)

or [Na+Ji affected ca2+

efflux in these vesicles but increased [Na+] 0 and [Na+)i prevented
Na+;ca 2 + exchange and favored Na+/Na+ exchange (157).

In the same
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.
investigators were unable to detect Na+ flux in the
prepara t ion,
presence of a ca 2 + gradient.

Yamamoto and Greef (432) observed that

the basal rate of Na+-dependent 45 ca 2 + uptake in guinea pig atria and
45 ca 2 +
diap h ragm were similar however, increased [Na+Ji· stimulated
uptake in atrial preparations but not diaphragm preparations.

These

and other experiments have shown that the Na+;ca2+ exchange mechanism
is temperature dependent (157), is modulated by Mg2+ (157), can be
influenced by membrane potential (321) and the Na+-dependent Ca 2 +
movements are highly dependent on [ca 2 +Ji (321).

Although Yamamoto

and Greef (432) suggested that most efflux occurs via ca2+_ATPase
causing it to be the sarcolemmal efflux component that regulated
[Ca2+Ji, the complexity of the feedback mechanisms regulating Na+;ca2+
exchange indicate that it may be functionally important, especially
when [Ca 2 +Ji is elevated (157,321).
Mitochondria contain approximately 40% of cellular ca2+ (35) and
appear to buffer large changes in [ca2+li using a ca2+ uniporter for
ca2+ uptake and an independently regulated Na+/ca2+ exchange for the
efflux of ca2+ (305).

A mitochondrial membrane potential across the

inner membrane (-150 to -180 mV) (16) is responsible for the uphill
transport of ca2+ into the mitochondrial matrix via an inner membrane
Ca 2+ uniport protein (35,305).
function of cytosolic [ca2+]

The ca2+ influx increases as a cubic

(305).

A Na+/ca2+ exchanger located on

the inner membrane moves ca2+ out of the mitochondrial matrix and
functions independently of the ca2+ uniport process (305).

Uniporter

and Na+;ca 2 + exchange activities work together to influence [ca2+li
and free [ca2+] in the matrix ([Ca2+lm) (305).
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sarcoplasmic reticulum (SR) contain -90% of the ca 2 + required
e activation of the contractile mechanism in skeletal muscle
for th
(180) .

The activator ca2+ can be can rapidly released and

resequestered by the SR.

These characteristics allow SR to act as the

· le controller of cytosolic free ca2+ in skeletal muscle
princip
(35,322).

Calcium is transported into the lumen of the SR via a Ca 2 +-

dependent ATPase which is primarily located in the longitudinal
cisternae and ca 2 + is released into the cytosol by a ca 2 + release
channel believed to be located on the terminal cisternae of the SR
(425,426).

The SR and sarcolemmal Ca 2 +-ATPases share many

similarities since both are Mg 2 + dependent and form a phosphorylated
intermediate during the ca 2 + transport process.

However, recent

studies have shown that inward Ca 2 + pumping by the SR is accompanied
by the outward movement of K+ (134).

When SR K+ channels are blocked,

H+ and Mg2+ appear to counter balance the ca2+ movements.

Kinetic

studies have shown that the 100 kDa SR ca 2 +-ATPase has a Km of 0.1-1

µM for free ca 2 + (35,56,274) and a Vmax of 0.4-3.6 µmol/mg protein/min
(35,56,322).

The activity of ca2+_ATPase is modulated by

phospholamban (Mr 6-11 kDa) (56,155,221) which can modulate ca2+
transport and ATPase activity (322).

Agents which activate SR ca2+_

ATPase activity such as cAMP-dependent protein kinase and calmodulindependent protein kinase are believed to activate the pump via
phosphorylation of phospholamban, although a recent study suggests
that they act via separate, additive pathways (153).

Once ca2+ enters

the SR lumen, most of it binds to the acidic 16 kDa protein,
calsequestrin (56,274).

This protein allows the SR to store
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uantities of ca 2 + while maintaining free [Ca 2 +] in the SR
millimo 1 a r q
iumen below 100 µM (322).
The mechanism responsible for ca2+ release from the SR is not
completely understood although various agents have been used to probe
its function.

Caffeine or ryanodine stimulate ca2+ release from SR

(l 2 8) and they are believed to maintain a ca2+ release channel in the
open configuration (138,283,302,334).
ryanodine binding (205,314).

Ruthenium red prevents

Cation counter-transport is postulated

.
c a 2+ re 1 ease as we 11 as during ca2+ uptake (134).
to occur d uring
Recently, Imagawa et al.

(205) isolated a 450 kDa, ryanodine-sensitive

protein in the terminal cisternae which is also believe to be the SR
ca2+ release channel (206,334).

A similar function has been ascribed

to a 60 kDa protein by Kim and Ikemoto (231).

In contrast, McWhirter

et al. (281,282) proposed that since many manipulations affect both
ca2+ uptake and release, the release mechanism may be accomplished by
a reversal of SR ca2+_ATPase.

However, many of the ca2+_modifying

agents cited by this group probably modify ca2+ uptake (282) and thus,
indirectly affect ca2+ release by modifying the activator ca2+
available for release.

This hypothesis has been largely discounted by

most investigators (56).

Cellular factors or functions which may

modulate the activity of the ca2+ release channel remain to be
investigated.
Ca 2 + cycling across the SR has physiological importance since
skeletal muscle depolarization results in SR ca2+ release followed by
tension development.

Several hypotheses have been proposed to explain

the mechanism responsible for excitation-contraction coupling.

Some
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investigators indicate that ca 2 + entry during an action potential
acted as a trigger to stimulate SR Ca 2 + release (144).
al.

Veragara et

(388,399) plus Volpe and coworkers (400) propose that

depolarization stimulates the production of inositol 1,4,5
triphosphate (IP3) which subsequently diffuses to the terminal
cisternae of the SR where it binds and causes SR ca2+ release.
Schneider and Chandler (355) were first to postulate that
depolarization stimulates asymmetric charge movement (253) within the
sarcolemmal membrane and subsequently this movement affected" ... long
molecules which extended to the adjacent projections of the SR
terminal cisternal membrane ... " (355), thus stimulating SR ca2+
release.

In support of this concept Cadwell and Caswell (53) isolated

a 300-325 kDa protein which they postulate connects the transverse
tubule to the sarcolemmal SR.

Charge movement may be associated with

ca2+ channels since ca2+ blockers have been shown to modify skeletal
muscle charge movement (253,406) and charge movements in general act
as gating currents for ion channel activation (253).

The hydantoin

analog dantrolene has been shown to block depolarization induced ca2+
release from barnacle muscle (111) and its mechanism of action may
provide increased understanding of excitation-contraction coupling
although dantrolene reportedly acts on both sarcolemmal and
sarcoplasmic reticular ca2+ release (45,46).
In skeletal muscle, most research has focused on the effect that
changing [ca 2 +]i has on skeletal muscle contraction.

In recent years

investigators have observed other ca2+_dependent activities such as,
2
Ca +-calmodulin sensitive proteins in the SR (358) and cytosol (52)
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and protein kinases in skeletal muscle (401).

Several cytosolic ca2+_

calmodulin binding protein in skeletal muscle are associated with
glucose metabolism (52,92,316).

Investigators also have observed that

[Ca2+li influences skeletal muscle proteolysis (148,443).

The

inositol phosphate - diacylglycerol second messenger system is not
well understood in skeletal muscle but has been observed in other
organ systems.

Studies in other tissues have revealed that (Ca 2 +Ji

and calmodulin may influence insulin receptor binding and post-binding
events (166,280), maximal Ica , s activation (30), and modulates cAMPdependent protein kinase activity by increasing phosphodiesterase
activity (352,379).

Many of these reactions remain to be investigated

in skeletal muscle.
4)
muscle.

ca2+ channel antagonists and their effects on skeletal
Specific ca2+ agonists and antagonists have been used to

isolate the ca2+ channel (141,150,151) in order to understand how the
ca2+ channel is activated and inactivated during cell activities.
Using organic Ca 2 + antagonists, investigators found that the Ica , s
channel was restricted to the transverse-tubule (t-tubule) membrane
(130,141,150).
with a

Ka

Binding studies determined that dihydropyridines bind

of 1-2 nM and a Bmax of

phenylalkylamines bind with a

Ka

-so

pmol/mg protein (141),

of 25-30 nM with a Bmax of -S0-70

pmol/mg protein (150,151,158) and benzothiazepines bind with a
35-50 nM and a Bmax of 50 pmol/mg protein (151).

Ka

of

More recently, the

Ca 2 + channel protein has been isolated and its subunit composition
determined with the help of receptor antagonists (64).

All three

types of ca2+ antagonists bind to a 145-170 kDa glycoprotein (64,151).
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Three

maJ·or subunits (a,~,~) of the purified protein have been

isolated using electrophoretic techniques (64,99).

Dihydropyridines

bind to the a-subunit (99), while phenylalkylamines bind to

the~

subunit and benzothiazepines bind to the ~-subunit (64,99).

The

functional significance of each subunit remains to be investigated
(64).

Agonists and antagonists also have been used to characterize

lca,s·
Studies in the early 1980s showed that the dihydropyridine Bay K
8644 enhanced Ca 2 + current in heart (188,247,343) and enhanced 4 5ea 2 +
uptake in Nal08-5 cells under resting and depolarized conditions
(146).

Subsequent studies in skeletal muscle have shown that the ca2+

agonist Bay K 8644 (0.1 µM) enhanced the amplitude of Iea,s' decreased
the time to peak lea s and shifted the threshold for Iea s activation
'
'
to more negative membrane potentials in voltage-clamped (-90 to -30
mV) semi-tendinosus muscles from frogs (204).

Similar results have

been observed in isolated myoballs from newborn rats (90) and rabbit
soleus muscle (253).

Members of all three families of organic

antagonists block voltage-activation of lea s in skeletal muscle (see
'
Table 1).
In skeletal muscles treated with ea2+ antagonists,
saturation binding is observed in the nanomolar range but functional
activity requires 2 to 3 fold higher concentrations (41,357).
Schwartz et al.

Whereas

(357) has postulated that many binding sites do not

represent functional channels, Lamb and Walsh (253) proposed that only

a fraction of the channels are open at any one time which results in a
requirement for higher effective antagonist concentrations.

The only

anomalous compound observed so far has been nitrendipine which binds
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TABLE I.

CHARACTERISTICS OF SKELETAL MUSCLE ca2+ CHANNEL BLOCKADE

Animal model

Muscle

Calcium
antagonist

Range of [ l
or Ka

source

Rana pipiens

sartorius

Verapamil

5 x 10- 6M

(229)

semitendinosus

Diltiazem
Nifedipine

Ka= 80µM
Ka=O. 9µM

(3)

sartorius

PN-200/110

Ka=430nH

(357)

Rana esculenta

semitendinosus

Nifedipine

lOµM

(204)

Newborn rat

thigh myoblast

PN-200/110

sternomastoid

Diltiazem

Rana temporaria
Frog

Rabbit

Verapamil
Nitrendipine

I

I

lo- 12 -l0-5M
lo-4-10-6
Ka=63µM
lOµM
1-lOµM-no
effect

(96)
(406)
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to s k

eletal muscle, but does not appear to have a functional effect on

skeletal muscle Ica,s (357,420).

Although some ca2+ antagonists

ellular activities unrelated to the ca2+ channel, 102 to 103
affect C
higher concentrations than those used in electrophysiological or
mechanical studies must be used before these effects are detectable
(207,407,408).
ca2+ agonists and antagonists also have been used to determine
the role that Ica,s activation and [Ca 2 +Ji play in excitationcontraction coupling and tension development in skeletal muscle.

The

calcium agonist Bay K 8644 was first used in 1983 when Schramm et al.
(356) observed that it increased blood pressure, peripheral
resistance, vascular smooth muscle contraction, and increased
contractility of the heart in vivo and in isolated, perfused
preparations.

Their in vitro studies established that a maximal

response in smooth and cardiac muscle could be obtained with lo-7 to
lo- 6 M Bay K 8644 and the Ec 50 was generally about lo-8 M.
Concentrations greater than 10-6 to 10-5 M tended to decrease cardiac
contractility and aortic contraction.

Subsequent studies in skeletal

muscle found that the ca2+ agonist Bay K 8644 enhanced the slow
component of tension development in frog semitendinosus muscles which
was also associated with the onset of Ica s activation (204).

'
Several investigators also have examined the ability of various
2
Ca + antagonists to block tension development in stimulated muscle and
neuromuscular preparations (10,327,347).

They have observed that ca2+

antagonists enhanced twitch or low frequency tension development in
amphibian and mammalian skeletal muscle (10,145,152,161,346,347,405)
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when

le

a,s

activation was thought to be minimal.

However, direct

pressure injection of Ca 2 + blockers (D-600, nifedipine) into muscle
fibers was without an effect on contraction (279) which suggests that
these agents may potentiate twitch development through membrane
effects unrelated to lca,s·

Nevertheless, lea s is implicated in the

'
development of tetanic contraction and the slow component of tension
development and ca 2 + antagonists do attenuate or block this later

phase of contractile development (145,152,204,346,347).

These results

indicate that the antagonists may have nonspecific effects on short
interval twitch development but activation of lca,s• the ensuing
increase in [Ca 2 +Ji, and the subsequent contractile response can be
blocked by Ca 2 + antagonists.

Calcium antagonists also influence

another aspect of excitation-contraction coupling that may or may not
be related to their effects on ca2+ channels.

Lamb and coworker (253)

as well as Rios and Brum (328) have found that nifedipine (2-lOµM) at
concentrations which affect lea s• decreases charge movement in

'
amphibian and mammalian skeletal muscle and this was associated with a
reduction in SR calcium release (328).

Nifedipine and other

dihydropyridines appear to either independently affect charge movement
and lea s (406-408) or affect a single, dihydropyrinde-sensitive

'

protein responsible for both the charge movement and leas (328).

'
Other ca2+ antagonists such as diltiazem enhance charge movement in
bullfrog semitendinosus muscle (407).

This drug also has been

associated with twitch and tetanic potentiation (161) as well as
attenuation of tetanic responses which may indicate a more complex
association between lea

'

8

and charge movement.
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overall, the results from antagonist receptor binding,
electrophysiological and mechanical studies suggest that under some
.tions voltage-sensitive Ca 2 + current can influence [Ca 2 +Ji and
con d].
influence cellular activities.

The role this channel has under

physiological conditions is not understood since investigators have
shown that it is not required for skeletal muscle mechanical activity.
A report in isolated perfused hearts (110) indicated that Ca 2 +
blockers affect glycolysis although the mechanism may be indirect.

An

earlier report (72) in skeletal muscle reported that verapamil
attenuated high K+-induced increases in respiration although
contraction was not affected which suggests that Ica s may cause

'
direct or indirect (e.g. via localized changes in [Ca 2 +Ji) effects on
metabolism.
5)

Pathophysiology associated with changes in one or more ca2+

controller functions or [Ca2+li·

Calcium regulation is altered in

several pathophysiological conditions which are in some cases
associated with metabolic abnormalities.

Scales et al.

(351) observed

that the maximum ca2+ capacity of the SR was significantly reduced
along with the SR protein/lipid ratio in a chicken model of muscular
dystrophy.

However, SR ca2+ uptake and ATPase were unaffected in this

model so the authors concluded that the altered capacity to accumulate
2
Ca + may be responsible for previously observed defects in excitationcontraction coupling (338).

Joffee et al.

(217) observed that

denervation increased basal levels of mitochondrial ca2+ and reduced
the capacity of mitochondria to accumulate ca2+ prior to uncoupling of
oxidative phosphorylation.

After denervation, the responsiveness of
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skeletal muscle glucose metabolism to insulin also is diminished
( 389 ).

They postulated (217) that mitochondrial alterations were due

to this organelle's attempt to buffer [ca2+li which increased when an
unregulated ca 2+ influx developed across the sarcolemmal membrane.
Increased sarcolemmal ca 2 + permeability was postulated to cause
alterations in cellular Ca 2 + regulation in muscles exposed to ca2+_
free media (372) and muscles from malignant hyperthermic pigs (329).
Studies in rats made diabetic with streptozotocin treatment indicate
that diabetes is associated with a reduction in sarcolemmal Na+;K+
ATPase activity (238), increased cellular (Na)+ and decreased [ATP)
(294).

Moore (292) also observed that insulin stimulated Na+;H+

exchange and thus the changes in skeletal muscle [Na+)i found during
the course of diabetes also were attributed to changes in Na+;H+
exchange.

Although neither group examined the subsequent effect of

[Na+Ji on [Ca2+li in the diabetic skeletal muscle, it is possible that
a reduction or reversal of Na+;ca2+ exchange may have resulted from
the increased [Na+]i such that there was an increase in [ca2+li·

In

support of this idea is the increased SR Ca2+ uptake and ca2+_ATPase
activity observed in similarly treated diabetic rats (153).

Longer

intervals of diabetes have been associated with a decrease in SR ca2+
uptake (123) and may signal an inability of the SR to maintain a
compensatory increase in ca2+ uptake over a prolonged interval of
increased [ca2+li·
Studies in various animal models of septic shock suggest that
alterations in ca2+ regulation also may occur in some organ systems
during this disease state.

Nelson and Spitzer (300) observed an
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exchangeable ca2+ in adipocytes from endotoxic rats.
increase ;n
L
Although they determined that the increase was due to a change in ca2+
bound to the extracellular glycocalyx (300), other investigators have
reported that cellular exchangeable ca2+ increased in livers and
skeletal muscle from endotoxic rats (122,348).

These changes were

attributed to alterations in cytosolic, mitochondrial or endoplasmic
reticulum (ER)/SR pools of Ca 2 + (122,348).

In subsequent studies,

Sayeed and Maitra (350) reported that resting cytosolic free (Ca 2 +J is
elevated in hepatocytes isolated from endotoxic rats.
Earlier investigators have provided evidence that ca2+ movements
across the plasma membrane, ER/SR and mitochondria were altered in
numerous organ systems during the septic shock and these alterations
may contribute to the changes in [Ca2+li·

In 1971, Hess and Briggs

(186) observed that myocardial SR ca2+ uptake was significantly
depressed when endotoxin was added to the media.

When endotoxin was

added to a heart-lung preparation myocardial SR Ca2+ uptake also
decreased (187).

Similar results were reported by Hulsman et al.

(201) in myocardial SR and by Sayeed (348) in microsomes isolated from
rat liver.

In addition, Hulsman et al.

(201) found that sarcolemrnal

Ca 2+-ATPase-induced movement of ca2+ was decreased after the addition
of endotoxin.

In contrast, ca2+ uptake increased in liver microsomes

isolated from acutely- and chronically-treated endotoxic rats (373).
Initial exposure to endotoxin in the chronic rats appeared to increase
hepatic endoplasmic reticulum (ER) ca2+ uptake and ca2+ content but a
similar effect was observed with the vehicle used for chronic
administration of endotoxin (osmotic pump) which prevented
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investigators from ascertaining the effects of endotoxin alone.

In

contrast, Sayeed (348) reported that ca2+ uptake was not affected in
ER isolated from acutely endotoxic rats at a time when exchangeable
ca2+ and cytosolic free ca 2 + (350) were increased in similarly treated
rats.

These results suggest that alterations in ER/SR Ca 2 + uptake

probably did not cause the change in [Ca 2 +Ji but may eventually be
affected by alterations in [ca 2 +li·

In addition, it would appear that

a direct effect of endotoxin was not responsible for the in vivo
changes which occurred in ca2+ uptake.

Alterations in calcium release

from the ER/SR during sepsis and septic shock also has been studied.
In hepatocytes isolated from endotoxic rats (acute), the ability of an
agonist (ie a-agonist, vasopressin) to transiently raise [Ca2+li was
markedly attenuated and this was attributed to a decrease in the
ability of the ER to release ca2+ (109,272).

Comparable results were

observed in hepatocytes from bacteremic rats given b· coli (273).

In

liver slices, norepinephrine-induced ca2+ efflux also was reduced in
slices from endotoxic rats (348).

These results suggest that ER ca2+

release may contribute to alterations in the regulation of ca2+ during
septic shock.
Studies of mitochondria indicate that this organelle also may
contribute to changes in cellular ca2+ regulation in endotoxic
animals.

Mela (284) reported that kidney mitochondrial ca2+ uptake

was reduced 75% in the presence of endotoxin.

In addition, ca2+

uptake in liver, brain, and kidney mitochondria was significantly
reduced 16-20 hrs after rats received an LD70 dose of b· coli
endotoxin (284).

Spitzer and Deaciuc (373) observed no change in
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mitOC

hondrial ca2+ uptake when livers were removed from acutely- and

chronically-treated endotoxic rats.

These results suggest that

perturbations in cellular Ca 2 + regulation may occur prior to changes
in mitochondrial handling of ca2+.
several studies indirectly suggest that ca2+ movements across
the plasma membrane may influence [ca 2 +Ji during septic shock.
Administration of ca 2 + channel antagonists to septic or endotoxic
animals prevents many of the changes in cellular ca2+ regulation or
ca2+_dependent processes.

Administration of diltiazem along with

endotoxin attenuated the increase in resting hepatocyte (ca2+]i and
restored the ability of an a-agonist to stimulate a transient rise in
(Ca2+li (350).

Diltiazem administration also prevented the

attenuation of IP3-mediated increase in (ca2+]i (272).

These results

suggest that alterations in plasma membrane ca2+ movements may alter
(Ca2+li and subsequently affect the ability of the ER to release ca 2 +.
Administration of ca2+ blockers also has improved survival in
endotoxic rats (122) and in bacteremic mice (40).

The ca2+ blocker

verapamil reduced endotoxin-stimulated production of prostaglandins
and thromboxanes in sheep (1).

The authors postulated that these

agents were responsible for changes in pulmonary mechanical and
hemodynamic functions during endotoxin shock.

Indeed, verapamil not

only reduced the eicosinoid production but also prevented or
attenuated the alterations in mechanical and hemodynamic functions
associated with endotoxin administration.

These results suggest that

plasma membrane ca2+ movements may be altered in several organ
systems.

CHAPTER II
3-0-METHYLGLUCOSE TRANSPORT IN SOLEUS MUSCLE OF BACTEREMIC RATS
A.

INTRODUCTION

Several clinical studies indicate that sepsis is associated with
carbohydrate metabolic alterations (88,175).

Septic patients are

frequently found to be glucose intolerant (88,175).

Similar results

were obtained in animals exposed to bacteremia (193,319).

The

carbohydrate metabolic alterations appear to be due to an imbalance
between glucose production and glucose utilization.
Overall glucose utilization appears to be elevated (429) or
unchanged (361) during endotoxemia or bacteremia when metabolic
clearance rate is measured.

Individual organs, such as adipose tissue

and blood cells appear to utilize glucose at an accelerated rate
(132,191).

Several studies on skeletal muscle have shown alterations

in basal and insulin-stimulated glucose utilization (132,274,325,326,
420).

Derangements in carbohydrate metabolism in skeletal muscle may

have serious consequences in septic patients as this organ plays a
major role in maintaining metabolic homeostasis.
The locus of the skeletal muscle metabolic defect may be one of
the control points during glucose metabolism, including glucose
transport, hexokinase, phosphofructokinase and/or pyruvate
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dehydrogenase.

Recent studies by Vary et al.

(397) observed that the

active form of hindlimb muscle pyruvate dehydrogenase (PDH) is
decreased during chronic sepsis.

Other investigators reported that

insulin stimulation of PDH also was depressed in septic muscle (337).
Membrane glucose transport is the first rate-limiting step and defects
in this step influence substrate availability to glycolysis and the
tricarboxylic acid (TCA) cycle.

A defect in glucose transport may

also exacerbate muscle PDH activity and energy availability.

The

purpose of this study was to investigate the affect of bacteremia on
soleus muscle membrane glucose transport in the presence and absence
of insulin.

Glucose transport was measured in soleus muscles under in

vitro and in vivo conditions using the nonmetabolizable glucose analog
3-0-methylglucose.
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B.

1)

Animal model:

MATERIALS AND METHODS

Male Holtzman rats weighing 80-100 g (4 wks

old) were fasted (15 hours, 4 p.m. - 7 a.m.) prior to the experiment
and allowed water ad libitum.

Bacteremia was induced in fasted rats

by an intraperitoneal (ip) injection of Escherichia coli (4 x 10 10
organisms/kg body wt., 0.5 ml) under light ether anesthesia.

Control

rats were fasted along with the bacteremic rats and were killed at the
same time.

Rats were killed by decapitation at 8 and 12 hours after

injection for the in vitro study.

Blood samples were collected in

heparin-lithium-fluoride coated tubes (Beckman Instruments, Inc.) for
analysis of plasma glucose and lactate and soleus muscles were rapidly
excised.
For the in vivo study, rats (80-100 g) were fasted (15 hrs) and
then

administered~.

coli bacteria, intraperitoneally (ip).

fasted control rats were injected with saline ip.

Pair

At 12 hrs post-

injection, blood samples and muscles were collected under ether
anesthesia and then rats were killed.

Blood samples were analyzed for

plasma glucose, lactate and 1 4 c-3MG.
2)

Preparation of E. coli:

&..,,. coli 25922 (American Type Culture

Collection, Rockville, MD) was maintained on blood agar plates and
transferred periodically.

Brain-heart-infusion (BHI) slants

containing bacteria obtained from blood agar plates were used to seed
BHI broth.

Prior to injections &..,,. coli was grown sequentially in two

5 ml tubes of BHI broth and the second tube was used to inoculate 500
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ml of BHI broth.

This culture flask was incubated for 12 hrs and all

cultures were incubated at 33°C in a Lab-line incubator (model 417).
To harvest bacteria, aliquots of bacterial suspension were centrifuged
for 10 minutes in sterile centrifuge tubes at 8600 x g in a Sorvall
centrifuge.

The supernatant was removed and pellets were resuspended

in sterile, isotonic saline and pooled.

The number of bacteria

present in the suspension was estimated using absorbance at 620 nm as
an indicator of bacterial number.

Serial dilution and pour plate

methods were utilized to determine absolute bacterial concentration.
3)

Plasma measurements:

Blood samples collected from decapitated

rats were immediately centrifuged in a Beckman Microfuge (model 12) at
11200 x g for five minutes.

Plasma samples were stored at

they were assayed for plasma glucose and lactate.

o0 c

until

For in vivo

experiments, blood was collected from the abdominal aorta in
anesthetized rats and treated in a manner comparable to decapitated
rat blood.

Plasma glucose was determined using a YSI 23A glucose

analyzer (Yellow Springs Instruments, Inc.) while plasma lactate was
analyzed with a YSI 23L lactate analyzer.

Duplicate readings were

obtained for each plasma sample.
4)

In vitro soleus muscle 3MG efflux:

The glucose transport

system was evaluated by measuring the efflux of 1 4 c-3MG from muscles.
Isolated soleus muscles were incubated in a 'loading' media of 3.0 ml
Krebs-Ringer-bicarbonate buffer (KRB, pH 7.4) containing 118 rnM NaCl,
1.2 rnM Mgso 4 , 1.2 rnM KH 2 Po 4 , 4.7 rnM KCl, 2.5 rnM Cacl 2 , 24 rnM NaHco 3
plus 2.3 rnM pyruvate, 2.0 rnM 3-0-methylglucose (3MG, Sigma) and 4 µCi

°f

14

C-3MG (Amersham, 0.65 µCi/mmole).

All incubations were carried
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out at 37°c in a metabolic shaker bath.

Each vial was capped with a

rubber stopper which was attached to a manifold for continuous
oxygenation with a humidified 95%02:5%C0 2 mixture.

After muscles were

loaded for a 60 min period, which results in a steady state
equilibrium of 3MG, they were washed in radioisotope-free KRB media at
3 7oc.

Washes were carried out by sequentially transferring muscles

through a series of vials containing 2.5 ml of wash media.

When

insulin was used, it was included at a concentration of 10 mU/ml in
the wash vials.

Soleus muscles incubated in this manner are viable up

to 240 minutes using viability indicators such as excitability,
intracellular K+ concentration and oxidation of pyruvate to C02 (246).
In addition, previous studies in our laboratory have shown that this
in vitro muscle preparation exhibited active amino acid transport for
up to 180 minutes at 37°c (223).

At the end of the washout, muscles

were lightly blotted on filter paper (Whatman #42) and weighed after
removing any tendon attached to the muscle.

Muscles were digested

overnight in 2.0 ml of tissue solubilizer (TS-1, Research Products
International) at 55°C.

The radioactivity in 2.5 ml of washout media

and digested muscles were counted in a liquid scintillation counter
(Packard Tri-Garb 460) and corrected for quenching.
The muscle counts were added to successive media counts in a
retrograde manner to quantify radioactivity remaining in the muscle at
various times during the washout.

14c-3MG efflux curves were

constructed by plotting base 1 o logarithm of muscle radioactivity
(DPM/g) versus washout time.
biphasic.

The efflux curves were invariably

The initial, rapid phase represented 14c-3MG efflux from
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the extracellular compartment (78,246).

This was followed by a

prolonged monoexponential efflux phase representing the transport of
radiolabel from the intra- to extra-cellular compartment.
Extrapolation of the monoexponential portion of the curve back to the
y-axis yields the size of the cellular 3MG compartment at the end of
the 'loading' period.

The cellular 3MG compartment size representing

steady state cellular uptake of 3MG, was expressed as µmole/g muscle.
The slope of the monoexponential portion was used to calculate the
rate coefficient (A) or the fractional efflux value in units of min- 1
(78) while the half life (t1;2) of the monoexponential phase of efflux
was equal to 0.693 /A.

The

values were estimated also by taking

the proportion of 14 c-3MG leaving the muscle cell per unit time for
each wash interval as given below:
(Initial DPM/g

5)

Final DPM/g)/(Initial DPM/g)
5 minutes

In vivo soleus muscle glucose uptake:

Ten to 40 minutes prior

to killing the control and bacteremic rats, they were injected iv with
0.5 ml of a solution containing insulin (50 mU/ml; Sigma, crystalline,
porcine), bovine albumin, fraction V (0.01%), unlabelled 3MG (50 mM)
and 14c-3MG (8 µCi/ml).

At 12 hours after the bacterial or saline

injection, rats were anesthetized and then blood samples and soleus
muscles were quickly removed.

Muscles were weighed after removing

tendon and were then placed in tissue solubilizer and digested
overnight in a water bath at 55°C.

Blood was centrifuged and the

plasma was assayed for metabolites as described in the plasma
metabolite section.

A 0.1 ml aliquot of plasma was mixed with 1.0 ml

73
of tissue solubilizer and incubated overnight at room temperature.
Muscle and plasma sample radioactivity was counted in the liquid
scintillation counter.
14c-Inulin was used to determine extracellular (ECS) and
intracellular (ICS) spaces in soleus muscles for calculating intraand extra-cellular 14 c-3MG concentrations.

ICS and ECS were

determined in both control and bacteremic rats under basal and
insulin-stimulated conditions.

To determine ECS and ICS, rats were

nephrectomized under ether anesthesia at 11 hours following injection
of saline or bacteria to prevent clearance of inulin (424).

For

nephrectomy, dorsal lateral incisions were made, kidneys were exposed
and excised after ligating the renal arteries.

Wound clips were

placed over the incisions and rats were allowed to recover.

Thirty

minutes later, 0.5 ml of saline containing 1 4 c-inulin (Amersham, 11.4
mCi/mrnol, 2 µCi/ml) with or without insulin (50 mU/ml) was injected
iv.

Thirty minutes after injections (12 hours after bacteria or

saline injection) rats were again anesthetized with ether to collect
blood and soleus muscles which were weighed immediately after removal.
Blood samples were centrifuged (11200 x g, Beckman Microfuge 12) and
0.1 ml plasma samples were digested in 1.0 ml of tissue solubilizer.
Meanwhile, muscles were dried in a Thelco vacuum oven (model 10) at
l00°c to determine the wet weight/dry weight ratio.

Muscles were

subsequently rehydrated with 0.1 ml of distilled water for 3 hours
before they were digested in tissue solubilizer overnight at 55°c and
their radioactivity determined.

Total, extracellular and

intracellular water were calculated as shown below:
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Total tissue water
(ml/g)

=

(wet wt. - dry wt)/wet wt.

Extracellular space (ECS)
(ml/g)

musclel4c-inulin (DPM/g)
plasma 14c-inulin (DPM/ml)

Intracellular space was determined from the difference between total
tissue water and extracellular water.

The cellular space measurements

in 12 hr control and bacteremic rat muscles were similar to those
values reported by Karlstad and Sayeed (224) for control and endotoxic
rat muscles, respectively.
Based on cellular space measurements, the intracellular and
extracellular contents of 14 c-3MG were determined.

Extracellular 14 c-

3MG content ([ 14 c-3MGlextracell) was calculated by dividing the plasma
concentration of 1 4 c-3MG by the specific activity of 1 4 c-3MG.
Intracellular 14c-3MG was then determined by using the following
equation:
[ 14 c-3MGJintracell=(Total muscle 3MG DPM/g)-(Extracell. 3MG DPM/g)
(nmol/ml)
(14c-3MG Specific activity DPM/nmole)
(Intracell. space ml/g)
The ratio of [14c-3MG] in the intracellular to extracellular space,
referred to as the distribution ratio (DR), indicates facilitated
sugar transport when <1.0 and uphill movement of sugar into the cell
when >1.0.
Statistics:

Plasma glucose and lactate values in control and

bacteremic rats were compared using a Student's unpaired t test.

In

Vitro fractional efflux data was analyzed using a two factor analysis
of variance (ANOVA), Tukey's multiple comparison test and a Trends
analysis.

In vitro washout curves (DPM/g) were fitted using linear

regression analysis and the y-intercept (3MG compartment size) and
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rate coefficients derived from the slope were compared using a
Student's unpaired t test.

In vivo data was analyzed using a 3 factor

ANOVA followed by a Tukey's multiple comparison test and a Trends
analysis on the SAS statistical computer package (Cary NC). All data
is expressed as mean±SEM.

A p<0.05 was considered significant.
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C.
1)

Lethality study:

RESULTS

The lethality associated with various

bacterial concentrations was established (Table 1).

We chose 4 x 1010

organisms/kg body wt. as the working dose for the metabolic studies.
At this dose, the mortality was 3% at 8 hours (1/28), 53% by 12 hours
(15/28) and 71% by 24 hours (21/28).

These rats exhibited typical

signs of sepsis including porphyrin secretion by lacrimal glands,
piloerection and lethargy.

Blood cultures were positive for Gram-

negative rods in similarly treated rats (Table 2).

Bacteria were not

present in blood taken from control rats.
2)
study:

Plasma glucose and lactate in rats used for in vitro muscle
In 8-hr bacteremic rats, plasma glucose was moderately

elevated above the time-matched control values (Fig. 1).

However, 12

hours after bacterial injection plasma glucose was the same in control
and bacteremic rats.

Although plasma glucose did not change markedly,

there were marked changes in plasma lactate levels with bacteremia.
In 8- and 12- hr bacteremic rats, plasma lactate was elevated 2-fold
above the time-matched control levels.
3)

In vitro soleus muscle 14 c-3MG efflux:

The biphasic efflux

of 3MG was apparent in curves shown in Figs. 2 and 3.

Efflux curves

were similar to those described by Clausen and colleagues (78,246).
The slow efflux phase was linear in each group (Figs. 2,3) indicating
transport of 3MG out of a single cellular compartment.

Correlation

coefficients (r2) for linear regressions and their significances are
also given in Figs. 2 and 3.

Calculation of t 1 ; 2 from the regressed

lines yielded values ranging between 25 to 30 minutes in the four
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Table 1.

Twenty four hour lethality of fasted rats given various

doses of bacteria, i.p.

E. coli CFUt x 1010/kg

%

lethality

Number of rats

CFU

colony forming units.

2

4

6

20

71

75

100

5

28

12

12

8

78

Table 2.

Number of colony forming units (CFUs) of Gram-negative rods

found in the blood of rats injected with 4xlol0 organisms/kg body wt.
at 6, 12 or 18 hours post-injection.

Values are rnean±SEM for rats (n)

injected with 4 x 10 10 organisms/kg body wt.

Hours post-bacterial

CFUs/ml blood

n

injection
i

6

3. 8±1. 7 xl06

7

12

5.0±4.8 xl08

5

18

1. 0±0. 7 xl06

5
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samples shown inside each bar.

samples;~Bacteremic

blood samples.
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test.
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Figure 2.

Amount of 14 c-3MG radioactivity (DPM/g) appearing in efflux

media during each 5 minute washout period in 8-hr fasted control (A)
and bacteremic (B) rat muscles.

Values are mean±SEM.

Linear

regression equations were used to derive the rate coefficient (A), yintercept and correlation coefficient (r2) from the 30 to 90 minute
interval for both groups. The significance of each correlation was
determined using a Student's t test (p value).

Control (n=l8),

A

0.025 min-1, y-intercept=357,190 dpm/g, r2=0.70 (p<0.001); Bacteremic
(n=20),

A =0.027 min-1, y-intercept=383,795 dpm/g, r2=0.70 (p<0.001).

A and y-intercept values were not different in control and bacteremic

rat muscles (p>0.05).
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Figure 3.

Amount of 14 c-3MG radioactivity (DPM/g) appearing in efflux

media during each 5 minute washout period in 12-hr fasted control (A)
and bacteremic (B) rat muscles.
described in Fig. 2.

Data was analyzed by the same method

Control (n=8), A = 0.020 min- 1 , y-intercept =

272,897 dpm/g, r2=0.70 (p<0.001) and; Bacteremic (n=8),
rnin-1*', y-intercept = 457,685 dpm/g *', r2=0.55 (p<0.05).

A = 0.029
*'using a

student's unpaired t-test, both A and 3MG content (y-intercept) were
significantly increased (p<0.05) in bacteremic rat muscles compared to
time-matched control muscles.
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Calculation of t1;2 from the regressed

· en in Figs. 2 and 3.
also giv

· lded values ranging between 25 to 30 minutes in the four
lines yie
treatment gro ups .

A t1;2 of 30 minutes for cellular efflux would

result in a near complete filling of the cellular compartment during
the 'loading' period of 60 minutes.
The size of the cellular 3MG compartment at steady state was
similar in noninsulin-treated muscles from 8-hr bacteremic and timematched control rats (Fig. 2).

However, 12 hours of bacteremia was

associated with a larger 3MG compartment compared to its time-matched
control (Fig. 3).

The slope of the entire cellular portion of the

efflux curve was used to calculate the rate coefficient of efflux.
There was no difference between rate coefficients from 8-hr control
and bacteremic rats (Fig. 2).

However, the rate coefficient was

significantly higher in 12-hr bacteremic rat muscles compared to the
time-matched control values (Fig. 3).
Fig. 4 illustrates the time course of 14 c-3MG fractional efflux
from sequential washout measurements in soleus muscles from 12-hr
time-matched control rats.

This figure also shows the effect of

insulin on 3MG fractional efflux.

Data obtained in the absence of

insulin were comparable to those obtained for other control and
bacteremic rat muscles, in that the fraction of radiolabel leaving the
cell (i.e. the rate coefficient) became relatively constant by 35
minutes of washout and remained so for the next 60 minutes.
Fractional effluxes (i.e. rate coefficients) from 30 to 70 min washes,
shown in Figs. 5 and 6, allowed comparisons of cellular effluxes from
various control and bacteremic rat muscles.

Basal fractional efflux
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Figure 4.

Fractional efflux of 14 c-3MG/g soleus muscle from fasted 12

hour control rats.

Fractional efflux of radiolabel 14 C-3MG was

calculated for each 5 minute interval as described in the Methods
section.

Fractional efflux remained relatively constant between 35

and 90 minutes in non-insulin treated muscles (n=8).

Insulin (10

mU/ml) transiently stimulated fractional efflux when it was added to
the washout media between 50 and 90 minutes.

Similar curves were

obtained for 12-hr bacteremic, 8-hr bacteremic and time-matched
control rat muscles (data not shown).
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Figure 5.

Basal (A) and insulin-stimulated (B) 14c-3MG fractional

efflux in soleus muscles from fasted 8-hr control (~,A-n=l8, B-n=lO)
and bacteremic ((), A-n=20, B-n=lO) rats.

Values are mean±SEM.

bacteremic group values were not significantly different from
corresponding controls (p>0.05, 2-factor ANOVA).
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Figure 6.

Basal (A) and insulin-stimulated (B) 14c-3MG efflux in

soleus muscles from 12-hr bacteremic ((),A-n=8, B-n=l7) and timernatched control (~, A-n=8, B-n=23) rats.

Values are mean±SEM.

Using a 2-factor ANOVA, basal 1 4 c-3MG efflux was elevated while
insulin-stimulated efflux was depressed in muscles from 12-hr
bacteremic rats compared to time-matched control muscles.
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in muscles from 8-hr bacteremic and time-matched control rats was not
different (Fig. SA).

Similar fractional efflux values were also

observed after insulin stimulation of muscles from 8-hr bacteremic and
time-matched control rats (Fig. SB).

Basal fractional efflux in 12-hr

bacteremic rats was significantly elevated compared to time-matched
control muscles (Fig. 6A).

The basal fractional efflux values shown

in Figs. S and 6 were comparable to slope derived rate coefficients in
Figs. 2 and 3.

Insulin-stimulated fractional efflux was depressed in

muscles from 12 hour bacteremic rats compared to time-matched controls
(Fig. 6B).

These data indicate that 12 hours of bacteremia inhibits

the ability of insulin to stimulate glucose transport.

The response

to insulin in 8-hr time-matched control rat muscles was different from
that observed in muscles from 12-hr control rats.

This could be due

to the difference in the duration of fasting and emphasizes the need
for time-matched control measurements.
4)

In vivo 3MG transport - To determine if alterations in

muscle sugar transport were present in vivo, 14c-3MG DRs were measured
in intact 12-hour bacteremic and time-matched control rats between 10
and 40 minutes after giving an injection of 14c-3MG with or without
insulin.

The DR increased linearly over time under basal conditions

in both control and bacteremic rats (Fig. 7A).

Basal DRs were not

different in muscles from bacteremic rats compared to control muscles
at any time point (p>O.OS) (Fig. 7A).

Insulin stimulation of 3MG

transport was apparent by 10 minutes after 3MG plus insulin
administration in both groups (Fig. 7B).

At 3S and 40 minutes, DR

exceeded 1.0 in control muscles but not in bacteremic muscles.

An
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Figure 7.

DR of [3MGlintrace11/[3MGlextracell in soleus muscles

between 10 to 40 minutes post- 14 c-3MG injection in fasted 12 hour
saline-injected([]) and bacteremic
absence of insulin.

<II)

rats in the presence and

Number of muscles shown inside each bar.

Basal DRs in control and bacteremic rats;

B: DRs in muscles from

insulin-treated (250 mU/kg) control and bacteremic rats.
mean±SEM.

A:

Values are

Comparisons between groups were carried out using a 3-

factor ANOVA followed by a Trends analysis for time comparisons and
Tukey's multiple comparison test for treatment and hormone
interactions with p<O.OS('tf) considered significant.
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analysis of variance determined that at these two time points, DRs in
muscles from bacteremic rats were significantly decreased compared to
control DRs.

These data indicate that insulin-stimulation leads to

uphill transport of sugar in controls but not in bacteremic rat
muscles.
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D.

DISCUSSION

In this study, a bacteremic model of Gram-negative sepsis was
used and verified by identifying Gram-negative rods in cultures of
blood (Table 2).

This model is similar to one described by Short et

al. with 70% lethality by 24 hours (364).

Although hypoglycemia was

not evident a marked lactic acidosis developed (Fig. 1), indicating
alterations in carbohydrate metabolism in this model of sepsis.

A

similar hyperlactacidemia has been reported in other bacteremic animal
models (193,364,420) and has been attributed to an overall increase in
anaerobic glucose metabolism (193).
Alterations in carbohydrate metabolism during sepsis have been
observed both clinically and experimentally (88,175,193).

Although

some investigators have not observed alterations in muscle glucose
utilization during sepsis (361), others have documented changes in
overall muscle glucose utilization and in pyruvate dehydrogenase
activity (274,325,326,397).

Alterations in glucose transport may also

contribute to changes in muscle glucose utilization.
To study glucose transport, glucose analogs such as 3MG or 2deoxyglucose (2DG) are used.

3MG is the preferred analog (366)

because it is transported but not further metabolized while 2DG is
transported and phosphorylated by hexokinase.

Under pathological

conditions, phosphorylation may also be a rate-limiting step and thus,
may complicate interpretation of changes in the transport process.
study 3MG transport in vitro, we used the technique of Clausen and

To
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colleagues (227,246) which measures 3MG efflux.

The efflux technique

allows the measurement of both the rate coefficient of the transport
pro

cess and the steady state cellular uptake of 3MG (246).
A change in rate coefficient reflects alteration(s) in the

transporter independent of any change in fluxes due to altered
substrate concentrations (78).

In the absence of insulin, rate

coefficients calculated from the slope of the monoexponential efflux
curve (Figs. 2,3) and from individual wash-out periods (Figs. 5,6)
were within 5% of each other in all groups of muscles.

Due to the

transient effect of insulin on 14 c-3MG efflux, the slope of the
monoexponential curve was not an adequate indicator of the insulin
effect.

Instead,

A derived from individual washouts gave a better

resolution of the insulin effect.
Fractional efflux curves obtained in this study (Figs. 5,6) were
qualitatively similar to those described by Kohn and Clausen (245,246)
although quantitative differences can be found between the two
studies.

Basal rate coefficients ranged from 0.015 to 0.025 min-1 in

the present study while Kohn and Clausen measured slightly lower
values.

This difference was most likely due to differences in

incubation temperatures.

In both studies, maximal doses of insulin

(10-100 mU/ml) produced a 4-fold increase in rate coefficients in
muscles from control rats (246).
The technique for measuring 14c-3MG transport in vivo in this
study was similar to the one described by Hom et al. (197,198).

One

limitation of their method was that changes in plasma glucose could
alter the uptake of sugar analogs due to competition between
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strates (197,249).

In the present study, the influence of plasma

iucose changes was eliminated by calculating the distribution ratio

g

of intracellular to extracellular 3MG concentrations rather than the
cellular uptake.

The time course of insulin stimulation of soleus

muscle sugar transport in the present study was similar to that found
by Hom et al.

(198).

They found maximal stimulation was obtained

between 30 to 60 minutes following the injection of insulin.
The in vitro measurements revealed that basal and insulinstimulated glucose transport was not affected by 8 hours of
bacteremia.

At this time point, rats developed hyperlactacidemia but

lethality was still very low (3%).

Although the increased plasma

lactate indicated metabolic changes, muscle membrane sugar transport
was presumably unaffected (Figs. 2,5).

After 12 hours of bacteremia,

a consistent increase in basal 3MG transport was observed under in
vitro conditions compared to time-matched control muscles (Figs. 3,6).
The increased basal transport was evident from measurements of both
rate coefficients and steady state cellular 3MG uptake.
possible mechanisms may explain this result.

Several

Previous studies

(28,245,369) have shown that an increased influx of Na+ in muscle
resulted in increased basal sugar transport.

In septic animals,

membrane permeability to Na+ (PNa) has been shown to increase in
skeletal muscles (137) which may account for the observed increase in
basal sugar transport found in vitro after 12 hours of bacteremia.
Other investigators have shown that elevated basal glucose oxidation
could be due to monokines (362) which are released during sepsis
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(Z67).

The trend for elevated basal glucose transport under in vitro

conditions was not found in the in vivo experiment.
The complexity of whole animal experiments probably led to
different results between the in vivo and in vitro experiments.
Hormonal or membrane compensations present within the animal but not
in the in vitro media may account for the discrepancy in results.
Catecholamines are elevated in septic rats (219,319,361) and both
epinephrine (E) and norepinephrine (NE) stimulate the Na+/K+ ATPase
pump (82,136).

In vitro muscles were probably not under the influence

of catecholamines since transport was measured after a 60 min loading
period.

As a result, the increased PNa present in septic muscle (137)

may result in elevated sugar transport under in vitro conditions.

The

elevated catecholamine levels present under in vivo conditions may
restore the transmembrane Na+ gradient in bacteremic rat muscles and
return basal sugar transport to the same level found in control rat
muscles.
Despite the elevation in basal 3MG transport under in vitro
conditions, insulin-stimulated transport was depressed in muscles from
12 hour bacteremic rats compared to time-matched controls (Fig. 6).
The diminished insulin-mediated response occurred when both lethality
(50%) and plasma lactate were markedly increased.

Thus, continued

metabolic deterioration during the course of bacteremia may lead to
adverse changes in membrane sugar transport and in turn, lead to
muscle glucose metabolic defects and augmented lethality.
Generally, skeletal muscle glucose transport is thought to be a
facilitated diffusion process and not a concentrative process.

In
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the increase in DR above unity, in vivo, in muscles from
'

. -treated control rats suggests a concentrative process (Fig.

insu 1 1n

7).

However, the mechanism of this process remains unknown.

The

finding of DR values being equal or less than unity in muscles of
insulin-treated bacteremic rats may indicate an abrogation of the
"concentrative" process.
Insulin receptor or post-receptor defects may be responsible for
the decrease in insulin-mediated sugar transport observed in vitro and
in vivo.

Insulin receptors may be down-regulated subsequent to a

bacteremia-induced hyperinsulinemia (319).

Post-receptor changes

including decreased insulin-mediated tyrosine kinase activity or
altered intracellular signaling may also be responsible for the
decrease in insulin-mediated sugar transport.

The absence of any

observable change in basal and insulin-stimulated sugar transport in
muscles from 8 hr bacteremic rats may be due to an absence of any
alterations in the PNa> insulin receptor or post-receptor defect at
that stage of bacteremia.
Altered glucose utilization during sepsis has been the subject
of numerous investigations.

The inappropriately low peripheral

glucose utilization observed in septic and surgical patients (88,175)
has been attributed in large part, to decreased skeletal muscle
glucose utilization (88,326).

More recent studies indicate that

peripheral glucose utilization was actually increased following
endotoxin administration and therefore, muscle glucose utilization was
probably elevated (429).

Several other investigators have directly

documented changes in muscle glucose utilization during sepsis.
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Elevated basal glucose utilization has been reported in rat soleus
muscles following cecal ligation and puncture (CLP) (420).

Filkins

and Figlewicz (132) also reported elevated glucose uptake in
diaphragms from endotoxic rats.

The results of the present study

support increased basal muscle glucose utilization previously observed
during sepsis.

Previous studies have shown insulin stimulation of

glucose utilization to be either unaffected or impaired.
et al.
-

Wichterman

(420) reported no change in soleus muscle glucose uptake in the

presence of insulin (0.5 and 5.0 mU/ml) 16 to 24 hours after CLP.
However, Raymond and colleagues (274,325) found that glucose uptake by
gracilis muscles from dogs exposed to endotoxin (0.5 mg/kg)

or~.

coli

did not become elevated in response to an insulin infusion (19.4 mU/kg
x min).

Similar results have been reported in soleus muscles from

acutely uremic rats (276).

The rate-limiting steps which may alter

glucose utilization during sepsis include glucose transport,
hexokinase, phosphofructokinase and pyruvate dehydrogenase.

The

present study shows that during sepsis, insulin stimulated membrane
glucose transport is altered.

Ryan and Clowes (337) showed that

insulin-stimulated pyruvate dehydrogenase activity was depressed in
diaphragms removed from cecal-ligated-rats.

These observations are

supported by the subsequent findings (274,325) of an attenuated effect
of insulin on glucose utilization during the septic state.
Alterations in these glucose metabolic rate-limiting steps during
sepsis are important as they could ultimately affect energy
availability for the muscle.

CHAPTER III

BASAL AND INSULIN-STIMULATED SKELETAL MUSCLE SUGAR TRANSPORT
IN ENDOTOXIC AND BACTEREMIC RATS

A.

INTRODUCTION

Alterations in carbohydrate metabolism during the course of
sepsis have been observed in several studies.

Whole body glucose

disposal is often elevated (429) and muscle is thought to contribute
to the increase in glucose utilization (13).

Paradoxically, sepsis is

associated with attenuated insulin-mediated glucose utilization (325).
Studies on muscle glucose metabolism during sepsis confirm the
increase in basal glucose utilization (420) and the blunting of
insulin-stimulated glucose utilization (325).
Recently, our studies have shown that alterations in muscle
membrane glucose transport also may contribute to changes in glucose
utilization during sepsis (413).

Soleus muscles removed from fasted

rats given Escherichia coli bacteria exhibited an increase in basal
sugar transport with attenuated insulin-stimulated transport.

Studies

carried out in vivo revealed that although soleus muscle basal sugar
transport was comparable to controls, insulin-mediated (250 mU/kg)
transport remained attenuated in bacteremic rats.

The blunting of

insulin action on muscle membrane glucose transport could contribute
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to

the altered muscle carbohydrate metabolism observed during the

course of sepsis.
The purpose of the present study was to characterize insulin
stimulation of muscle membrane glucose transport during sepsis.
Whereas one maximal dose of insulin was used in the previous study
(413), this study evaluated the dose-response relationship to gain a
more complete understanding of the coupling between the insulin
receptor and glucose transport.

The sensitivity and responsiveness of

soleus muscle glucose transport to insulin stimulation was tested in
the 12 hr fasted bacteremic model described in the previous study.
Soleus muscle primarily consists of slow-twitch, oxidative fibers (7)
which are considered highly insulin-sensitive (245).

In this study,

glucose transport was evaluated also in epitrochlearis muscle which
consists of 65% fast-twitch, glycolytic, 10-15% slow-twitch,
oxidative, and 20% fast-twitch oxidative fibers (305).

Finally,

muscle sugar transport was measured in endotoxic rats to determine
whether the changes in basal and insulin-mediated sugar transport
observed in bacteremia were common to both models.

Studies of

alterations in sugar transport in several skeletal muscle types and
models of sepsis and septic shock might identify the primary
regulatory site(s) for changes in glucose metabolism observed in
septic patients.
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1)

Animal model:

MATERIALS AND METHODS
Male Holtzman rats weighing 80-100 g were

given an intraperitoneal (ip) injection of live

~-

coli (American Type

culture Collection 25922, 4 x 10 10 organisms/kg body wt in 0.5 ml), iv
with Salmonella enteritidis endotoxin (DIFCO, Boivin preparation; 40
mg/kg in 0.5 ml), or saline (0.5 ml) after a 15 hr fast.

All

injections were done under light ether anesthesia and rats were
allowed water ad libitum throughout the experiment.

Endotoxin-

injected rats (E) and time-matched controls (C-5) were killed by
decapitation 5 hrs after injection while rats injected with bacteria
(B) along with time-matched controls (C-12) were killed by
decapitation 12 hrs after injection.

In each group, blood samples

were collected and centrifuged for analysis of plasma glucose (Yellow
Springs Instruments, YSI 23A glucose analyzer) and lactate (YSI 23L
lactate analyzer) and soleus muscles were rapidly excised.

In some

experiments, epitrochlearis muscles were excised from 12-hr bacteremic
and time-matched control rats.

All muscles were mounted on aluminum

holders and kept at resting length throughout the experiment.
2)

Preparation of E. coli:

described previously (413).

~-

coli cultures were prepared as

Briefly,~-

coli was grown on blood agar

plates and maintained on brain-heart-infusion (BHI) slants.

Bacteria

from the slants were grown sequentially in two 5 ml tubes of BHI broth
and the second culture was used to inoculate 500 ml of BHI media which
was cultured for 12 hrs.

All cultures were incubated at 33°c in a VIP
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incubator (model 417).

Bacteria were harvested by centrifuging the

suspension and resuspending the pellet in sterile, isotonic saline.
Bacterial concentration was determined using absorbance (620 nm) and
dilution pour plate methods described in an earlier paper (413).
3)

3MG efflux from isolated muscles:

evaluated as described previously (420).

Glucose transport was

Briefly, efflux of 14 c-3-0-

methylglucose (1 4 c-3MG) from isolated soleus or epitrochlearis muscles
was measured after incubating muscles in 3.0 ml of Krebs-RingerBicarbonate (KRB) 'loading' media containing 118 mM NaCl, 1.2 mM
MgS0 4 , 1.2 mM KH2P04, 4.7 mM KCl, 2.5 mM CaCl2, 24 mM NaHC03 plus 2.3
mM pyruvate, 2.0 mM 3-0-methylglucose (3MG) and 4 µCi 14c-3MG for 60

min.

Epitrochlearis muscles were 'loaded' in 2.0 ml of the KRB

solution containing 5 µCi 14c-3MG.

All incubations were carried out

at 37°c in a metabolic shaker bath and were continuously gassed with a
humidified 95%02:5%C02 mixture.

Muscles were sequentially washed in

vials containing radioisotope-free KRB (2.5 ml for soleus, 2.0 ml for
epitrochlearis) for 5 min intervals at 37°C for 70 min following the
'loading' period.

To determine the effect of insulin on sugar

transport, insulin was added in concentrations ranging from 0.1 to 200
mU/rnl (0.7-1300 nM), in 50- through 70-min wash vials.

At the end of

the washout, soleus muscles were lightly blotted on filter paper
(Whatman 42), weighed and digested overnight in 2.0 ml of TS-1 tissue
solubilizer (Research Products International) at

ss 0 c.

Epitrochlearis

muscles were treated similarly but were digested in 1.0 ml of tissue
solubilizer.

The radioactivity in the washout media and digested
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les was counted in a liquid scintillation counter (Packard Tri-

carb 460) and corrected for quenching.
The radioactivity remaining in a muscle (DPM/g) after each wash
was quantified by adding muscle counts to those in the media in a
retrograde fashion.

14 c-3MG efflux curves exhibited a biphasic

pattern consisting of an initial rapid efflux of radioactivity from
the extracellular compartment followed by a more prolonged
monoexponential phase representing the transport of radiolabel 3MG
from the intra- to extra-cellular compartment (245,413).

The rate

coefficient or fractional efflux value (A ,min-1) was estimated from
the prolonged monoexponential phase by measuring the proportion of
14c-3MG leaving the muscle cell per unit time for each wash interval
as given below:
Fractional efflux

(~)

(Initial DPM/g - Final DPM/g)/(Initial DPM/g)
5 minutes

The stimulation of transport by insulin was assessed at the highest
fractional efflux value obtained for each dose of insulin.
4)

Statistics:

A Student's t-test was used to compare plasma

glucose and lactate values in experimental (i.e. bacteremic or
endotoxic) and control rats.

Fractional efflux in control and

experimental muscles were compared using a repeated measures 2-way
analysis of variance (ANOVA) followed by Tukey's multiple comparison
test on the SAS statistical package (Cary, NC).

Maximal response and

EC5os (1/2 effective concentration) for control and experimental
muscles were determined from the percent increase in insulinstimulated efflux (% increase above basal efflux) for each dose of
insulin using the ALLFIT (Biomedical Computing Technology Information
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center, Vanderbilt Medical Center) computer program (108).

Control

and experimental EC50 and maximal responses were compared using a
Student's unpaired t-test.

All data is expressed as mean±SEM with 'n'

indicating the number of muscles in each group.

A p<0.05 was

considered significant for all statistical analyses.
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1)

RESULTS

Lethality data and plasma metabolites.

Lethality in the

bacteremic model has previously been shown to be 55% at 12 hrs and 70%
by 48 hrs (413).

The rats

given~-

enteritidis endotoxin exhibited

33% mortality (26/78 rats) at 5 hrs and 73% mortality at 48 hrs
(43/59).

Plasma glucose (PG) and lactate (PL) were measured as

indices of metabolic alterations at the time muscles were removed from
endotoxic or bacteremic rats and their respective time-matched
controls.

Plasma lactate increased in 12-hr bacteremic rats compared

to time-matched controls (B = 2.7±0.2 mM, n=28; C-12 = 1.1±0.2 mM,
n=28; p<0.05) while plasma glucose remained unchanged (B = 93.6±2.7
mg%, n=28; C-12 = 95.3±1.8 mg%, n=28; p>0.05).

At 5 hrs post-

endotoxin injection, a more marked increase in plasma lactate (E
4.9±0.3 mM, n=49; C = 1.1±0.1 mM, n=44; p<0.05) plus a decrease in
plasma glucose (E = 56.7±4.7 mg%, n=49; C = 95.3±1.7 mM, n=44; p<0.05)
was found compared to control values.

The lethality and plasma levels

of metabolites in bacteremic and endotoxic rats indicated metabolic
disturbances in the experimental rats at the time muscles were
removed.
2)

Basal membrane sugar transport in muscle.

As in previous

studies (245,413) fractional efflux representing the prolonged
monoexponential phase of 14c-3MG efflux was constant by 35 min of
washout.

Therefore, washouts from 35 min on were analyzed in the

present study.

Basal 1 4 c-3MG transport was similar among control
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muscles (Table 1).

However, basal 14c-3MG transport in muscles from

l2-hr bacteremic rats was elevated compared to controls (Table 1) as
was reported previously (413).

Transport was also increased in

epitrochlearis muscles from bacteremic rats compared to time-matched
control values (Table 1).

Comparable results were found in soleus

muscles from endotoxic rats, where basal transport increased compared
to control rat muscles (Table 1).

The results of these experiments

indicate that elevated basal sugar transport in muscle was common to
different models of septic shock, as well as in muscles of diverse
fiber types.
3)
muscle.

Insulin-stimulated membrane sugar transport in rat soleus
In 12-hr bacteremic and 5-hr endotoxic rats as well as their

respective time-matched controls, insulin stimulated soleus muscle
membrane sugar transport in a dose dependent, saturable manner (Figs.
1,2).

Transport in 12-hr control rat muscles (Fig. 1) was stimulated

with as little as 0.10 mU/ml of insulin; 1.0 to 10.0 mU/ml insulin was
required to maximally stimulate 3MG transport.

Results with 10.0

mU/ml of insulin are comparable to those obtained in a previous study
(413).

In 5-hr control muscles (Fig. 2), 0.25 mU/ml of insulin was

required to stimulate transport with 100 mU/ml insulin required to
attain maximum stimulation.

Maximal insulin-stimulated transport was

similar among 5-hr and 12-hr control muscles (Table 2).
In muscles from bacteremic rats, 0.10 mU/ml insulin stimulated
transport with maximal stimulation occurring at an insulin
concentration of 10.0 mU/ml (Fig. 1).

Transport in bacteremic and

control muscles was not further stimulated with 100 mU/ml of insulin
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Table 1.

Basal 14 c-3MG fractional efflux in soleus and epitrochlearis

muscles from 12 hr fasted bacteremic (B), and 5 hr fasted endotoxic (E)
rats and their respective time-matched controls (12-hr-C, 5-hr-C).

Treatment

Muscle

n

Basal 14c-3MG Efflux
/..

(min-l)t

Soleus

56

0.0195±0.0007

Epitrochlearis

16

0.0193±0.0019

Soleus

48

0.0221±0.0007*

Epitrochlearis

16

0.0259±0.0013*

5-hr-C

Soleus

82

0.0188±0.0005

5-hr-E

Soleus

84

0.0209±0.0006*

12-hr-C

12-hr-B

iFractional effluxes in experimental (B,E) and control (C) muscles
were compared using a Student's unpaired t-test.
mean±SEM with p<0.05 (*) considered significant.

Values shown are
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Figure 1.

The effect of insulin dose on 14c-3MG efflux in 12 hr fasted

bacteremic (B,()) and time-matched control

(C-12,~)

rat soleus muscles.

Insulin concentrations ranged from 0.1 to 10.0 mU/ml as shown by A)
0.10 mU/ml

(C-12 n=8, B n=8); B) 0.50 mU/ml (C-12 n=8, B n=8); C) 1.00

mU/ml (C-12 n=8, B n=8); and D) 10.00 mU/ml (C-12 n=8; B n=8).

Efflux

responses to representative insulin doses are shown to demonstrate the
shift from an enhanced to an attenuated response in bacteremic rat
muscles compared to controls with increasing insulin concentrations in
the media.

Fractional efflux values are mean±SEM with a p<0.05 ("'k)

considered significant.

A 2-factor, repeated measures A.NOVA followed

by Tukey's multiple comparison test was used to compare fractional
efflux in bacteremic and control rat muscles using the SAS statistical
package.
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Figure 2.

The effect of insulin dose on 14 c-3MG efflux in soleus

muscles from 5 hr fasted endotoxic (E,()) and time-matched control (C-5,
~)

rats.

Insulin concentrations ranged from 0.10 to 100.00 mU/ml as

shown by A) 0.10 mU/ml (C-5 n=lO, E n=lO); B) 0.25 mU/ml (C-5 n=lO, E
n=lO); C) 1.00 mU/ml (C-5 n=9, E n=9); and D) 100.0 mU/ml (C-5 n=9, E
n=8).
Fig. 1.

Insulin doses shown reflect the shift in response described in
Statistical analyses were carried out as described in Fig. 1

with a p<0.05 (-tc) considered significant.
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Table 2.

Maximum response (min- 1 , and % stimulation) and EC50 (nM)

values in 12 hr bacteremic (B), 5 hr endotoxic (E) and time-matched
control (12-hr-C, 5-hr-C) rat soleus muscles.
Treatment

Maximal Response

EC50

%increase above basal

nM

12-hr-C

1. 34±0. 23

0.0599±0.0018

226.30±17.29

12-hr-B

1.16±0. 26

0.0515±0.0024*

144. 90±12. 4 7'~

5-hr-C

2.39±0.65

0.0586±0.0021

221. 44±18. 74

5-hr-E

0.92±0.20*

0.0512±0.0019A-·-

134.64± 9.48*

tvalues were derived from the insulin dose-response curves shown in
Figs. 3 and 4 using the ALLFIT computer package.

The maximum responses

and EC50 in experimental (B,E) and control (C) were compared using a
Student's unpaired t-test.
considered significant.

Values are mean±SEM with p<0.05 (*)
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1
(C-12\ = 0.0492±0.0021 min-1, n=8; BA= 0.0437±0.0020 min- , n=8).

To

assess glucose transport sensitivity and responsivity to insulin,
fractional efflux in the presence of insulin (Fig. 1) as well as the
ALLFIT dose-response curves (Fig. 3) were analyzed for 12 hr bacterernic
and control rat muscles.

Greater stimulation of sugar transport was

observed in bacteremic rat soleus muscles at low insulin concentrations
(0.10 mU/ml) compared to time-matched controls (Fig. 1).

At 0.25 and

0.50 mU/ml of insulin, 3MG transport was similar in muscles from
control and bacteremic rats (Fig. 1) although the degree of stimulation
in bacteremic rat muscles was attenuated compared to controls due to
increased basal transport (Fig. 3).

Maximal stimulation of transport

using 1.0 and 10.0 mU/ml insulin was significantly (p<0.05) lower in
bacteremic rat muscles compared to controls (Fig. 1).

Dose-response

analysis (ALLFIT, Fig. 3) revealed that the sensitivity (EC50) of
insulin-mediated transport in bacteremic rat muscles tended to increase
compared to controls although the difference was not significant due to
the large variance in the calculated EC50 (Table 2).

Maximal percent

stimulation by insulin (ALLFIT, Fig. 3, Table 2) was clearly lower in
bacteremic rat muscles compared to controls.
Membrane 3MG transport in epitrochlearis muscles from 12-hr
bacteremic rats was measured to determine whether changes in membrane
sugar transport were present in fast-twitch, glycolytic muscle.

An

elevated basal 3MG transport (Table 1) and attenuated insulin-mediated
transport (Fig. 4) at high insulin concentrations compared to control
values indicated that alterations in the sugar carrier were also
present in fast-twitch, glycolytic muscles.

116

---)(

300

::J

G>

0

c
0

·.;:

g
.....

200

U-

----------1/y/t/r,--

c:>
~

r()
I

u
!
.E

100

G>

en

0

G>

.....

u

c

~

( Insulin

~;""

/

/

,,,,""'

/

/

/

04'-l!:..:,','--..,---,.--.,-~~--..,.-~--,~-,---.~~~-,-~~-r~r-1
) 0
0

Figure 3.
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7.7
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15.0 mU/ml

Insulin-mediated 14c-3MG transport (% increase above basal)

dose-response curve for soleus muscles from 12 hr fasted bacteremic (B,
()) and time-matched control (C-12,~) rats.
using the ALLFIT computer package.

The curves were generated
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Basal and insulin-mediated (10 mU/ml) 14c-3MG efflux in

epitrochlearis muscles from 12 hr fasted bacteremic ((), n-16) and
time-matched control

(~.

n~l6)

('tr) considered significant.

rats.

Values are mean±SEM with p<0.05

Fractional efflux in bacteremic and

control rat muscles was compared with a 2-factor, repeated measures
ANOVA and Tukey's multiple comparison test using the SAS computer
package.
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At 0.10 mU/ml, insulin significantly stimulated transport in
mus C

les from endotoxic rats and 100 mU/ml of insulin was required for

the maximal transport response (Fig. 2). Sugar transport was not
stimulated any further with 200 mU/ml insulin (EA= 0.0466±0.0021, n
9; c-5A = 0.0537±0.0038, n = 10).

As with bacteremia, low

concentrations of insulin (0.10 and 0.25 mU/ml) stimulated transport
more in endotoxic-treated muscles compared to time-matched controls
(Fig. 2).

At intermediate insulin doses (0.25 to 1.0 mU/ml), muscle

membrane transport was elevated to similar levels in endotoxin-treated
and time-matched controls (Fig. 2).

As in bacteremic rat soleus

muscles, 3MG transport with 10.0 and 100.0 mU/ml insulin was
significantly attenuated in endotoxic rat muscles compared to timematched control values (Fig. 2).

The greater increase in fractional

efflux at low insulin concentrations in endotoxic rat muscles was
supported by the ALLFIT analysis (Fig. 5) showing a decreased EC 5 o in
the endotoxic group compared to controls (Table 2).

The maximal

response determined with ALLFIT was significantly attenuated in muscles
from endotoxic rats (Fig. 5, Table 2) compared to controls as was shown
by the fractional efflux measurements at the high insulin
concentrations of 10.0 and 100.0 mU/ml.

Overall, the fractional efflux

data and the ALLFIT analyses for both endotoxic and bacteremic rat
muscles indicated a trend for an increased sensitivity of muscle
glucose transport to insulin with significant attenuation of maximal
insulin-mediated transport.
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as described in Fig. 3.
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D.

DISCUSSION

This study has provided further information about changes in the
muscle membrane glucose carrier which occur during a Gram-negative
septic injury.

An endotoxic shock model described previously by our

laboratory (223) was used in addition to the previously used ~. coli
bacteremic model (413).

Five hrs after endotoxin administration, the

rats exhibited a pronounced hypoglycemia and hyperlactacidemia
accompanied by approximately 40% lethality.

The bacteremic model was

associated with 50% lethality at 12 hrs and hyperlactacidemia.

The

pronounced hypoglycemia described in endotoxic models (223,429) was not
as evident with bacteremia.
by 48 hrs.

Both models resulted in 70-90% lethality

The similarity in the lethality at the time of muscle

removal and at 48 hrs along with the rise in plasma lactate provided
the rationale for comparing cellular processes in muscles from
endotoxic and bacteremic rats.
The measurements of sugar transport in 12-hr bacteremic rat
soleus and epitrochlearis muscles and in 5-hr endotoxic soleus muscles
(Table 1) confirmed that basal transport is elevated during the
development of septic shock as was shown previously by this laboratory
(413).

Since skeletal muscle constitutes approximately 40% of body

mass and consumes approximately 35% of the available glucose in control
rats (101), the increase in basal glucose transport activity found in
muscles from septic rats may contribute to elevated glucose utilization
observed in various septic animal models (420,429) and in septic
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patients (89).

Increased basal 2-deoxyglucose uptake also has been

reported in epitrochlearis muscles from endotoxin-treated rats (13).
The mechanism(s) responsible for changes in basal glucose transport are
unknown.
Other physiological and pathophysiological events also alter
basal glucose transport.

Investigators have shown that exercise

stimulated (436) glucose transport in perfused hindlimb preparations
while denervation decreased basal glucose transport measured in vitro
(SO)

but not in vivo (389).

Unlike denervation, 'unloading' of rat

soleus muscle for 6 days in vivo (a procedure which leads to muscle
disuse with altered neural input) leads to an elevation of in vitro
basal glucose transport (185).

These studies indicate that neural

influences can modulate muscle glucose transport.

Studies have also

been done to examine the effect of diet on sugar transport.

Starvation

resulted in an increase in basal transport (42) while carbohydrate
feeding reduced the exercise-induced increase in basal 3MG transport
(436).

Streptozotocin-induced diabetes in rats caused a reduction in

basal glucose transport in epitrochlearis muscles (403).

Circulating

monokines, which are produced in response to endotoxin, also alter
glucose transport (258).

Lee et al. (258) reported that tumor necrosis

factor (TNF) and an unidentified monokine caused an increase in basal
glucose transport in the L6 muscle cell line.

Thus, alterations in

neural and humoral influences, and circulating insulin levels, which
are implicated in the septic injury process, modulate glucose transport
activity and may be involved in altering glucose transport in sepsis.
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Mechanisms responsible for the observed increase in basal
glucose transport following bacterial or endotoxin injection may be
related to cellular respiratory activity.

Decreased mitochondrial ATP

generation without a change in total tissue ATP is known to increase
membrane glucose transport (442).

In several studies, a change in

skeletal muscle redox state signaling a shift from aerobic to anaerobic
metabolism was associated with unaltered total tissue ATP and energy
charge.

The observed increase in basal glucose transport was

presumably due to decreased aerobic mitochondrial ATP generation
(420,442).

The elevated basal 3MG transport with endotoxemia and

bacteremia observed in the present study may result from this type of
metabolic shift.
The decreased responsiveness of the muscle glucose transporter
to insulin and the possible shift in insulin sensitivity following
endotoxic or bacterial injury may result from alterations in insulin
receptor-glucose transport coupling.

Starvation (42), denervation

(389) and anoxia (442) also have been associated with changes in
insulin-mediated glucose uptake or transport.

These studies implicated

altered membrane receptor number, insulin-glucose transport coupling or
the availability of glucose transporters.
The number of insulin receptors may be reduced during a septic
injury and this may lead to the reduced 3MG transport response observed
in muscles incubated with high doses of insulin (10-100 mU/ml).

A

reduction in insulin binding has been described following anoxia (441),
high fat diets (172), and obesity (203).

Investigators also have noted

the presence of post-receptor defects in these models (172,203,441).
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However, the decrease in receptor number contributing to a decrease in
responsiveness was accompanied by a shift in sensitivity to the right
as discussed by Flier (139).

Since in our study, there was a shift in

sensitivity to the left in the endotoxic rat muscles (Fig. 5, Table 2)
and a somewhat similar tendency in the bacteremic rat muscles (Fig. 3,
Table 2), the decreased responsiveness in these two groups could not be
ascribed to a loss of available insulin receptors.

In some conditions,

such as streptozotocin-induced diabetes, a decrease in insulin
responsiveness was actually associated with an increase in the number
of insulin receptors rather than a decrease (51).
The decreased responsiveness could be alternatively due to an
alteration in post-insulin-binding events. Altered skeletal muscle
glucose metabolism with such pathophysiological models as denervation
(140), diabetes (51), and uremia (276) has been attributed to postinsulin binding defects.

Studies focusing on post-insulin binding

defects have described alterations in insulin

~-subunit

tyrosine kinase

activity in skeletal muscle following diabetes (51) and obesity (261).
In these conditions, both autophosphorylation of tyrosine kinase and
phosphorylation of exogenous substrates by this enzyme were
significantly reduced (51,261).
on the insulin

~-subunit

An alteration in the ATP binding site

also has been described and linked to a

decrease in responsiveness to hormone (76).

The exact nature of the

insulin signal which activates glucose transport remains unknown.
Recent investigations have shown a role for ca2+_calmodulin-dependent
process(es) (166), protein kinase C (33), cGMP and cAMP (15), and
adenosine (366) in insulin signaling of the transport process.

Other
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studies have shown that ions (e.g. ca2+, Na+) may be involved in
insulin-mediated transport (85).

These ions are normally kept

regulated but during sepsis their gradients may be altered (349) and
lead to the changes observed in glucose transport.

Additionally,

insulin is believed to increase glucose transport by mobilizing the
cytosolic transporters into the plasma membrane (410).

Decreased

intracellular stores of glucose transporters available for
incorporation into the plasma membrane may also account for a decrease
in insulin-mediated glucose transport.
tyrosine kinase, ATP available for

Alterations in insulin receptor

~-subunit

phosphorylation and/or

post-receptor mechanisms may account for the findings in the present
study.

CHAPTER IV
SKELETAL MUSCLE CALCIUM UPTAKE IN BACTEREMIC RATS
A.

INTRODUCTION

Investigators have reported alterations in cellular calcium
regulation in various organs of animals in endotoxin shock or in
isolated tissue/cell/organelle preparations exposed to endotoxin in
vitro (186,201,272,350,373).
~

Direct addition of endotoxin to

incubation media resulted in decreased ca2+ uptake in cardiac
sarcoplasmic reticulum (186) and decreased ca2+ ATPase activity (201).
Calcium regulation appeared to be altered in the livers of endotoxic
rats (272,350,373).

Nelson and Spitzer (300) reported altered ca2+

regulation in adipocytes from endotoxic rats while Sayeed and Maitra
(350) observed increased cytosolic free ca2+ in hepatocytes from
endotoxic rats.

Studies have also shown altered hormone-mediated

intracellular calcium mobilization in livers of endotoxic rats (272).
Moreover, diltiazem treatment of rats prevented changes in cellular
calcium regulation in endotoxin-injected rats (272,350).

Recently,

treatment of bacteremic mice with ca2+ channel blockers increased
survival (40).

Alterations in cellular ca2+ regulation may occur in

several tissues including skeletal muscle.
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Our previous studies in bacteremic and endotoxic rats have shown
altered skeletal muscle glucose transport (413,416).

Holloszy and

Narahara (196) first proposed that calcium may modulate membrane
glucose transport.

Experiments in skeletal muscle indicate that agents

known to increase basal glucose transport also increase ca 2 + efflux and
that changes in cell Ca 2 + are thought to mediate the effects of these
agents on glucose transport (80).

In addition, ca2+ has been shown to

modulate insulin-mediated sugar transport in adipocytes (118,312).
These modulatory effects of ca 2 + led us to hypothesize that altered
ca2+ regulation contributes to the changes observed in basal and
insulin-mediated sugar transport during bacteremia.
The objective of the present study is to determine whether or
not there are alterations in ca 2 + regulation in skeletal muscle of
bacteremic rats.

The cellular ca2+ regulation was assessed through

measurements of ca2+ uptake in resting and depolarized (60 mM K+)
soleus muscles from control and bacteremic rats.

Bacteremic rats were

treated with diltiazem to determine whether alterations in ca2+
regulation could be attenuated or prevented by this treatment.
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B.
1)

Animal model.

MATERIALS AND METHODS
Male, Holtzman rats (80-100 g) were fasted

overnight and given san intraperitoneal (ip) injection of sterile
saline (control) or bacteria (4 x 10 1 0 Escherichia coli/kg).
were prepared as described previously (413).

Bacteria

In some rats, an

intravenous (iv) injection of diltiazem (2.4 mg/kg) was administered to
rats 10 hrs after bacterial or saline injection.

Twelve hrs after

bacterial or saline injection, rats were decapitated and blood was
collected for measurement of plasma metabolites.

Plasma glucose and

lactate were measured on a YSI 23A and YSI 23L analyzers.

After

decapitation, soleus muscles were quickly removed and placed on
aluminum holders.
2)

45ca2+uptake measurements.

45ca2+ uptake was measured using

a modification of the technique described by van Breeman and McNaughton
(394).

Muscles were preincubated in a metabolic shaker bath (37°C) for

45 min in 2.5 ml of oxygenated (95%02:5%C02) Krebs-Ringer-Bicarbonate
(KRB) media containing 1 mM CaCl2 and 5 mM glucose.

Muscles were then

incubated at 37°C in 2.0 ml of the oxygenated KRB containing 1 mM
CaCl2, 5 mM glucose and 3.0 µCi 4 5caC12 (Amersham) for intervals
ranging from 5 min to 4 hrs.

To prevent evaporation, incubation vials

were capped with rubber stoppers and oxygenated for 5 min every hour.
A 20 µl sample of the uptake media was counted to determine specific
activity.

After the 45ca2+ uptake period, bound and unbound

extracellular ca2+ were removed by incubating muscles for 60 min in 3.0
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ml of an oxygenated, radioisotope-free Hepes buffer solution (pH 7.4)
containing 134 mM NaCl2, 4.0 mM KCl, 1.0 mM MgCl2, 6 mM NaOH, plus 20

mM Hepes, 2 mM LaCl3 and 5 mM glucose.

Muscles were digested overnight

in tissue solubilizer (Research Products International) and then
radioactivity was measured in a liquid scintillation counter (Packard
Tri-Garb 460) and corrected for quenching.

Calcium uptake was

determined from the radioactivity remaining in the muscles using the
following equations:
45ca2+ specific activity: (
DPM
)
(nrnole ca2+)
ca2+ uptake:

(
nrnol
)
( g wet wt. )

DPM/ml medium
nrnol ca2+;ml medium
DPM/g wet wt.
45ca2+ Specific Activity

To measure the efflux of 4 5ca2+, muscles were incubated at 37°C in 2.5
ml of KRB containing 45 ca2+ for 1 hr and sequentially washed in 2.0 ml
of radioisotope-free Hepes buffer every 10 min for 100 min.
Radioactivity in both washes and digested muscles was measured with a
liquid scintillation counter and corrected for quenching.
To determine the effect of high K+ on 45 ca2+ uptake, the above
protocol was used except muscles were transferred after 60 min from the
KRB incubation media to media (pH 7.4) containing 65 mM NaCl, 60 mM
KCl, 1.1 mM MgS04, 1.1 mM KH2P04, and 1 mM CaCl2 plus 24 mM NaHC03, 5
rnM glucose and 3 µCi/vial 45 ca 2+.

ranged from 5 min to 2 hrs.

Incubation times in high K+ media

Time-matched muscles were incubated in KRB

media containing 4.5 mM KCl for similar intervals of time.

The

extracellular radioactivity in muscles incubated in high K+ was removed
in 3.0 ml of modified Hepes buffer containing 74 mM NaCl, 60 mM KCl,
1.0 mM MgCl2, 6 rnM NaOH, 20 mM Hepes, 2 mM LaCl3 and 5 mM glucose for
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min while time-matched muscles were similarly washed in 4.5 mM K+

Hepes buffer.
3)

Statistics.

The results of the sugar transport and 45ca2+

studies were compared using multifactorial repeated measures analysis
of variance (ANOVA) with BMDP (Los Angeles, CA) and post hoc NewmanKeuls tests with SAS (Cary, NC) statistical packages.
expressed as mean±SEM.

Results are
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C.

1)

RESULTS

Effect of diltiazem on plasma metabolites.

Glucose and

lactate were measured in plasma collected from 12 hr control and
bacteremic rats treated with iv diltiazem (2.4 mg/kg) at 10 hrs.
Plasma glucose (PG) was not appreciably changed in bacteremic rats
(Table 1) as was observed in earlier studies (413).

Diltiazem

treatment did not alter either control or bacteremic PG values (Table
1).

However, plasma lactate (PL) increased significantly in 12 hr

bacteremic rats compared to controls.

Diltiazem treatment had no

effect on PL in control rats but administration of 2.4 mg/kg diltiazem
decreased plasma lactate in bacteremic rats.

Plasma lactate in

bacteremic rats treated with diltiazem was still elevated compared to
control values (Table 1).
2)

Effect of bacteremia on 45ca2+ uptake in soleus muscle.

In

measurements of skeletal muscle 45ca2+ uptake, radiolabeled 45ca2+ was
removed from extracellular sites by incubating muscles in La3+_
containing media.

To ascertain whether La3+ caused changes in 45ca2+

taken up into the intracellular compartment, we measured release of
45 ca 2 + from muscles in the presence and in the absence of La3+.

Figure

1 shows that during the initial 30 min, radiolabeled muscles released
45 ca2+ at a rapid rate in the presence and absence of La3+.

Although

the rapid release of 4 5ca2+ represents release from extracellular sites
(125,174), this method does not allow for adequate analysis of
extracellular 45 ca 2 + washout.

The subsequent release of 45ca2+ during
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Table 1.

Plasma glucose and lactate levels in control and bacteremic

rats treated with diltiazem.

Plasma Glucose

Treatment

Plasma Lactate

mQ"%

rnM

Control - 12 hr

93.1±6.2 (8)t

1. 2±0. l+

(8)

Bacteremic - 12 hr

97.9±3.6 (8)

2.8±0.2 *

(8)

101.5±5.5 (4)

1. 0±0 .1 +

(4)

Control + iv DZ
(2.4 mg/kg)
Bacteremic + iv DZ
(2.4 mg/kg)

94.9±3.6 (8)

1.9±0.2*+ (8)

.
t Diltiazem (2.4 mg/kg) was administered
to rats 10 hrs after bacteria
or saline injection and blood was collected from 12 hr control and
bacteremic rats following decapitation.

Blood was quickly centrifuged,

plasma samples collected and analyzed for glucose and lactate.
shown is mean±SEM.

Data

Results were analyzed with 2-factor ANOVA and

Newman-Keuls post-hoc tests.

*p<0.05 vs control; +p<0.05 vs

bacteremia; ( ) =number of animals.
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Figure 1.

The effect of La3+ on 45ca2+ release (DPM/g wet wt.) from

control soleus muscles.

All muscles were preincubated at 37°C for 45

min in radioisotope-free KRB and then incubated in oxygenated KRB
containing 1.5 µCi 4 5ca2+/ml for 60 min.

Next, muscles were

sequentially washed every 10 min for 100 min in 2 ml of nominal ca2+
(no added ca2+) buffer in the presence ((),n-4) or absence (~,n-4) of
2 rnM La3+.

Muscles were digested overnight and then, muscles plus

washes were counted in a liquid scintillation counter.

The

radioactivity remaining in muscles after each wash (DPM/g) was
determined by retrograde addition of muscle and media counts.
shown are mean±SEM.

Results
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the next 70 min occurred in the absence of La3+ but not in its
presence.

These data confirm previous findings that La 3+ blocks the

efflux of intracellular ca 2+ (277,412).

The time course of Ca 2+ uptake

by soleus muscles from control and bacteremic rats is shown in Fig. 2.

Although, during the initial 30 to 90 min the rate of ca 2+ uptake
appeared to be higher in bacteremic rat muscles than in controls, both
groups of muscles exhibited maximal 45 ca2+ uptake by the end of 3-4
hrs.

Clearly, the amount of time required to reach 1/2 maximal uptake

was significantly reduced in bacteremic rat muscles compared to
controls.

The best fit of uptake curves was determined using Sigmaplot

(Jandel Scientific; Sausalito, CA) and ca2+ uptake did not conform to
monoexponential behavior in muscles from control and bacteremic rats.
Instead, the best fit of the ca2+ uptake was obtained with a third
order polynomial regression (C r2 = 0.99, p<0.05; B r2 = 0.98, p<0.05
with ANOVA).

An isotopic steady state of ca2+ uptake was achieved by

90 min in bacterernic rat muscles and by 3 hrs in controls.

When

muscles were depolarized in media containing 60 rnM K+, ca2+ uptake
transiently increased at 65 min in both control (Fig. 3A) and
bacteremic rat muscles (Fig. 3B).

The increase in 45ca2+ uptake seen 5

min after presumed depolarization with 60 rnM K+ was larger in
bacteremic rat muscles

(~C=72.5;

~B=203)

than in controls in spite of

the increased level of ca2+ uptake in resting bacterernic rat muscles.
In both control and bacteremic rat muscles 45ca2+ uptake was not
different in resting muscles and muscles incubated in high K+ for
longer than 5 min (data not shown).
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Figure 2.

ca2+ uptake in soleus muscles from 12 hr fasted control

n-4-8) and bacteremic (4, n=4-8) rats.

Some rats received 2.4 mg/kg

diltiazem iv 10 hrs after bacterial injection

cm.

n=4).

ca 2+ uptake in

control rats which received 2.4 mg/kg diltiazem are not shown.
uptake was measured as described in the Methods.
Mean±SEM.

<•.

ca2+

Results shown are

Results were analyzed with 3-factor ANOVA (time, bacteria,

diltiazem) and post-hoc Newman-Keuls tests with p<0.05 considered
significant.

*p<0.05 vs control.
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Figure 3.

Effect of 60 rnM K+ on Ca 2 + uptake in soleus muscles from

control and bacteremic rats.

Values in panel A (control rat muscles)

are ca2+ uptake at 60 min in the presence of 4.5 rnM K+ ([], n=8), and
after an additional incubation for 5 min (65 min) in the presence of
4.5 rnM K+ ([], n=8) or 60 rnM K+ (~, n=8).

Values in panel B

(bacteremic rat muscles) are ca2+ uptake at 60 min in the presence of
4.5 rnM K+ (~, n=4), and after additional incubation for 5 min (65 min)
in the presence of 4.5 rnM K+ (~, n=8) or 60 rnM K+ (~, n=8).
shown are mean±SEM.

Results

Results after 60 rnM K+ in control and bacteremic

rats were analyzed using a 3-factor ANOVA (time, bacteria,

[K+]) and

Newman-Keuls post-hoc tests with a p<0.05 considered significant.
*p<0.05 vs 60 min value;
media) control muscle.

+p<0.05 vs simlarly treated (same [K+]
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3)

45ca2+ uptake in rats treated with diltiazem.

Diltiazem

(DZ,iV) treatment at 10 hrs reduced 4 5ca2+ uptake in control rat
muscles between 2 and 3 hrs of incubation (2hr uptake = 518±24 nmoles/g
wet wt., n=4; 3hr uptake = 590±49 nmoles/g wet wt., n=4) but did not
affect the maximal 45 ca 2+ uptake.

This treatment also significantly

reduced uptake in bacteremic rat muscles between 30 min and 1 hr which
were the time points where ca 2+ uptake increased the most compared to
control muscles (Fig. 2).

When compared to untreated controls, the

time to 1/2 maximal uptake was no different (C 30 min = 260±3 nmoles/g
wet wt, n=4; B+DZ 30 min

281±13, n=4; p>0.05; C 1 hr= 448±28, n=8;

B+DZ 1 hr= 487±54, n=4; p>0.05 using ANOVA).
at about 2 hrs in both groups of muscles.

Steady state is reached
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D.

DISCUSSION

Overall, the results show increased ca2+ uptake in soleus
muscles of bacteremic rats (Fig. 2) and enhancement in its response to
K+-induced depolarization (Fig. 3).

The increased ca2+ uptake was

prevented by treating animals with the ca2+ blocker diltiazem when
bacteremia (413) and associated metabolic disturbances were present in
animals (Table 1, Fig. 2).

The soleus muscle 45ca2+ uptake

measurements allowed us to assess both ca2+ ion movements and the
steady state cellular ca2+ content.

The ion movements were presumed to

be movements into the intracellular compartment, as the washing of
muscle in La3+_containing, ca2+_free media after the uptake periods
prevents the uptake and accumulation of ca2+ into extracellular
compartments (277,394).

Several investigators (277,394,412) have used

La3+ in 45ca2+ uptake experiments as a means to displace extracellular
bound ca2+ and to prevent the loss of intracellular ca2+.

Sometimes

erroneous results have occurred with the La3+ technique because it has
not completely inhibited the loss of 4 5 ca2+ from cells (393).

In the

present study, sequential washes of muscle with and without La3+ showed
complete inhibition of cellular ca2+ loss in the presence of La3+ (Fig.
1).

The steady state cellular exchangeable calcium measured in this

study (C = 741±34 nmol/g wet wt, n=4; B = 719±58, n=4) was comparable
not only to other skeletal muscle measurements (174), but also to
measurements in other organs such as liver (350) and nerve cells (22).
Borle (35) observed that freshly isolated cells or cultured cells from
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various tissues have an average of 5.0±0.7 nrnol exchangeable ca 2+/mg
protein which also is equivalent to values reported in this study (C
4 .94±0.23 nrnol/mg protein; B

=

4.80±0.39 nrnol/mg protein).

Based on

the observed inhibition of intracellular ca2+ loss with La 3+ and the
similarity of our calculated values of cellular ca2+ with those
reported in the literature, we believe that the La3+ technique allowed
a reasonable estimation of the exchangeable cellular ca2+ contents.
The inward movement of calcium in the control as well as the
bacteremic rat muscles (Fig. 2) could not be resolved as monoexponential transport.

Thus, the 4 5ca 2+ uptake probably did not represent

inward movement of ca 2+ through a single sarcolemmal calcium entrance
site.

Non-monoexponential behavior is expected when there is movement

of ca2+ through more than one rate-limiting route.

Multiple routes of

ca2+ entry could be in series or in parallel with each other (390).

In

resting skeletal muscle, cellular ca2+ exchange with sarcoplasmic
reticulum and mitochondria along with the sarcolemmal ca2+ leak
channels would account for the multiple routes of inward ca2+ movement
(125).
The cellular steady state calcium distribution was unaffected
with bacteremia (Fig. 2), indicating that the bacteremic injury did not
produce gross alterations in the exchangeable calcium contents of
skeletal muscle.

In contrast, an increase in skeletal muscle

exchangeable calcium was found with endotoxemia (122).

Although

endotoxic injury has some features in common with bacteremia, endotoxic
animals exhibit cardiovascular and metabolic changes over a shorter
period of time compared to bacteremic animals (416).

The lack of
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change
tO

in skeletal muscle exchangeable ca2+ in our study could be due

the slower progression of bacteremic injury.

Although cellular

exchangeable Ca 2 + was unaffected, a substantially shorter time was
·red to reach 1/2 maximal calcium uptake in bacteremic rat muscle

req Ul.

compared to controls (Fig. 2).

This suggests an enhanced rate of

inward ca2+ movement in bacteremic rat muscles.

Increased inward

movement of ca 2 + could result from decreased ca2+ uptake by cellular
organelles, increased release of Ca 2 + from these organelles and
increased permeability of ca 2 + across the plasma membrane.
Results similar to those observed in bacteremic rat muscle were
reported by Borle (39) who showed a decrease in the time to 1/2 maximal
ca2+ uptake without a change in steady state exchangeable ca 2 + content
in monkey kidney cells treated with metabolic inhibitors.

Borle (35)

postulated that an initial decrease in ca2+ uptake by cellular
organelles resulted in elevated cytoplasmic free ca 2 + and the increased
(Ca2+li was responsible for stimulating ca 2 + influx.

Increased

cytosolic free ca2+ appears to stimulate ca 2 + influx via a (Na+Jidependent and ATP-dependent mechanism in excitable cells (113).

The

increase in ca2+ influx probably occurs via ca2+_ca2+ exchange, and not
voltage-gated ca2+ channels.
An increase in cytosolic free Ca2+ modulating increased Ca 2 +
movement is compatible with previous findings of increased cytosolic
Ca 2+ in the liver cells after endotoxic injury (350).

Other investiga-

tors (373) have reported decreased ca2+ uptake in organelles isolated
from endotoxic rat liver.

This information further supports the con-

cept that decreased ca2+ movement into organelles with an intermediary
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2
increase in cytosolic free ca + could contribute to an increase in ca +
uptake (Fig. 2).

A reduction in ca 2 + uptake by cellular organelles

also has been described in skeletal muscles from diabetic rats (123)
and in denervated rat skeletal muscle (217).

These two pathophysio-

logical conditions are associated with attenuated insulin-mediated
sugar transport as is observed in bacteremic rat muscles (413,416).
Although cellular exchangeable calcium contents were unchanged
with bacteremia in the present study, the enhanced rate of ca2+
movement may alter intracellular ca 2 + availability or ca2+ mobilization
by organelles in skeletal muscle which could lead to changes in ca2+_

dependent cellular functions.

Previous studies in our laboratory

showed alterations of basal and insulin-mediated sugar transport in
soleus muscles from bacteremic rats (413,416).

Several investigators

propose that ca2+ modulates basal and insulin-mediated glucose
transport (80,118,312).

The observed increase of inward ca2+ movement

in resting bacteremic rat soleus muscles supports the idea that
disturbances in ca 2 + regulation could modulate skeletal muscle sugar
transport via unknown mechanism(s).

In preliminary experiments,

diltiazem administered to bacteremic rats 10 hrs after bacterial
injection prevented the changes in skeletal muscle glucose transport
while earlier injections were not beneficial (417).
In the present study, diltiazem prevented the increased inward
movement of ca2+ observed in bacteremia (Fig. 2).

Previous studies of

hypoxia, anoxia, and ischemia-induced injury suggest that ca2+ blockers
protected cardiac tissue against injury only when the tissue was
stimulated, indicating that plasma membrane ca2+ channels were in the
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activated state (69).

The ability of ca2+ antagonists to block tension

development also was stimulus dependent (152).

The skeletal muscle of

bacteremic rat might also be in an activated state, as there is
evidence for skeletal muscle depolarization in septic animals (387).
The beneficial effect of ca2+ blockers is believed to be due to
prevention of sarcoplasmic reticulum ca2+ release subsequent to
activation of sarcolernmal ca 2 + channels.

Sayeed and Maitra (350) also

proposed that excessive stimulation of agonist-mediated ca2+ channels
on the plasmalernma of hepatocytes from endotoxic rats caused increased
cytosolic free ca 2 + and eventually resulted in desensitization of
agonist-stimulated ca 2 + mobilization from endoplasmic reticulum.

The

results of the present study are consistent with the concepts derived
from hypoxic/ischemic studies and work done on endotoxic shock.
Alternatively, the results may be explained by the vasodilatory
actions of diltiazem on the vasculature (409).

Increased peripheral

vascular resistance occurs in septic shock, especially in skeletal
muscle (194), and diltiazem may prevent the resulting 02 deprivation
from causing the observed increase in bacteremic rat muscle ca2+ uptake
(Fig. 2).

However, vascular resistance presumably was not altered in

control muscles and diltiazem treatment also caused a decrease in ca 2 +
uptake (Fig. 3) which suggests that diltiazem had a direct effect on
skeletal muscle.

The observed effects of diltiazem on ca2+ regulation

in hepatocytes (268,350) as well as skeletal muscle (Fig. 2) and on
survival in bacteremic mice (40) suggest that alterations in ca2+
regulation occur in various organs during septic shock.

The protective

effect of diltiazem on skeletal muscle ca2+ regulation (Fig. 2) and on
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plasma lactate (Table 1) when diltiazem was administered 10 hrs after
the introduction of bacteria support the use of ca 2 + blockers for
potential benefit in the treatment of septic shock.
The enhanced ca2+ uptake in the presence of high K+ in
bacteremic rat muscles (Fig. 3) indicates that the ca2+ mobilization
across the plasma membrane/sarcoplasmic reticulum upon skeletal muscle
depolarization is also altered by bacteremia.

Several investigators

have reported increased cellular respiration and metabolism in skeletal
muscles incubated in high K+ media (307,395).

Membrane depolarization

as well as ca 2 + release from the sarcoplasmic reticulum were required
for the high K+-induced increases in respiration (395).

Increased ca 2 +

uptake also has been observed with high K+ (125,307) and it was
attributed to the entry of Ca 2 + across the plasma membrane after
release of ca2+ from the sarcoplasmic reticulum (395).

From these

observations, we surmise that an indirect stimulation of ca2+ uptake
may result from increased ca2+ release from the sarcoplasmic reticulum
in bacteremic rat muscles.

Diltiazem also has prevented K+-induced

contracture (345), which indicates that high K+ depolarization resulted
in the opening of voltage-gated ca2+ channels on the sarcolemma.

Sato

and Fujino (347) have shown that coupling between high K+-induced
depolarization and sarcoplasmic reticulum ca2+ release can be blocked
With the ca2+ channel blocker, nicardipine.

They proposed that the

Ca 2+ channel protein can modulate the conformation of a second protein
on transverse-tubules which undergoes a conformational change and
allows sarcoplasmic reticulum ca2+ channels to open.

Alterations in
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these proteins in bacteremic rat muscles may increase ca 2+ release from
the sarcoplasmic reticulum and stimulate overall ca 2+ uptake.

CHAPTER V
EFFECT OF CELLULAR CALCIUM MODIFIERS ON SKELETAL MUSCLE
SUGAR TRANSPORT IN BACTEREMIC RATS
A.

INTRODUCTION

Several investigators have previously described a modulatory
role for ca 2+ in basal sugar transport (25,26,85) and a recent report
has shown a role for ca 2+ in insulin-mediated sugar transport (118).
Clausen and coworkers reported increased 4 5ca2+ efflux and elevated
basal sugar transport in soleus muscles exposed to reagents, trypsin,
hydrogen peroxide, veratrine, or 2,4-dinitrophenol (368) and to
electrical stimulation or hyperosmolar media (85).

The increases in

ca2+ efflux and glucose transport were temporally related to each other
but the magnitude of the 4 5ca2+ efflux change did not always correlate
with the magnitude of sugar transport changes.

More recent studies in

adipocytes (312) have shown that increased sugar transport resulting
from the addition of vanadate, hydrogen peroxide, phorbol ester or,
concanavalin A can be prevented with [Quin-2-AM]
introduced into cells to quench ca2+ signals.

(15-150 µM) which was

In addition, an increase

in cytosolic ca2+ was detected in adipocytes treated with sulfonylureas
(117) which are known to stimulate adipocyte and myocyte sugar transport (211,330).

These results suggest that agents which increase

cytosolic free ca2+ stimulate membrane sugar transport.
145

Calcium may be
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involved in the modulation of insulin-mediated transport by protein
kinase C (236,431).

Calcium may also affect calmodulin enhancement of

insulin receptor kinase activity and thus, modulate the ability of
insulin to stimulate glucose transport (166).
Recent studies from our laboratory have shown that calcium
regulation is altered in skeletal muscles from fasted rats given an
intraperitoneal (ip) injection of live bacteria (Escherichia coli) 12
hrs earlier (414).

In addition, elevated basal and attenuated insulin-

mediated sugar transport have been observed in these muscles (416).
The purpose of this study is to determine whether changes in cellular
ca2+ are involved in the sugar transport alterations observed in
bacteremic rat muscles.

To address this problem, 3MG transport was

measured in control rat muscles exposed to agents which modify ca 2 +
movements across the sarcolemma and/or cellular organelles.

In other

experiments, we ascertained the effect of the ca2+ modifying agents on
sugar transport in muscles of bacteremic rats.

To modify intracellular

ca 2 + we employed varying extracellular (ca2+], ca2+ ionophores (A23187,
ionomycin), ryanodine, or a reduced transmembrane Na+ gradient.
One postulated outcome of these experiments was that these
agents might change sugar transport in control muscles but may not
further affect it in bacteremic rat muscles.

Alternatively, these

agents could change transport in control muscles and further alter
transport in bacteremic rat muscles such that comparable sugar
transport would be observed in control and bacteremic rat muscles.
Changes in control muscle transport unrelated to those occurring in
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bacteremic rats would suggest that altered ca2+ regulation did not
contribute to bacteremic rat muscle alterations in sugar transport.
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B.

1)

Animal model.

MATERIALS AND METHODS

Male, Holtzman rats (80-100 g) were fasted

overnight and given sterile saline (control) or bacteria (4 x 10 10
Escherichia coli/kg) ip.
previously (413).

Bacteria were prepared as described

Twelve hrs later, rats were decapitated, soleus

muscles were quickly removed and mounted on aluminum holders at
approximately resting length.
2)

3-0-Methylglucose transport.

using an efflux technique (413).

Sugar transport was measured

Briefly, muscles were 'loaded' with

14c-3-0-methylglucose (14c-3MG) in 3.0 ml of Krebs-Ringer-bicarbonate
(KRB) media for 60 min and then sequentially washed in 2.5 ml of
radioisotope-free KRB every 5 min for 70 min at 37°C.
present in wash media between 50 and 70 min.

Insulin was

Muscles were digested in

tissue solubilizer (TS-1, Research Products International) overnight
and then muscles and wash media were counted in a liquid scintillation
counter (Packard Tri-Carb 460).

Radioactive counts were added in a

retrograde fashion to determine the amount of radioactivity remaining
in the muscle after each wash.

Fractional efflux (\ ,min-1) was

estimated from the DPM/g at the beginning and end of each wash.
The physiological media (pH 7.4) used to measure 3MG transport
in experiments with varying extracellular ca2+ ([Ca2+] 0
KRB media.

)

was a modified

The modified media contained 124 mM NaCl, 4.5 mM KCl, 1.1

mM MgS04, 0-7.5 mM CaCl2, 6 mM NaOH, 30 mM Hepes as well as 2.0 mM
unlabelled 3MG and 2.3 mM pyruvate and this media was present
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throughout the experiment.

No significant difference in basal or

insulin-mediated transport were observed in control rat muscles
incubated in these modified media compared to normal KRB media.

The

KRB medium was gassed with 95%02:5%C02 while the modified KRB medium
was oxygenated with 100% 02.
Ionophores, when present were added to both the 'loading' and
•wash' media and these experiments were performed in the dark.

Both

A23187 (Calbiochem) and ionomycin (Calbiochem) stock solutions (10 mM)
were prepared with dimethylsulfoxide (DMSO, Sigma) while the ryanodine
(Calbiochem, 10 mM) stock solution was prepared with saline.
concentration of DMSO in the KRB and modified KRB was

~12mM

The final
(0.08%) and

0.5% DMSO had no effect on basal or insulin-mediated 3MG transport in
control rat soleus muscles (417).
In experiments designed to decrease the transmembrane Na+
gradient, extracellular (Na+] ([Na+] 0

)

was reduced (40.5, 80.3 mM) in

another modified KRB buffer for the 'load' and 'wash' periods.

The KRB

used in 80 mM Na+ experiments contained 60 mM choline chloride, 55 mM
NaCl, 5 mM KCl, 1.2 mM MgS04, 1.2 mM KHzP04, 2.5 mM CaCl2. 23 mM
NaHC03, 2.3 mM pyruvate (Na+ salt) and 2.0 mM 3-0-methylglucose (3MG).
The 40 mM Na+ - KRB contained 101 mM choline chloride, 14.2 mM NaCl, 5
rnM KCl, 1.2 mM MgS04, 1.2 mM KH2P04,

2.5 mM CaCl2, 24 mM NaHC03, 2.3 mM

pyruvate (Na+ salt) and 2.0 mM 3MG.

Media was adjusted to pH 7.4 with

choline bicarbonate (Sigma).
3)

ca 2+ uptake experiments.

45ca2+ uptake was measured using a

previously described La 3+ technique (394).

Briefly, the muscles were

preincubated for 45 min and then incubated for 1 hr in KRB media (1.5

150
µCi/ml) before transferring them to KRB media containing 1 µM ryanodine
45 ca 2+
plus 3 µCi 45ca2+ to determine the effect of ryanodine on
uptake.
hrs.

Incubations with ryanodine were carried out for 5 min to 2

Ryanodine also was present during the La3+ wash.

The same

protocol was also used to test the effects of 40 mM Na+ on 45 ca 2+
uptake with modifications to the media.

The media used for low [Na+] 0

(40.2 mM) incubations (2.0 ml) consisted of 101 mM choline chloride,
16.2 mM NaCl, 5 mM KCl, 1.2 mM MgS04, 1.2 mM KH2P04 and 1 mM CaCl2 plus
24 mM NaHC03, 5 mM glucose and 3 µCi 4 5caC12.

Muscles were washed in a

modified Hepes buffer (pH 7.4) containing 92 mM choline chloride, 40 mM
NaCl, 4.5 mM KCl, 1.0 mM MgCl2 plus 2 mM LaCl3, 5 mM glucose and 20 mM
Hepes.
4)

Statistics.

The results of the sugar transport and 4 5ca 2+

studies were compared using multifactorial repeated measures analysis
of variance (ANOVA) with BMDP (Los Angeles, CA) and post hoc Student's
Newrnan-Keuls tests with SAS (Cary, NC) statistical packages.

In some

instances, an unpaired Student's t-test was used to compare the percent
increase above basal 3MG transport caused by insulin with a p<0.05
considered significant.

Results are expressed as mean±SEM.
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C.
1)

RESULTS

Effect of [Ca 2+1 0 on 3MG Efflux.

The overall effect of

[Ca2+] 0 on sugar transport in control or bacteremic rat muscles was
minimal unless ca2+ was excluded from the medium.
ca2+ 0

,

In the absence of

there was an increase in basal transport and an attenuation of

insulin-mediated response in control muscles (Fig. lA).

Lowering

[Ca2+] 0 to 0.1 mM had no effect on basal or maximum insulin-mediated
3MG efflux in control muscles compared to control muscles incubated
with 2.5 mM ca2+ (Fig. lA).

As [ca2+] 0 was increased from 2.5 to 5.0

mM, there was no significant effect on basal or maximum insulin-

mediated transport (Table 1).

An increase in [Ca 2+] 0 to 7.5 mM

elevated both basal and insulin-mediated 3MG transport in control
muscles but the percent increase from basal to hormone-stimulated
conditions was similar with 2.5, 5.0 and 7.5 mM ca2+ 0 (2.5mM ca2+
181±21%, n=8; 5.0 mM ca2+

=

173±12%, n=l2; 7.5mM ca 2+ = 170±26%, n=8;

p>0.05 using ANOVA).
Figure lB and Table 1 show the effect of [Ca 2+] 0 on sugar
transport in bacteremic rat muscles.

When ca2+ was absent from the

medium, basal transport was elevated at one time point during sugar
efflux (42.5 min) but not at the adjacent efflux time points (37.5 or
47.5 min) compared to results with 2.5 mM ca2+ 0

.

A [ca2+] 0 of 0.1 mM

had no effect on basal or insulin-mediated sugar transport.

Increasing

Ca 2+0 to 5.0 and 7.5 mM had no effect on basal sugar transport (Table
l) in the muscles from bacteremic rats.

Insulin-mediated transport was
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Figure 1.

Effect of decreased extracellular (ca2+] ([Ca2+] 0 ) on basal

and insulin-mediated (10 mU/ml) 3MG transport in soleus muscles from:
A) 12 hr control (C) and B) 12 hr bacteremic (B) rats.
were: 1) 0 mM added ca 2+0

The (Ca 2+J 0

Cn=8,Bn=8); 2) 0.1 mM ca 2+0 (~

((),

Cn=8,Bn=8) and; 3) 2.5 mM or 'normal' ca2+ 0 (~, Cn=8,Bn=8).

,

Muscles

were 'loaded' and 'washed' in modified KRB media (see METHODS)
containing the desired (Ca 2+] 0

.

3MG transport is expressed as

fractional efflux of 3MG ( A, min-1) and results shown are mean±SEM.
3-factor analysis of variance (ANOVA) with repeated measures
(Bacteremia, (ca2+] 0

,

time) followed by Newman-Keuls post-hoc analysis

were used to compare 3MG transport in muscles from various groups of
animals.

A p<0.05 was considered significant; *'p<0.05 vs muscles from

similarly treated rats (C,B) incubated with 2.5 mM ca2+ 0

.

Transport

differences in muscles from C vs B rats are discussed in the text.
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Table l.

Effect of increases in [Ca2+] 0 on basal and insulin-mediated

3MG transport in soleus muscles from 12 hr control and bacteremic rats.
Treatment

[CaL+]

n

Basal
A. x 102(min-l)

rnM

2.5

Control, 12 hr

8

5.0

Control, 12 hr

12

7.5

Control, 12 hr

2.5

Insulin-media tee
1
A. x 102(min- )

1. 849±0. 158.

5.580±0.201

2.140±0.065

5.790±0.149

8

2.361±0.208*

6.263±0.115A·'-

Bacteremic, 12 hr

12

2.34l±0.10ot

4.106±0.177t

5.0

Bacteremic, 12 hr

8

2.645±0.139t

4.690±0.185*t

7.5

Bacteremic, 12 hr

8

2.745+0.249

4.665+0.143*t

•Transport

.

(A. , min -l ) was measured in soleus muscles from 12-h

control and bacteremic rats.The desired [Ca2+] 0 was present in the
'load' and 'wash' media for 3MG transport studies.

Results shown are

rnean±SEM with basal transport recorded from 47.5 min values and
insulin-mediated transport obtained from the peak (57.5 min) values.
Results were analyzed using a 3-factor ANOVA (See Table 2) followed by
a Newrnan-Keuls post-hoc test with p<0.05 considered significant.
*p<0.05 vs same treatment (C or B) with 2.5 rnM ca 2+ in media; tp<0.05
vs control with same [ca2+] in media.

155
elevated in muscles incubated with 5 or 7.5 mM ca 2+ compared to 2.5 rnM
ca2+ (Table 1) although the percent stimulation by insulin was not
different (2.5 rnM = 83±12%, n=lO; 5.0 rnM ca2+ = 80±3, n=8; 7.5 mM ca 2+
83±20%, n=8; p>0.05 using ANOVA).
As was observed at 2.5 rnM ca2+ 0 (420,423), basal sugar transport
was elevated and insulin-mediated transport was attenuated in bacteremic rat muscles (Fig. lB, Table 1) incubated with (Ca2+] 0 of 0 to 5 rnM
compared to control muscles (Fig. lA, Table 1).
mM ca2+ 0

,

In the presence of 7.5

insulin-mediated transport was attenuated in bacteremic rat

muscles compared to control muscles while basal transport was not
different (Table 1).
2)

Effect of A23187 on 3MG Efflux.

In control soleus muscles,

A23187 (0.1 or 1 µM) had no effect on basal 3MG transport (Fig. 2)
compared with transport in the absence of ionophore (Fig. lA).

Yet 0.1

µM A23187 inhibited insulin-stimulated transport slightly and 1 µM
A23187 caused a large reduction in insulin-mediated 3MG transport (Fig.
2) compared to measurements without ionophore (Fig. lA).

Addition of 1

µM ionophore to bacteremic rat muscles had no effect on basal (+A23187
A= 2.440±0.148 min-1, n=lO; -A23187 A = 2.341±0.100, n=l2) or insulinmediated 3MG transport (+A23187 \ = 3.906±0.247 min-1, n=lO; -A23187 \
= 4.106±0.177, n=l2).

Basal and insulin-mediated transport were

similar in control and bacteremic rats in the presence of 1 µM A23187
(2.5 rnM ca 2+ 0

).

Muscles were incubated with 1 µM A23187 and varying (ca2+] 0 to
study modulation of sugar transport by (ca2+] 0 in the presence of
ionophore (Table 2).

In control muscles, a reduction of (Ca 2+] 0 to
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Figure 2.

Effect of [A23187] on basal and insulin-stimulated (10

mU/ml) 3MG transport (A, min-1) in muscles from 12 hr control rats.
Concentrations included 0.1 µM (I;., n-8) and 1.0 µM (() , n-8) A23187.
Muscles were 'loaded' and 'washed' in modified KRB media (see METHODS)
containing 2.5 mM ca2+ 0 with or without A23187.

Mean transport in

control muscles (no A23187) is shown for comparison(-----, n-8, see
Fig. 1 for mean±SEM).

A repeated measures 2-factor ANOVA followed by

student's Newman-Keuls post-hoc tests were used to analyze the effect
of A23187 on sugar transport with p<0.05

<*')

considered significant.
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Table 2.

Effect of A23187 on basal and insulin-mediated 3MG transport

(A, min-1) in soleus muscles from 12 hr control (C) and bacteremic (B)

rats.
Treatment

[caz+] 0

n

Basal

Insulin-mediated
A x 10 2 (min- 1 )

mM

>. x 10 2 (min-l)
2. 380±0. 211 a

3.907±0.238

Control

8

0

Control

6

0.1

2.168±0.122

3.912±0.116.

Control

8

2.5

2.073±0.149

3.919±0.222•

Control

8

5.0

2.787±0.369*•

4.742±0.220*•

Bacteremic

8

0

3 . 011±0 . 198 t •

4.375±0.208*

Bacteremic

8

0.1

2.783±0.093t

4.380±0.155*

Bacteremic

10

2.5

2.440±0.148

3.906±0.247

Bacteremic

10

5.0

2.562±0.153

3.876±0.1nt•

aA23187 (1 µM) was present in the incubation media throughout the
experiments.

Basal and insulin-mediated 3MG transport values were

derived as described in Table 1.

Results shown are

repeated measures 3-factor ANOVA (bacteremia; [ca2+] 0

mean±SEM.
;

A23187) followed

by a Newman-Keuls post-hoc test were used to analyze data.
of significance was set at p<0.05;
with 2.5 mM ca2+ in media;
A23187 plus same [Ca2+] 0

;

A

The level

*p<0.05 vs same treatment (C,B)

tp<0.05 vs control incubated with 1 µM
•p<0.05 vs same treatment (C,B) incubated

without A23187 (see Table 1).
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zero or 0.1 µM in the presence of A23187 had no effect on basal or
insulin-mediated transport compared to muscles incubated with 2.5 mM
ca2+ plus A23187 (Table 2).

Addition of 5 mM ca2+ along with A23187

increased basal and insulin-mediated transport in control muscles
although the percent increase in transport by insulin at 2.5 and 5 mM
ca2+ was similar (2.5 mM ca2+

92±11%, n=8; 5.0 mM ca2+ = 91±9, n=8;

p>0.05 using unpaired Student's t-test).
The effect of (Ca 2+] 0 on 3MG transport in the presence of
ionophore also was measured in bacteremic rat muscles (Table 2).

Basal

3MG transport in the presence of A23187 was further enhanced when
[Ca2+] 0 was 0 mM but was unchanged with 0.1 or 5 mM ca2+ compared to
muscles incubated with 2.5 mM ca2+ (Table 2).

Insulin-mediated

transport in the presence of ionophore tended to be higher when 0 or
0.1 mM ca 2+0 was present than transport measured in the presence of 2.5
mM ca2+ plus ionophore (Table 2).

However, the percent stimulation of

transport by insulin was not significantly different among the various
[Ca 2+] 0 (60±15% at 2.5 mM ca2+, n=lO; 65±12% at 0.1 mM ca2+, n=8; 55±13
at 0 mM ca2+, n=8; p>0.05 using ANOVA).

Insulin-mediated 3MG transport

in bacteremic rat muscles incubated with 5 mM ca2+ plus ionophore also
was not significantly different from the response with 2.5 mM ca2+ plus
ionophore (Table 2).
Results also were analyzed to determine whether A23187 affected
transport in muscles from control or bacteremic rats.

As expected,

ionophore had no effect on basal or insulin-mediated transport in
control (Fig. lA

VS.

Table 2) or bacteremic (Fig. lB vs. Table 2) rat

muscles in the absence of ca2+o·

While no effect of ionophore was
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observed on basal transport with 0.1 - 5 mM ca2+ in bacteremic rat
muscles (Fig. lB, Tables 1,2), ionophore increased basal transport when
5 mM ca2+ 0 was present in control muscles (Table 1 vs 2).

A23187

reduced insulin-mediated 3MG transport in control muscles (Fig. 2) to
values that were comparable to those observed in bacteremic muscles
(Table 2).

When [Ca 2+J 0 was varied in the presence of ionophore

insulin-mediated 3MG transport in control muscles was only slightly
different from transport in bacteremic rat muscles (Table 2).
3)

Effect of ionomycin on 3MG transport.

Ionomycin (1 µM)

significantly increased basal 3MG transport in control (Fig. 3) and
bacteremic (Fig. 4) rat muscles compared to transport in the absence of
ionomycin (Fig. lA,B respectively).

The increase in basal transport

resulted in similar values in control and bacteremic rat muscles (Figs.
3,4).

Insulin-stimulated 3MG transport was significantly decreased in

control muscles (Fig. 3) but was unchanged in muscles from bacteremic
rats (Fig. 4).

Ionomycin reduced insulin-mediated transport in control

and bacteremic rat muscles to comparable values and insulin did not
significantly stimulate 3MG transport above basal values in either
group (Figs. 3,4).
4)

Effects of ryanodine or low [Na+ 0 1 on 3MG transport.

In

control rat soleus muscles, ryanodine (1 µM) produced results similar
to those of ionomycin (Fig. 3).

Basal 3MG transport increased

significantly (Fig. 3) and insulin did not significantly stimulate
transport.

Basal and insulin-mediated 3MG transport in control rat

soleus muscles were not altered when [Na+J 0 was reduced from 140 to 80
rnM (Table 3).

Further reduction of [Na+) 0 to 40 mM resulted in
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Figure 3.

Effect of ionomycin (1

µM, ~,

n=8), ryanodine (1

µM,

.A ,

n=8) or low [Na+) 0 (40 mM, () , n=8) on basal and insulin-mediated 3MG
transport (A ,min-1) in muscles from 12 hr control rats.

Data from

experiments with ionomycin and 40 mM Na+ were analyzed as described in
Fig. 4.

Results from ryanodine experiments were analyzed using 2-

factor ANOVA followed by Newman-Keuls post-hoc tests with a p<0.05
considered significant.

Mean transport in control muscles (no media

modifications) is shown for comparison(-----).
mean±SEM.

All results are

1),<0.05 vs control muscles, no media modifications.
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Figure 4.

Effect of ionomycin (1 µM, ~, n=8) or low [Na+) 0 (40 mM,(),

n-8) on basal and insulin-mediated 3MG transport (min-1) in muscles
from 12 hr bacteremic rats.

Average transport·in bacteremic rat

muscles incubated without media modifications (-----, Fig. lB) is shown
for comparison to other treatments.
mean±SEM.

Data from other groups is shown as

Results from control (Fig. 1,4) and bacteremic (Fig. 2,5)

rat muscles incubated with (Fig. 4,5) and without (Fig. lA,B) ionomycin
were compared using a repeated measures 3-factor (bacteremia,
ionomycin, time) followed by a Newman-Keuls post-hoc test with p<0.05
considered significant.
incubated with 40 mM Na+.

Similar analyses were carried out for muscles
*'p<0.05 vs C muscles with same media

modifications; +p<0.05 vs muscles from similarly treated rats (C or B),
no media modifications.
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Table 3.

Effect of 80 rnM Na+ on basal and insulin-mediated 3MG

transport (A, min- 1 ) in soleus muscles from 12 hr control rats.
Treatment

n

Basal
A x 102(min-l)

Insulin-mediated
A x 10 2 (min- 1 )

Control

8

1.849±0.108.

5.580±0.201

80 rnM Na+

7

2.114±0.091

5.357±0.201

•Results shown are mean±SEM with basal and insulin-mediated transport
derived as described in Table 1.

The effect of Na+ was analyzed using

a 1-factor ANOVA and there was no significant effect (p>0.05) of 80 rnM
Na+ on transport.
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elevated basal and attenuated insulin-mediated transport in control
rats (Fig. 3).

In muscles from bacteremic rats, media containing 40 mM

Na+ also was associated with increased basal transport (Fig. 4).

Peak

insulin-mediated transport was similar in bacteremic rat muscles
incubated with 40 and 140 mM Na+ 0 although 3MG transport did not return
toward basal values in muscles incubated with 40 mM Na+ (Fig. 4).
Basal transport in the presence of 40 mM Na+ was enhanced in bacteremic
rat muscles (Fig. 4) compared to controls (Fig. 3) at 37.5 and 47.5
min.

Basal and peak insulin-mediated transport were similar in control

(Fig. 3) and bacteremic (Fig. 4) rat muscles incubated with 40 mM Na+.
5)

45ca2+ uptake with ryanodine or 40 mM Na+.

45ca2+ uptake

also was measured to determine whether the ryanodine or low [Na+] (40

mM) alter cellular ca2+ regulation (Fig. 5).

Low [Na+] (40 mM) in the

media increased both the rate of 45ca2+ uptake and the steady state
uptake of ca2+ in soleus muscles.

Ryanodine had a similar general

effect although ca2+ uptake at 15 min was comparable to basal uptake
(Fig. 5).
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Figure 5.

45ca2+ uptake in muscles from 12 hr control rats which were

incubated with no additions ([], n=4-8), low [Na+] 0 (40 mM,
ryanodine (1

µM, ~,

n=4).

II,

n=4) or

Muscles were transferred to media

containing 1.5 µCi/ml 45ca2+ plus 40 mM Na+, ryanodine, or no additions
after a 1 hr incubation in KRB plus 1.5 µCi/ml 45 ca 2+.
are mean±SEM.

Results shown

Skeletal muscle ca 2+ uptake in the presence of ryanodine

or 40 mM Na+ was compared to uptake in control (no additions) muscles
using a repeated measures 2-factor ANOVA (ionomycin or [Na+], time)
followed by a Newman-Keuls post-hoc test with p<0.05 ("'k) considered
significant.
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D.

DISCUSSION

The modulatory effects of ca2+ on skeletal muscle basal and
insulin-mediated sugar transport were examined using various agents
known to increase intracellular ca 2 + ((ca2+li).

These agents were

present in the muscle incubation media for a period of 90 min which
should allow for a steady state of cellular ca2+ and eliminate
transient ca 2 + buffering effects of sarcoplasmic reticulum (SR) and
mitochondria.
lular (Ca 2 +J

Earlier studies indicated that an increase in extracel([Ca 2 +J 0

)

stimulated calcium uptake (23).

The ionophore

A23187 increased 4 5ca 2 + uptake in soleus muscle (80), raised total ca 2 +
content in perfused rat hindlimbs (28), and elevated resting muscle
tension without affecting membrane potential (171).
effects should increase [ca2+li·

Collectively these

Ionomycin increased the Ca 2 + influx

(266) and stimulated ca2+ release from organelles (18,226).

Both

A23187 and ionomycin caused a sustained increase in cytosolic ca2+ in
isolated myoblasts (215).

Ryanodine which binds to SR membranes (314)

increased ca2+ release from the SR into the cytosol (138).
of [Na+]

0

Reduction

also raised [ca2+li via a reduction or reversal of Na+;ca2+

exchange (94).

Sodium/calcium exchange has been observed in skeletal

muscle (157) although its physiological importance is unknown.

In the

present study, both ryanodine and 40 mM Na+ significantly stimulated
Ca 2+ uptake compared to resting Ca2+ uptake (Fig. 5).
The increased basal transport observed in control muscles when
Ca 2+ 0 was excluded from the medium (nominal ca2+ 0
earlier studies (15,28,80).

)

is in contrast to

The elevated basal sugar transport

observed with nominal ca2+ 0 may be due to a decrease in [ca2+li under
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these conditions.

Baker and Carruthers (15) reported that media with

nominal ca2+ decreased [Ca 2 +Ji in barnacle muscles.

It is plausible

that ca2+i availability may be required for a regulated level of
glucose transport and with a decrease in [ca2+li there may be release
of that regulation.

Work in isolated cardiac myocytes (71) suggested

that reducing [ca2+] 0 to very low levels caused alterations in membrane
permeability to several electrolytes and this affected the cellular
regulation of these ions.

Changes in cellular metabolism (decreased

protein synthesis) also were observed in these cells.

However, some

investigators have reported that ca2+_free media had no effect on basal
sugar transport (15,28,80).

Reduction of [ca2+] 0 also has been as-

sociated with membrane depolarization (98,215) and increased cytosolic
ca2+ (215) presumably from SR ca2+ release (215) or altered Na+/ca2+
exchange (98).

We cannot rule out that exposure to nominal ca2+ media

for prolonged periods of time may result in the release of intracellular stores of ca2+ which in turn would lead to an increase in basal
transport.

An increase in [ca2+] 0 to 7.5 mM produced an increase in

basal transport (Table 1).

In support of this data are reports that

increased [Ca2+] 0 elevated basal sugar transport in skeletal muscle
(80).
To obtain greater increases in [Ca 2 +Ji, calcium ionophores were
added to the media.
[Ca 2 +]

0

Addition of A23187 in the presence of normal

(2.5 mM) had no effect on basal 3MG transport (Fig. 2) which

agrees with work of Hall et al.

(178).

Other investigators have

observed that A23187 increased (26,80) or decreased (240) skeletal
muscle sugar transport and the difference between studies may be due to
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the different [A23187] (80,178,240), or the length of exposure to
A23187 (26,80,240).

The increased basal transport observed with 5.0 mM

ca2+ in the presence of A23187 (Table 2) but not in its absence (Table
1) indicates that A23187 (1 µM) increased basal transport in a Ca 2+dependent manner.

Ca 2+ ionophores also increased basal transport in

previous studies by Clausen (80) and Bihler et al. (26).

The elevated

basal 3MG transport observed with ionomycin was greater than with
A23187, presumably due to a greater ability of ionomycin to increase
cellular ca2+ (215) via ca2+ influx (266) and release of ca2+ from
intracellular stores (18,226).

Draznin et al. (118) did not observe

any effects of ionomycin (1 µM) on 2DG uptake in isolated adipocytes
but a short incubation period was used in their studies.

A23187

(26,178) and ionomycin (226) sometimes affect the movement of other
ions in the cell, but the similar actions of both ionophores and
ryanodine suggests that changes in [Ca 2+Ji were involved in the altered
sugar transport.
Ryanodine and low [Na+] 0 increased basal 3MG transport (Fig. 3)
in a manner very similar to the effect of ionomycin in control muscles
and they also stimulated ca2+ uptake (Fig. 5).

The ability of ryano-

dine to increase SR ca2+ release (138) is consistent with the idea that
major alterations in ca2+i regulation caused the observed increase in
basal 3MG transport.

In earlier studies, cell respiration increased in

rat diaphragms treated with 6 x 10- 6 M ryanodine (418) without causing
changes in mitochondrial oxygen consumption or oxidative phosphorylation (216) and without exhausting the energy supply (359).

The

increased basal transport observed in control muscles incubated with 40
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mM [Na+J 0 (Table 3, Fig. 3) also appears to be due to changes in

cellular [Ca 2+J.

Kipnis and Parrish (234) did not observe any effect

of decreased [Na+] 0 on basal sugar transport in skeletal muscle.
However, other investigators reported elevated basal sugar transport
with decreased [Na+] 0 (246) or with agents which increased [Na+Ji (28).
These authors (29) postulated that an increase in [Na+Ji indirectly
elevated basal transport when [Ca 2 +Ji increased after reduction or
reversal of sarcolemmal Na+;ca 2+ exchange.

Bihler et al. (28) also

suggested that increased [Na+]i caused ca2+ release from intracellular
organelles.

The effects of 40 mM Na+ 0 are relevant to sepsis since

membrane depolarization and increased [Na+Ji have been observed in
skeletal muscles from bacteremic animals (387).
The results of this study support the concept that an optimal
range of [ca2+li is required to maintain control of membrane glucose
transport.

The 25% increase of basal sugar transport in control

muscles incubated with nominal ca 2+ 0 could result from a loss of
cellular regulation of sugar transport (Fig. 1).

At the other extreme,

muscles incubated with ionomycin, ryanodine or low [Na+] 0 could also
increase [ca 2+Ji (Fig. 3) to such an extent that sugar transport
regulation is lost.

These results suggest an optimal range of [ca2+li

is required for cellular regulation of sugar transport which is similar
to the concept of Draznin et al. (118).

Ionomycin, ryanodine and 40 rnM

[Na+] 0 increased basal 3MG transport 65-70% in control muscles and 3545% in bacteremic rat muscles such that 3MG transport was not different
in the two groups.

The actions of these agents to increase the uptake

or release of ca2+ may cause major alterations in basal sugar
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transport.

Since nominal [ca 2+J 0 or 5.0 mM ca2+ 0 plus A23187 (Table 2)

had no effect on bacteremic muscles (Table 2) but increased basal
transport in control muscles (+35-40%) to values equal to those
observed in bacteremic rats, it would appear that the degree of altered
ca2+ regulation was similar in this set of control and bacteremic rat
muscles.

Altered ca2+ regulation may change basal sugar transport via

its effects on glucose transporter turnover (81), phosphorylation of
the glucose transporter by protein kinase C (427), and or indirect
effects of protein kinase Con the insulin receptor (236,431).
There has been controversy about the importance of ca2+ in the
modulation of insulin-mediated sugar transport (80,239).

The at-

tenuated insulin-mediated 3MG transport in control muscle observed with
nominal ca2+ 0 (Fig. 1) is similar to that observed in dialyzed barnacle
muscles (15) and isolated adipocytes (118).

Although insulin can

stimulate sugar transport somewhat in the absence of [Ca 2+J 0

,

it

appears that a minimal [ca2+) 0 may be required for optimal insulin
action (15,118).

Recent results from Draznin et al. (118) also suggest

that an optimal range of [ca2+li is required for maximal insulinmediated sugar transport and when [ca2+]i is out of this range there is
an attenuation of insulin-mediated sugar transport.

In isolated

adipocytes insulin-mediated 2DG uptake was enhanced as [Ca 2+] 0 was
raised from 0.1 to 2.0 mM but further elevations or reductions in
[ca 2+] 0 attenuated insulin-mediated sugar transport (118).

In the

present study, [Ca2+] 0 above nominal levels had no effect on insulinmediated sugar transport (Fig. 1, Table 1).

The discrepancy between

these findings may be related to increased calcium permeability in
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isolated cells in comparison to an isolated, intact muscle.

In

agreement with the work of Draznin et al. (118) was the attenuated
insulin-mediated sugar transport observed in control muscles incubated
with A23187 (1 µM) or ionomycin (1 µM) (Figs. 2,3).

These ionophores

should have caused larger increases in cellular [Ca2+] than high
[Ca 2+] o·

Hall et al. (178) also reported that A23187 decreased

insulin-mediated skeletal muscle xylose transport and Bihler and
coworkers (26) observed similar results using 3MG transport
measurements in rat hemidiaphragms.
The attenuated insulin-mediated 3MG transport observed in the
presence of ryanodine or 40 mM Na+ was similar to the effect of
ionomycin (Fig. 3).

The effects of ryanodine on insulin-mediated sugar

transport have not been studied previously but caffeine which also
releases SR ca2+ (127), attenuated insulin-mediated sugar transport
(85).

Bihler et al. (25) previously studied the transmembrane [Na+] 0

gradient effect on sugar transport and they reported that slight
reductions in the Na+ gradient enhanced insulin-mediated sugar
transport while large decrements in the gradient led to attenuated
insulin-mediated transport.

Clausen and Flatman (86) reported that

cardiac glycosides had little or no effect on insulin-mediated
transport in rat soleus muscles which may be analogous to the effect of
80 mM Na+ 0 on insulin-mediated 3MG transport (Table 3).

These results

suggest that large magnitude changes in the [Na+] gradient must occur
before significant increases in [ca2+li occur and lead to attenuated
insulin-mediated sugar transport.
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Overall, these results suggest that when [Ca 2 +Ji increases above
an optimal range, there is a diminshed ability of insulin to stimulate
sugar transport.

Ionophores, ryanodine and 40 mM Na+ all attenuated

insulin-mediated 3MG transport in control rats (Fig. 3).

The lack of

effect of A23187 and 40 mM Na+ on insulin-mediated 3MG transport in
bacteremic rat muscles (Table 2, Fig. 4) suggests that a previous
alteration in ca 2 + regulation may occur in vivo in skeletal muscles
from bacteremic rats which was not further affected by these
treatments.

However, ionomycin attenuated insulin-mediated 3MG

transport in bacteremic rat muscles (Fig. 4) suggesting that ionomycin
caused a more profound change in ca2+ regulation which further
aggravated the sugar transport disturbances that develop during
bacteremia.

The increase in basal transport which may accompany the

loss of insulin effectiveness may signal a loss of cellular glucose
transport regulation.

Recently, altered ca2+ regulation has been

described in obese individuals (120) and obesity also is associated
with an attenuation of insulin-mediated sugar transport (435).

CHAPTER VI
THE EFFECT OF CA 2+ CHANNEL AGONISTS AND ANTAGONISTS ON
SKELETAL MUSCLE SUGAR TRANSPORT
A.

INTRODUCTION

Studies concerned with the relationship between sarcolemmal ca 2+
movements and skeletal muscle function have focused on ca2+ movements
during electrical (4,17,116,204,253,406) and mechanical activity (152,
204,346,347).

A channel responsible for most of the ca 2+ current (lea)

is voltage-sensitive (17,73,116,406) and is located primarily in the
transverse-tubules of the sarcolemma (130,141,150).

Electrophysiology

studies indicate that this channel is analogous to the "slow" inward
ca2+ channel in cardiac and smooth muscle (159).

Although the Ica is

not necessary for electrical or mechanical activity in skeletal muscle
(161), it appears to contribute to action potentials (204,229) and
tension development (152,204) during prolonged depolarizations.

ca2+

movements through this channel are blocked by dihydropyridine, phenylalkylamine, and benzothiazipine antagonists (3,159,204,229,406) and
enhanced by dihydropyridine agonists (204).

These compounds also

inhibit receptor operated ca2+ channels in other tissues such as liver
(200) but receptor-operated channels have not been extensively studied
in skeletal muscle.
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Although some studies suggest that inward ca 2+ movement may
influence skeletal muscle metabolism, the effect that ca 2+ channel
activation may have on cellular metabolism in this tissue has not been
established.

Potassium-induced depolarization stimulated oxygen

consumption (395,396), glycolysis (393,396), and glucose transport
(391) in skeletal muscle.

Verapamil prevented the increase in

skeletal muscle respiration in K+ depolarized cells (72).

These

results suggest that activation of sarcolemrnal ca2+ channels may
influence metabolism.

In addition, slightly elevated [K+] 0 increased

cellular respiration without causing contraction which indicates
metabolic processes may be more sensitive to inward ca 2+ movements
than mechanical activities.
Intracellular ca2+ appears to modulate skeletal muscle sugar
transport (298,369) and such a modulation could occur through changes
in ca2+ channel activation (417).

Under pathophysiological conditions

such as diabetes or bacteremia, attenuated insulin-mediated sugar
transport is observed (420,423) and is associated with changes in
cellular ca2+ regulation (415).

In a previous study from our

laboratory (417), treatment of bacteremic rats with a ca2+ antagonist
prevented alterations in skeletal muscle sugar transport which we
postulated was the result of the antagonist's ability to maintain
cellular ca2+ regulation in these rat muscles.
The purpose of this study was to determine whether the agonists
and antagonists of the sarcolemrnal ca2+ channel, through their effect
on cellular ca2+, could modulate basal and insulin-mediated skeletal
muscle sugar transport.

We hypothesized that while a low

r

r
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concentration of agonist may activate inward ca2+ movement and
stimulate sugar transport, a high agonist concentration may enhance
inward ca 2+ movement to adversely affect cellular ca2+ regulation such
that (Ca 2+Ji fails to modulate sugar transport.
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B.

MATERIALS AND METHODS

The effect of the dihydropyridine agonist Bay K 8644 on basal
and insulin-mediated 3-0-methylglucose (3MG) transport and on 45 ca 2+
uptake were measured in isolated soleus muscles.

Other experiments

assessed the ability of dihydropyridine or benzothiazepine antagonists
to prevent agonist-mediated effects on transport or ca2+ uptake.
1)

Glucose transport measurements.

Fasted male, Holtzman rats

(80-100 g) were given an intraperitoneal (ip) injection of 0.5 ml
saline.

Twelve hrs later rats were decapitated, and soleus muscles

were quickly removed and placed on aluminum holders.

Sugar transport

was measured using the efflux technique described in previous studies
(413,416).

Briefly, muscles were 'loaded' with 14c-3-0-methylglucose

(1 4 c-3MG) for 60 min in Krebs-Ringer-Bicarbonate (KRB) media and then
washed in radioisotope-free KRB for 5 min intervals over a period of
70 min at 37°C.
washes.

Insulin was added to the media during the 50 - 70 min

Muscles were digested with tissue solubilizer and both

muscles and washes were counted in a liquid scintillation counter.
The fractional efflux of 14c-3MG (A,min-1) was calculated from the
amount of radioactivity present at the beginning and end of each wash.
When present, calcium agonists (Bay K 8644) and antagonists
(nifedipine, nitrendipine and diltiazem) were added to both 'load' and
'wash' media.

Bay K 8644 and nitrendipine were gifts of Dr. Scriabine

from Miles Laboratories, Inc. (New Haven, CT) and diltiazem was the
gift of Marion Laboratories, Inc. (Kansas City, KS).

Nifedipine was
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obtained from Sigma.

Stock solutions (10-20 mM) of Bay K 8644,

nifedi-pine, and nitrendipine were prepared with dimethylsulfoxide
(DMSO, Sigma).

The highest concentration of DMSO added to the KRB

media was 12 mM (0.08%) and in a previous study 0.5% DMSO had no
effect on 3MG transport (417).

Diltiazem stock solutions (10-20 mM)

were prepared in 0.9% saline.
2)

45ca2+ uptake measurements.

To measure 45ca 2+ uptake in

soleus muscles, they were preincubated in KRB (2.5 ml) containing 1.0
mM ca2+ and 5 mM glucose (KRB-G) for 45 min and then transferred to

2.0 ml of KRB-G containing 3 µCi of 45ca2+ for 1 hr, at which time
45ca2+ uptake was approaching a steady state.

The muscles were then

incubated in KRB-G containing 45ca2+ (3 µCi) plus agonist and/or
antagonists for 5 min up to 2 hrs.

A 20 µl aliquot of medium was

counted in a liquid scintillation counter to determine the specific
activity.

After the 45ca2+ uptake period, muscles were washed for 70

min in Hepes buffer without added ca2+ but which contained 2 mM La3+
to remove extracellu-lar-bound ca 2+ and to prevent the loss of
intracellular ca2+ (415).
water bath.
measured.

All incubations were carried out in a 37°c

Muscles were digested overnight and the radioactivity was
Both 3MG transport and ca2+ uptake studies were performed

in the dark when ca2+ agonist or antagonists were present.
3)

Statistics.

The results of the sugar transport and 4 5ca2+

studies were analyzed using a multifactorial repeated measures
analysis of variance (ANOVA) using the BMPD (los Angeles, CA) statistical package and a post hoc Student's Newman-Keuls test with the SAS
(Cary, NC) statistical package.

Results are expressed as mean±SEM.
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C.
1)
transport.

RESULTS

Effect of ca 2+ agonist on skeletal muscle 3MG

Low concentrations of Bay K 8644 (0.25 µM) enhanced

insulin-mediated sugar transport (Fig. lB) compared to control values
but had no affect on basal transport.

In the presence of 0.5 µM Bay K

8644, basal 3MG transport increased significantly and insulin-mediated
transport (Fig. lC) was higher than control values at 52.5 min but not
when peak stimulation was observed at 57.5 min.

Enhanced basal 3MG

transport was also observed with 2-6 µM Bay K 8644 (Fig. lD-F).

The

two higher concentrations (4, 6 µM) produced a progressive attenuation
of insulin-mediated 3MG transport (Fig. lE,F) compared to control
values.
2)

Effect of ca2+ antagonists + Bay K 8644 on 3MG transport.

The dihydropyridine antagonist nifedipine (Fig. 2) blocked the effects
of Bay K 8644 on 3MG transport (Fig. 2, Table 1).

The enhanced

insulin-mediated 3MG transport observed with 0.25 µM Bay K 8644 (Table
1) was prevented with 1 µM nifedipine.

Nifedipine alone (1 µM)

increased basal 3MG transport slightly but had no effect on insulinmediated 3MG transport (Table 1).
Although 2 µM nifedipine had no effect on the Bay K 8644 (6 µM)
induced elevation of basal 3MG transport, 4 µM nifedipine reduced
basal transport to values observed in control muscles (Fig. 2).
Whereas 2 µM nifedipine (Fig. 2) partially countered the agonistinduced (6µM Bay K 8644) attenuation of insulin-mediated 3MG transport
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Figure 1.

Effect of [Bay K 8644] on basal and insulin-mediated 3MG

transport (A, min- 1 ) in rat soleus muscles.

Bay K 8644 was present

throughout the 'load' and 'wash' and the Bay K 8644 concentrations
used were A) 0 µM (n=8), B) 0.25 µM (n=8), C) 0.50 µM (n=ll), D) 2 µM
(n=4), E) 4 µM (n= 8), F) 6 µM (n=lO).

Results shown are mean±SEM for

efflux measurements made between 35 and 70 min during the 'wash'
period.

Data was analyzed using a 2-factor, repeated measures

analysis of variance (ANOVA) followed by Newman-Keuls multiple
comparison test (MCT) with p<0.05 considered significant.
control, no Bay K 8644.
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Figure 2.

Effect of nifedipine (2 µM - •

, n-4; 4 µM - O , n-8)

on

basal and insulin-mediated 3MG transport in the presence of 6 µM Bay K
864q.

Results for experiments done in the presence of nifedipine are

shown as mean±SEM for efflux measurements made between 35 and 70 min
during the wash period.

Mean values for 3MG efflux in control muscles

(----, n-8) and muscles incubated with 6 µM Bay K 8644 alone (· ·· ·,
n-10) also are shown for comparison (see Mean±SEM values in Fig. 1).
Data was analyzed using a 3-factor, repeated measures ANOVA followed
by a Newman-Keuls MCT with p<0.05 considered significant. ~p<0.05 vs
control, no additions; +p<0.05 vs 6-µM ~ay k 8644 alone.
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Table 1.

Basal and insulin-mediated 3MG transport in muscles

incubated with 0.25 µM Bay K 8644, Bay K 8644 plus 1 µM nifedipine, or
no additions (control).

Treatment

n

Basal
>. x 10 2 (min-l)

Insulin-mediated
>. x 10 2 (min-l)

Control

8

1. 849±0 .108•

5.580±0.201

Nifedipine (lµM)

8

2.454±0.203*

5.298±0.261

Bay K 8644 (0.25µM)

8

1. 822±0. 087

6.268±0.126*

Bay K 8644 +
Nifedipine

8

1.908±0.082

5.681±0.183t

•When present, the dihydropyridines were added to both the
'load' and 'wash' media using concentrations shown in the Table.
Basal 3MG efflux was assessed using the 47.5 min value and insulinmediated efflux was determined at 57.5 min.
mean±SEM.

Results shown are

Data was analyzed using a 2-factor ANOVA followed by a post

hoc Newrnan-Keuls test with a p<0.05 considered significant.
vs control;

tp<0.05 vs Bay K 8644 alone.

*p<0.05
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(Fig. lF), 4 µM nifedipine completely released the inhibitory effects
of 6 µM Bay K 8644 on insulin-mediated 3MG transport (Fig. 2).
Nifedipine alone (2 and 4 µM) also significantly (p<0.05) increased
basal (2 µMA = 2.445±0.284, n=4; 4 µMA = 2.179±0.129, n=8) and
significantly attenuated insulin-stimulated (2 µMA
n=4; 4 µM A
values.

=

4.638±0.343,

3.952±0.148, n=8) 3MG transport compared to control

In contrast to the effect of nifedipine, nitrendipine did not

reverse the effects of 6 µM Bay K 8644 on basal or insulin-mediated
3MG transport at any of the concentrations tested (1-10 µM) (Table 2).
Preincubation of muscles with 10 µM nitrendipine for 10 min however,
potentiated the Bay K 8644-mediated increase in basal transport (Table
2) when compared to the effect of Bay K 8644 alone (Fig. lF).
Nitrendipine alone had no effect on basal or insulin-stimulated 3MG
transport (Table 2).
The benzothiazepine calcium antagonist diltiazem has somewhat
different actions than dihydropyridines (159).

Addition of 10 µM

diltiazem had no effect on the elevated basal 3MG transport observed
with 6 µM Bay K 8644 but 20 µM DZ (+Bay K 8644) reduced basal
transport to control values (Fig. 3).

Whereas, the addition of 10 µM

diltiazem partially reversed the attenuation of insulin-mediated 3MG
transport produced by 6 µM Bay K 8644 (Fig. 3), 20 µM diltiazem restored insulin-mediated transport to control values (Fig. lA).

Basal

and insulin-mediated 3MG transport in muscles incubated with 20 µM
diltiazem were not different from that in control muscles (Table 3).
3)

Effect of ca2+ calcium channel modifiers on 45ca2+ uptake.

To determine whether Bay K 8644 and nifedipine affected sugar
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Table 2.

Effect of nitrendipine on basal and insulin-mediated 3MG

transport in soleus muscles incubated with and without Bay K 8644 (6

µM).

-BAYK8644

+6 µM BAYK8644
[Nitrendipine]
µM
n

+ Insulin

n

Basal

+Insulin

2.336±0.068. 4. 263±0 .115

8

1.849±0.108+ 5. 580±0. 201 +I

6

2.520±0.161

4.200±0.256

4

1.762±0.099+ 5.165±0.471+

6

2.256±0.240

4.421±0.165

4

2.268±0.251

6

2.871±0.164* 4.355±0.194

0

10

1
10
Preinc-10t

Basal

N.D.

5.023±0.406
N.D.

•Mean±SEM represent 3MG transport rate coefficients in units of A
x 10 2 min-1.

3MG efflux at 47.5 and 57.5 min respectively, represents

basal and insulin-mediated 3MG transport.

Data was analyzed using a

3-factor (Bay K 8644, nitrendipine, time) ANOVA and NeWIIlan-Keuls MCT
with p<0.05 considered significant.
+p<0.05 vs +6 µM Bay K 8644.

*p<0.05

vs no nitrendipine;

tindicates nitrendipine was added to

incubation media 10 min prior to Bay K 8644.
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Figure 3.

Effect of diltiazem (10 µM

-~.

n=8; 20 µM -(), n=8) on

basal and insulin-mediated 3MG transport in the presence of 6 µM Bay K
8644.

Results for experiments done in the presence of diltiazem are

shown as mean±SEM for efflux measurements made between 35 and 70 min
during the wash period.

Mean values for 3MG efflux in control muscles

(----, n=8) and muscles incubated with 6 µM Bay K 8644 alone (· · · ·,
n=lO) also are shown for comparison (see Mean±SEM values in Fig. 1).
Results were analyzed using a 3-factor, repeated measures ANOVA
followed by a post hoc Newrnan-Keuls test with p<0.05 considered
significant.

+p<0.05 vs 6 µM Bay K 8644 alone.
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Table 3.

Basal and insulin-mediated 3MG transport in muscles

incubated with and without diltiazem.

Treatment

n

Basal

>. x 10 2 (min- 1 )

Insulin-mediated

>. x 102 (min- 1 )

Control

8

1.849±0.108.

5.580±0.210

20 µM DZ

8

2.166±0.244

5.158±0.219

•niltiazem was added to both the 'load' and 'wash' media.
shown are mean+SEM.

Results

Results from control and diltiazem-treated

skeletal muscles were not significantly different when compared using
a 2-factor ANOVA followed by post-hoc Newman-Keuls test with p<0.05
considered significant.
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transport via changes in cellular ca2+, 45ca2+ uptake was measured
(Fig. 4).

Bay K 8644 (6 µM) significantly increased soleus muscle

ca2+ uptake at all time points.

Although compared to controls the

uptake remained elevated between 15 min through 2 hrs in the presence
of Bay K 8644 (6 µM) plus 4 µM nifedipine, the increase was of lesser
magnitude than that observed with Bay K 8644 (6 µM) alone.
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Figure 4.

Effect of Bay K 8644 (Control=[], n=4-8; 6 µM = ~. n=4)

or Bay K 8644 (6 µM) plus nifedipine (4 µM, ~ , n=4) on ca2+ uptake in
rat soleus muscles.

Dihydropyridines were added to the ,incubation

media at 60 min and results shown are mean±SEM for 60 through 180 min
incubations.

ca2+ uptake measurements were analyzed using a 3-factor

ANOVA and Newman-Keuls MCT with p<0.05 considered significant.
l\<0.05 vs control, no additions; ..,ftp<0.05 vs 6 µM Bay K 8644, no
nifedipine.
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D.

DISCUSSION

Previous studies utilizing the ca2+ agonist Bay K 8644
primarily focused on the electrophysiologic properties of ca 2+
channels in nerve (146), cardiac (247,343,356), smooth (142,356), and
skeletal (90,204,253) muscle.

Bay K 8644 effects on ca2+i-dependent

activities such as contractile force development also have been
studied (253).

In contrast, the present study evaluated the effects

of the ca 2+ channel agonist on a metabolic function in skeletal muscle
viz. sugar transport.

Previous investigators proposed a role for ca2+

in the modulation of basal (80) and insulin-stimulated (369) sugar
transport in skeletal muscle and adipose tissue.

The results of the

present study indicate that alterations in sarcolemmal ca2+ channel
activity affect both basal and insulin-mediated transport.

We

postulate that the activity of the ca2+ channel can influence (ca2+li
and in turn lead to modulation of sugar transport.

In our study, the

channel activity was modulated by adding known ca2+ channel agonists
and antagonists.
Maximal stimulation of glucose transport, with 10 mU/ml
insulin, was further enhanced with 0.25 µM Bay K 8644 (Fig. lB); a
similar Bay K 8644 concentration is known to augment lea (90,204,253),
to shift the threshold for lea to more negative membrane potentials
(91), and to enhance depolarization-induced contraction (204) in
skeletal muscle.

These data suggest that 10-7 M Bay K 8644 enhances
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insulin-mediated glucose transport via changes in sarcolemmal ca2+
movements.
A high [Bay K 8644] (6 µM) attenuated the insulin-mediated 3MG
transport response (Fig. 1 B-F) and augmented ca2+ uptake (Fig. 4).
Bay K 8644 also is known to increase 45ca2+ uptake in resting
neuroblastoma-glioma cells (146).

However, in another study, there

was no effect of the agonist on lea or tension development in skeletal
muscle (253).

Skeletal muscle 45 ca 2+ uptake has not been previously

measured in the presence of Bay K 8644.

From our results, we

postulate that 0.25 µM Bay K 8644 increased (Ca2+li to a level within
an optimal range which resulted in in an enhanced ability of insulin
to stimulate glucose transport.

The high [Bay K 8644] (6 µM) appeared

to increase (ca 2+Ji beyond that optimal range such taht cellular
regulation of insulin-mediated sugar transport was adversely affected.
Cardiac contractile responses were also shown to be diminished when
the [Bay K 8644] was increased to 5 x lo-6 to lo-5 M; these findings
were interpreted to indicate that the decreased response was due to
antagonistic effects of Bay K 8644 at higher concentrations (356).
To confirm that the effects of Bay K 8644 on sugar transport
resulted from its agonistic actions on ca2+ channels, ca2+ antagonists
were added along with Bay K 8644 during sugar transport and ca2+
uptake measurements.

Previous investigators reported that the

dihydropyridine antagonists nifedipine and nisoldipine blocked Bay K
8644-induced prolongation of Purkinje fiber action potentials (382)
and decreased the sensitivity of the cardiac contractile response to
Bay K 8644 (356). Nifedipine is known to also prevent the effects of
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high [Bay K 8644] (>5 x lo- 6 M) effects on rabbit aortic strip force
development (356).

A similar antagonism of Bay K 8644 effects was

observed in the present study.

Nifedipine prevented:

1) the

enhancement by low [Bay K 8644] (0.25 µM) of insulin-mediated sugar
transport (Fig. lB, Table l); 2) the high [Bay K 8644]-induced (6 µM)
diminution of the insulin-mediated 3MG transport (Fig.s 2 vs lF) and;
3) the high [Bay K 8644]-mediated increase in ca2+ uptake (Fig. 4).
In contrast to the action of nifedipine, nitrendipine had no effect on
Bay K 8644-induced alterations in sugar transport (Table 2).

Previous

investigators reported that nitrendipine binds to rat and rabbit
skeletal muscle (141,357) but it apparently is unable to functionally
block mammalian skeletal muscle ca2+ channels (357,406).
The benzothiazepine diltiazem also blocks ca2+ channels (406),
but it apparently does not antagonize the effects of Bay K 8644 in a
competitive manner (146,235).

In the present study, increases in

[diltiazem] progressively restored the Bay K 8644-induced attenuation
of insulin-mediated sugar transport toward control values (Fig. 3).
The [diltiazem] required to prevent the high [Bay K 8644] effects
(Fig. 3) was approximately 10 fold higher than the nifedipine
concentration required for similar results (Fig. 2), but it was
similar in magnitude to the EC50 for its actions on Ica (406).
Diltiazem administered to bacteremic rats also prevented the
development of altered skeletal muscle ca2+ regulation (415) and
prevented changes in sugar transport (417).

Although diltiazem blocks

Ca 2+ channel activation, it appears to be less effective than
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dihydropyriudine antagonists (146) because it enhances dihydropyridine
binding to the sarcolemma (235,270,327).
Overall, these results support our hypothesis that Bay K 8644
increases (ca2+]i which leads to altered insulin-mediated sugar
transport in skeletal muscle via its actions on a sarcolemmal ca 2+
channel.

Dihydropyridine and benzothiazepine ca2+ antagonists appear

to inhibit the agonist-mediated inward ca2+ movements (Fig. 4) which
prevents changes in insulin-mediated transport (Figs. 2,3).

In the

case of high concentrations of Bay K 8644 (6 µM), these antagonists
appear to prevent cellular (ca2+] from increasing beyond an optimal
range for cellular function.

Draznin et al. (118) recently introduced

a similar hypothesis from experiments in adipocytes where an optimal
range of cellular ca2+ was required for maximal stimulation of sugar
transport by insulin.

Although the exact processes affected by

altered ca 2+ regulation are not completely understood, recent studies
indicate that mobilization of glucose transporters into the plasma
membrane is ca2+ sensitive (2,427).

Other investigators postulate

that the ca2+ dependent enzyme protein kinase C may phosphorylate the
insulin receptor and thus, modulate basal and insulin-mediated glucose
transport (68,129,236,431).
Basal 3MG transport also was affected by the ca2+ agonist and
antagonists although the changes were of lesser magnitude than the
alterations in insulin-mediated transport.

Bay K 8644 concentrations

greater than 0.25 µM increased basal 3MG transport (Fig. 1 B-F) and
nifedipine (4 µM) and diltiazem (20 µM) concentrations which prevented
the Bay K 8644-induced alterations in insulin-mediated transport also
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prevented the increase in basal 3MG transport (Figs. 2,3).

Our

results agree with those of Holloszy and Narahara (196) showing that
electrical stimulation, which presumably augments lea• increased
skeletal muscle trnasport.

Increased basal glucose transport was

detectable with 0.5 µM Bay K 8644 (Fig. lC) while higher
concentrations of agonist were required to observe an effect on
insulin-mediated transport (Fig. 1 D-F).

Detection of basal transport

changes at lower [Bay K 8644] suggests that alterations in basal 3MG
transport may be more sensitive to changes in ca2+ regulation than
insulin-mediated 3MG transport.
Although 4 µM nifedipine blocked the Bay K 8644-induced
alterations in insulin-mediated 3MG transport (Fig. 2), nifedipine
alone (see RESULTS) produced inhibitory effects similar to high [Bay K
8644) (6 µM) (Fig. lF).

Nifedipine alone also enhanced ca 2+ uptake

(see RESULTS) to a similar degree as observed with Bay K 8644 plus
nifedipine (Fig. 4).

Although the enhancement of ca2+ uptake was

quantitatively similar in the presence of nifedipine alone and Bay K
8644 plus nifedipine (Fig. 4) these two treatments resulted in
opposite effects on 3MG transport (Fig. 2 vs. see RESULTS).

These

results suggest that nifedipine alone may have agonistic effects to
increase ca2+ uptake and that such an agonistic effect of nifedipine
could have contributed to the alterations in sugar transport in the
presence of nifedipine alone.

In previous studies nifedipine acted

only as an antagonist as it reduced Ica• decreased charge movement,
and reduced the slow component of tension development in depolarized
skeletal muscle (3,5,204,252,253,328).

Nifedipine had no effect on
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resting skeletal muscle (204,252,328).

We cannot rule out that the

effects of nifedipine on skeletal muscle sugar transport may be due to
nonspecific effects unrelated to its effects on ca 2+ channels.
Nitrendipine (Table 2) had no effect on 3MG transport which agrees
with previous reports that nitrendipine had no antagonistic actions on
skeletal muscle (357,406).

Diltiazem alone (10,20 µM) also had no

significant effect on basal or insulin-mediated sugar transport (Table
3) which supports earlier work indicating that skeletal muscle
stimulation or depolarization are required for diltiazem action
(3,308,345,406).
In summary, our data support the hypothesis (417) that altered
[Ca 2+Ji regulation can contribute to changes in basal and insulinmediated sugar transport.

ca2+ channel activity appears to influence

or modulate metabolic functions along with its effects on mechanical
(253) functions in skeletal muscle.

The efficacy of ca2+ blockers may

be due to their effects on metabolic as well as mechanical functions.

CHAPTER VII
EFFECT OF DILTIAZEM ON SKELETAL MUSCLE 3-0-METHYLGLUCOSE
TRANSPORT IN BACTEREMIC RATS
A.

INTRODUCTION

Both in vitro (325,420) and in vivo (430) studies have shown
alterations in skeletal muscle carbohydrate metabolism during septic
shock.

Changes in glucose utilization occur when at least one rate-

limiting step is altered.

Membrane sugar transport is the first rate-

limiting step in carbohydrate metabolism (79) and recent studies
indicate that both basal and insulin-mediated transport are altered in
skeletal muscles from bacteremic rats (413,416).

The intracellular

signals responsible for modulating both basal and insulin-mediated
sugar transport under physiological conditions are not completely
understood.

One possibility that may account for these changes is a

nonspecific increase in sugar permeation into bacteremic rat muscles.
To evaluate such changes in sugar permeation we measured transport in
the presence and absence of the specific sugar transport inhibitor
cytochalasin b and transport activity at low temperature (O.s 0 c) when
carrier-mediated transport is minimal (245).
Calcium has been shown to alter sugar transport (245) although
its site of action and its role under physiological conditions are
195
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controversial (79,239).

Several investigators have shown that changes

in intracellular ca2+_binding proteins can alter basal (236,431) or
insulin-mediated (236) glucose transport activity.

Changes in

intracellular ca2+ regulation are postulated to be involved in the
pathophysiology of septic shock (350).

In a previous study, cytosolic

free ca2+ was increased (350) while ca2+ release from the endoplasmic
reticulum was attenuated (272) in hepatocytes from endotoxic rats.
These effects were prevented when diltiazem was coadministered with
endotoxin (272,350).

A recent study in bacteremic rats also has shown

that skeletal muscle ca 2+ uptake was altered and could be prevented
with diltiazem treatment (414).
To evaluate whether an elevation of cell calcium during
bacteremia contributed to altered sugar transport, a slow-channel
calcium blocker was administered to rats and its ability to prevent
changes in sugar transport was evaluated.

Also, we ascertained the

ability of a ca2+ blocker to reverse bacteremia-induced glucose
transport alterations in vitro.

In additional experiments, we

investigated whether a ca2+ agonist (Bay K 8644) could aggravate the
bacteremia-induced sugar transport alterations.
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B.
1)

Animal model.

MATERIALS AND METHODS
Male, Holtzman rats (80-100 g) were fasted

overnight and given an intraperitoneal (ip) injection of sterile
saline (control) or bacteria (4 x 1010 Escherichia coli/kg).
were prepared as described previously (413).

Bacteria

In some experiments,

control and bacteremic rats received an intravenous (iv) injection
(0.5 ml/injection) of diltiazem (DZ) at one of the times post-saline
or -bacterial injection and one of the doses listed:

A) 1.2 mg/kg DZ

at 7.5 hrs; B) 1.2 mg/kg DZ at 0 and 7.5 hrs; C) various doses of DZ
(0.6-2.4 mg/kg) at 10 hrs.

Twelve hrs after bacterial injection, rats

were decapitated, soleus muscles were quickly removed and mounted on
aluminum holders at approximately resting length.
2)

3-0-Methyl~lucose

transport.

using an efflux technique (245,413).

Sugar transport was measured

Briefly, muscles were 'loaded'

with 14 c-3-0-methylglucose (14c-3MG, Arnersham) at 37°c in 3.0 ml of
Krebs-Ringer-bicarbonate (KRB) media for 60 min and then sequentially
washed in 2.5 ml of radioisotope-free KRB every 5 min for 70 min at
37°c.

Insulin was present in wash media between 50 and 70 min.

Muscles were digested in tissue solubilizer (TS-1, Research Products
International) overnight and then muscles and wash media were counted
in a liquid scintillation counter (Packard Tri-Garb 460).

Radioactive

counts were added in a retrograde fashion to determine the amount of
radioactivity remaining in the muscle after each wash.

Fractional
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efflux (A,min- 1 ) was estimated from the DPM/g at the beginning and end
of each wash.
In some experiments, muscles were exposed to low temperature
(0.5°C) or cytochalasin b (cyt b, Sigma) to determine whether changes
in carrier-mediated sugar transport or nonspecific sugar permeability
occurred with bacteremia.

Muscles in the low temperature study were

'loaded' with 14c-3MG in KRB buffer at 37°c for 60 min and then
sequentially washed in radioisotope-free KRB for 70 min at 0.5°C.

The

same protocol was used in cyt b studies except muscles were 'loaded'
with radioactivity and then sequentially washed in radioisotope-free
KRB containing 25 µM cyt b at 37°C.

In experiments testing the in

vitro effects of diltiazem or Bay K 8644, the antagonist or agonist
was added to both the 'load' and 'wash' media.

Rats in these

experiments also were not given iv diltiazem therapy.

Stock solutions

of 30 mM cyt b and Bay K 8644 were prepared with dimethylsulfoxide
(DMSO, Sigma) and the final DMSO concentration in the KRB media was
0.08%

(~12

mM).

DMSO concentrations of 0.5% had no effect on basal (C

A= 1.849±0.108 min-1, n=8; DMSO A = 1.831±0.112, n=4; p>0.05 with
unpaired t-test) or insulin-mediated 3MG transport (CA - 5.580±0.201,
n-8; DMSO A

=

5.735±0.423, n-4; p>0.05).

Experiments with cyt b, Bay

K 8644, or DZ added to incubation media (in vitro) were done in the
absence of room lights.
3)

Statistics.

The results of the sugar transport studies

were compared using multifactorial repeated measures analysis of
variance (ANOVA) and post hoc Student's Newman-Keuls tests with the
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BMDP (Los Angeles, CA) and SAS (Cary, NC) statistical packages.
Results are expressed as rnean±SEM.
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C.
1)

RESULTS

3-0-Methylglucose permeability during bacteremia.

Low

temperature incubations or additions of cytochalasin b to incubation
media were carried out to determine whether altered membrane
permeability produced the changes in basal and insulin-mediated 3MG
transport observed in muscles from bacteremic rats (413,416).

In both

control and bacteremic rats, low temperature substantially reduced 3MG
transport (C A at 37°C = 1.849±0.108, n=8; BA at 37°c = 2.341±0.100,
n=l2; vs Fig. 1) and there was no difference in transport between
control and bacteremic rat muscles at the low temperature (Fig. 1).
These results suggest that elevated basal 3MG transport in bacteremic
rats was due to changes in the glucose transport protein rather than
increased nonspecific sugar permeability.

Addition of 25 µM cyt b

reduced 3MG transport to similar values in 12 hr control and
bacteremic rats at all time points (Fig. 2).

Insulin was unable to

stimulate 3MG transport in the presence of cyt b in both 12 hr control
and bacteremic rats indicating that the insulin effect was mediated
via changes in the glucose transporter.
2)

Effect of diltiazem on sugar transport.

Diltiazem added to

the incubation media did not reverse the changes in 3MG transport
observed in bacteremic rats (Fig. 3).

Diltiazem (20 µM) increased

basal transport in bacteremic rat soleus muscles and had no effect on
insulin-mediated transport.

Diltiazem administered iv to rats at 0

and/or 7.5 hrs after bacterial injection did not ameliorate (Fig. 4B)
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Figure 1.

The effect of low temperature (0.5°C) on basal 3MG

transport in 12 hr control ( •
soleus muscles.

, n=8) and bacteremic (

0 , n=l6)

rat

Muscles were 'loaded' with 1 4 c-3MG at 37°C and

sequentially washed at 0.5°C.

Results are mean±SEM.

All points were

significantly decreased (p<0.05) compared to similar muscles incubated
at 37°c.

3MG transport was not signficantly different (p>0.05) when

comparing vlues from control and bacteremic rat muscles with a 2-way
ANOVA a post-hoc Newman-Keuls test.
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Figure 2.

The effect of cytochalasin b (cyt b, 25 µM) on basal and

insulin-mediated 3MG transport in 12 hr control (
bacteremic ( () ,n-8) rat soleus muscles.

~

,n-8) and

Muscles were 'loaded' with

14 c-3MG in the absence of cyt b and then washed in media containing 25

µM cyt b.

Results are mean±SEM.

All points are significantly

decreased (p<0.05) compared to similarly treated control (C) and
bacteremic (B) rats (basal values - see RESULTS; Cw/insulin A
5.580±0.201, n=8; B w/insulin A - 4.106±0.177,,n=l2).

=

3MG transport

was compared between control and bacteremic rat muscles using 2-way
ANOVA and post-hoc Newman-Keuls tests and was not significantly
different (p>0.05).
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Figure 3.

Effect of 20 µM diltiazem (DZ) on basal and insulin-

mediated 3MG transport in 12 hr bacteremic rat soleus muscles (No DZ =
~.n-12; w/DZ

=

()

,n=6).

containing 20 µM DZ.

Muscles were 'loaded' and 'washed' in media

Results are mean±SEM.

3MG transport was

compared in 12 hr bacteremic rat muscles with and without DZ using a
2-way ANOVA and post-hoc Newman-Keuls tests with a p<0.05
considered significant.
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204
the elevated basal and attenuated insulin-mediated 3MG transport
previously observed in bacteremic rat muscles (413,416).

Instead,

basal 3MG transport increased further in rats given 1.2 mg/kg
diltiazem at 7.5 hrs (Fig. 4B).

Insulin-stimulated 3MG transport was

significantly increased at 52.5 min in muscles from bacteremic rats
given 1.2 mg/kg diltiazem at 7.5 (Fig. 4B) or given 1.2 mg/kg at 0 and
7.5 hrs (Fig. 4B) after bacterial injection compared to untreated
bacteremic rats.

However, peak transport (57.5 min) was not altered

by diltiazem treatment (Fig. 4B).

In control rats, basal transport

was 1.849+0.108 min-1 (n=8) and insulin-mediated transport was
5.580±0.201 min-1 (n=8).

Basal transport was not altered while

insulin-mediated transport was decreased slightly in muscles from
control rats treated with one diltiazem injection at 7.5 hrs compared
to untreated controls (Fig. 4A).

Two diltiazem injections increased

basal transport and led to a moderate attenuation of insulin-mediated
3MG transport (Fig. 4A).
In control rats given diltiazem 10 hrs post-saline injection,
1.2 mg/kg diltiazem increased basal transport significantly but 2.4
mg/kg diltiazem had no effect compared to controls (Table 1).
Insulin-mediated 3MG transport was not altered by 1.2 mg/kg diltiazem
but 2.4 mg/kg diltiazem decreased peak transport (Table 1).

When

diltiazem treatment was given 10 hrs after bacterial injection, 3MG
transport was restored toward control values in 12 hr bacteremic rat
muscles (Fig. 5).

Diltiazem (0.6-2.4 mg/kg) given to bacteremic rats

at 10 hrs did not significantly reduce the elevated basal 3MG
transport observed in untreated septic rats (Fig. 5A-D).

Instead,
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Figure 4.

The effect of 1.2 mg/kg diltiazem on skeletal muscle 3MG

transport when it was administered iv at 7.5 hrs or at 0 and 7.5 hrs
(total = 2.4 mg/kg) after saline (Fig. 4A) or bacterial (Fig. 4B)
injection.

Transport is shown before (basal) and after the addtion of

insulin (10 mU/ml) to soleus muscles from 12 hr control (Fig. 4A,~ ,
7.5 hr n=8;(), 0+7.5 hrs n=6) and bacteremic (Fig. 4B,~ ,7.5 hr n=8;
()

,0+7.5 hrs n=8) rats.

The average fractional efflux values (see

ref. 416) in non-DZ-treated control (A) and bacteremic (B) rat soleus
muscles (----) also are shown.

Results shown are mean±SEM.

Sugar

transport in diltiazem-treated and nontreated rats (control and
bacteremic) was compared using a 2-way ANOVA and post-hoc Newman-Keuls
tests with a p<0.05 considered significant.
group (control, bacteremic), no DZ.
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Table 1.

Basal and insulin-mediated 3MG transport in skeletal muscles

from control rats given various doses of diltiazem.

[ Dil tiazem]
mg/kg

n

Basal

I. x 102 (min- 1 )

Insulin-mediated

1
2
I. x 10 (min- )

0

8

1.849±0.108.

5.580±0.201

1. 2

6

2.308±0.176*

5.347±0.184

2.4

7

2.015±0.088

5.138±0.155*

•The two doses of diltiazem used are shown in the table.
Diltiazem was administered 10 hrs after saline-injection and muscles
were removed for glucose transport measurements 2 hrs later.

Basal

and insulin-mediated transport (mean±SEM) are expressed as fractional
efflux (). x lo-2 min-1).

Results were compared to basal and insulin-

mediated 3MG transport in soleus muscles from non-treated control rats
using 1-factor ANOVA and Newman-Keuls post-hoc tests.
was considered significant.

A p<0.05 ( * )
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Figure 5.

The effect of various doses of diltiazem (DZ), administered

iv 10 hrs after bacterial administration, on basal and insulinmediated 3MG transport in soleus muscles from 12 hr bacteremic rats.
The doses of DZ administered were A) 0.6 mg/kg, n=8; B) 1.2 mg/kg,
n=8; C) 1.8 mg/kg, n=8; D) 2.4 mg/kg, n=8; with average transport
values in muscles from nontreated 12-hr bacteremic rats also shown
(----, see Ref. 416).

Results of transport in DZ-treated rat muscles

are shown as mean±SEM.

Sugar transport was compared between DZ-tnd

bacteremic rats were compared using 2-way ANOVA and post-hoc NewmanKeuls tests with a p<0.05 considered significant.

°*p<0.05 vs

similarly treated control muscle; tp<0.05 vs control or bacteremic
muscle not incubated in Bay K 8644.
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basal transport in muscles from 12 hr bacteremic (Fig. SD) rats
treated with 2.4 mg/kg diltiazem was intermediate between 12 hr
bacteremic values (untreated) and 12 hr, untreated control vlues.
Basal transport also was not different when muscles from 12 hr
bacteremic (Fig. SD) rats treated with 2.4 mg/kg diltiazem were
compared to controls (Table 1) indicating a tendency for basal
transport to return toward control values.

Diltiazem treatment at 10

hrs produced more dramatic results in insulin-mediated 3MG transport
in 12 hr bacteremic rat muscles (Fig. SA-D).

The peak insulin-

mediated response was significantly increased in muscles from 12 hr
bacteremic rats given 1.2, 1.8 and 2.4 mg/kg of DZ at 10 hrs.

Peak

insulin-mediated transport in bacteremic rat muscles after treatment
with 2.4 mg/kg was not different from control values (Table 1 vs. Fig.
SD; 2-way ANOVA, p>O.OS at all time points).
3)

Effect of Bay K 8644 of 3MG transport.

Two concentrations

of Bay K 8644 (0.2S, 6 µM) were used in transport studies to determine
whether further changes in transport occur with a ca2+ agonist in
bacteremic rat muscles.

At both concentrations, basal and peak

insulin-mediated 3MG transport were not different from transport in
bacteremic rat muscles incubated without Bay K 8644 (Table 2).

In

addition, basal and insulin-mediated 3MG transport was not different
in 12 hr control and bacteremic rat muscles incubated with 6 µM Bay K
8644 (Table 2).
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Table 2.

Effect of [Bay K 8644] (0,0.25,6 µM) on 3MG transport in

control and bacteremic rat muscles.

Treatment

[Bay K 8644]

n

Basal
AX 102(min-l)

µM

Insulin-mediated
1
;\ x 102(min- )

Control

0

8

1.849±0.108.

5.580±0.201

Control

6

10

2.336±0.068*

4.263±0.115*

Bacteremic

0

12

2.341±0.100+

4. 106±0. 177+

8

2.557±0.171

4.271±0.146

8

2.481±0.200

4.184±0.254

Bacteremic
Bacteremic

0.25
6

•Muscles were 'loaded' and 'washed' in media containing the same
[Bay K 8644].

Basal and insulin-mediated 3MG transport were measured

using fractional efflux values (;\ x 102 min-1) and results shown are
mean±SEM.

Sugar transport in muscles from control and bacteremic rats

were compared using 2-way ANOVA and post-hoc Newman-Keuls tests with a
p<0.05 considered significant.

*p<0.05 vs similarly treated control

muscle; tp<0.05 vs control or bacteremic muscle not incubated in Bay K
8644.
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D.

DISCUSSION

The results obtained with low temperature and cyt b indicate
that the altered basal and insulin-mediated 3MG transport observed in
bacteremic rat muscles (Figs. 1,2) were due to specific changes in
carrier-mediated sugar transport.

Furthermore, the present study

supported the concept that altered ca2+ regulation could contribute to
changes in carrier-mediated sugar transport in bacteremic rat muscles.
The changes in skeletal muscle sugar transport were prevented with the
ca 2 + blocker diltiazem (Fig. 5) and diltiazem has previously been
shown to prevent the alterations in ca2+ regulation observed in
muscles from endotoxic or bacteremic rats (122,414).
In previous studies, ca2+ blockers decreased the lethality (40)
of a bacteremic insult and partially prevented alterations in
hepatocyte and skeletal muscle ca2+ regulation (122,254,350).
Diltiazem added to the bacteremic rat muscles in vitro was unable to
affect sugar transport (Fig. 3) indicating that diltiazem could not
reverse cell ca2+ regulation changes which occur in vivo.

In

addition, several regimens of diltiazem administered to bacteremic
rats were unable to prevent sugar transport alterations (Fig. 4)
indicating that the dose and time of administration were critical.
this study, administration of diltiazem 10 hrs after bacterial
injection prevented alterations in basal and insulin-mediated sugar
transport in bacteremic rat muscles in a dose-dependent manner.
2.4 mg/kg dose of diltiazem provided maximal protection against

The

In
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changes in muscle ca2+ uptake in a previous study (414) and also
prevented sugar transport (Fig. 5) alterations in this study.

These

results support the idea that the altered sugar transport observed in
bacteremia and endotoxic shock models is associated with changes in
ca2+ regulation (348).

As changes occur in cellular ca 2+ regulation,

insulin's ability to regulate sugar transport appears to be
diminished.

This diminution in transport was greater than the

increase in basal transport observed in bacteremia.

Diltiazem

treatment restores the insulin response to an optimal level.

The

effect of diltiazem on insulin-mediated 3MG transport probably is
therefore more relevant in the restoration of glucose utilization in
septic states than diltiazem effects on basal transport.

The

attenuated insulin-mediated sugar transport in muscles from bacteremic
rats may be a contributing factor to inadequate energy availability
(89).

A diminution in energy availability does not appear to preceed

the changes in glucose transport in the present experiments.

If

depleted energy stores caused the cahnges in glucose transport,
insulin would be unable to stimulate transport (442) and the basal 3MG
fractional efflux would continuously increase as ion gradients
dissipated and cellular swelling occurred (245).

Restoration of the

insulin response with diltiazem treatment may allow the cell to
maintain an adequate energy supply and cellular function.
In skeletal muscle, diltiazem as well as other ca2+ antagonists
block slow inward ca2+ currents (Ica•s) (3), but appear to have no
effect on fast inward ca 2+ currents (Ica•f) (9).

Calcium antagonists

also block agonist-coupled ca2+ channels in hepatocytes (200,350).
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Walsh et al. (406) reported the half-maximal inhibition of Ica
occurred with 63 µM diltiazem in mammalian skeletal muscle.

Other

studies have shown that low concentrations of diltiazem (~ 10- 7 M)
potentiated mechanical activity (405) but had no effect on Ica·

Very

high concentrations of diltiazem (~ lo-4 M) affect tension development
as well as sarcoplasmic reticulum ca2+ uptake and release in skinned
toad muscle (207).

Overall, these studies indicate that diltiazem in

the lo-5 to lo-6s action on sugar transport in bacteremic rat muscles
was due to restoration of intracellular ca2+ regulation.
Bay K 8644 primarily acts on transverse-tubule ca2+ channels to
decrease the threshold required for ca2+ channels to open (204).

Bay

K 8644 effects on ca2+ channel conductance have been demonstrated over
short periods of time but its effects on tension development suggest
both short (seconds) and long term (minutes) effects (204).

In this

study, the longer term effects of Bay K 8644 on ca2+ may cause
alterations in control muscle ca 2+ regulation that are similar to
those observed in bacteremic muscles.
The steps leading to altered muscle carbohydrate metabolism
during bacteremia and associated septic shock are not completely
understood.

Previous investigators have postulated that increased

circulating insulin levels (48) or increased reliance of cells on
carbohydrates to meet their energy demands leads to the increased
glucose utilization observed in septic patients (268).

The mechanism

responsible for the glucose intolerance observed in septic patients
(268) and the decreased ability of insulin to stimulate glucose
utilization in isolated perfused skeletal muscle (325) has not been
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elucidated (31).

The results of this study suggest that alterations

in cell ca2+ can modulate muscle sugar transport and altered ca2+
regulation may cause the changes in glucose metabolism observed in
septic shock (Figs. 4,5, Table 2).

ca2+ has been known to have a role

in skeletal muscle glycolysis (227) and cell respiration (395), and
recent studies have shown that Ca 2 + acts as a modulator of sugar
transport (118).

CHAPTER VIII
SUMMARY OF CONCLUSIONS
Skeletal muscle carbohydrate, lipid, and protein metabolism are
altered during sepsis and septic shock (232,290).

Skeletal muscle

energy is derived primarily from lipid utilization under physiological
conditions (304).

However, lipid consumption is decreased with sepsis

(12) and carbohydrate metabolism is increased as a means of meeting
energy demands (89).

Several previous investigators observed

alterations in skeletal muscle carbohydrate utilization during septic
shock (13,420).

Glucose transport is a primary regulatory step in

skeletal muscle glucose utilization (233) and alterations in transport
activity may ultimately affect the ability of the cell to obtain
energy from carbohydrates.

The purpose of this dissertation was to

determine whether alterations in skeletal muscle glucose transport
occur during septic shock.

To this end, basal and insulin-mediated

glucose transport were measured and found to be altered in skeletal
muscles from bacteremic rats.

Subsequent studies elucidated possible

mechanisms involving cellular ca2+ regulation that contribute to the
changes in transport.

In this chapter, a summary of the results and

conclusions drawn are presented along with possible factors leading to
changes in transport.
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A.

CHARACTERIZATION OF 3-0-METHYLGLUCOSE TRANSPORT
IN RAT SOLEUS MUSCLE DURING BACTEREMIA

The initial studies characterized the changes in glucose
transport that occur in rat skeletal muscle during the course of
bacteremia.

Basal and insulin-mediated glucose transport were not

affected in soleus muscles from 8-hr bacteremic rats despite the
presence of a slight hyperglycemia and hyperlactacidemia.

In

contrast, soleus muscles from 12-hr bacteremic rats developed elevated
basal transport but stimulation of 3-0-methylglucose (3MG) transport
by a supramaximal dose of insulin was attenuated compared to timematched, saline-injected control values.

Epitrochlearis muscles from

12-hr bacteremic rats developed changes in glucose transport similar
to those observed in soleus muscles.

Subsequent experiments

established that the responsiveness of glucose transport to insulin
was attenuated yet the sensitivity of transport was not changed in the
muscles from bacteremic rats.

Changes similar to those observed in

bacteremic rats were observed in soleus muscles removed from rats
receiving endotoxin 5-hrs earlier, except the sensitivity of the
transport process to insulin was enhanced.

The in vitro studies

presumably indicate inherent changes in skeletal muscle glucose
transport.

When sugar transport was measured in vivo basal transport

was unaltered in soleus muscles from 12-hr bacteremic rats.

Injection

of a high dose of insulin to animals initially stimulated transport
equally in soleus muscles of control and bacteremic rats.

However,
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later in the course of the in vivo experiment, insulin supported an
"uphill" movement of glucose in control muscles but not in muscles
from the 12-hr bacteremic rats.

Thus, compensatory mechanisms appear

to operate in vivo so that the inherent sugar transport changes (i.e.
in vitro measurements) are not demonstrable in skeletal muscle glucose
transport during bacteremia.

The changes in transport observed in

vitro indicate that there is impaired regulation of glucose transport
in skeletal muscle.
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B.

DETERMINATION OF CELLULAR ca2+ ALTERATIONS
IN SOLEUS MUSCLES FROM BACTEREMIC RATS

The next study determined whether ca2+ regulation was altered
in skeletal muscles from bacteremic rats.

Cellular ca 2+ uptake and

steady state exchangeable Ca 2+ were measured in soleus muscles from
12-hr bacteremic and time-matched control rats using radiolabeled ca 2+
(45ca2+).

The exchangeable ca2+ content in muscles from bacteremic

rats was not different from that in controls.

However, the time

required to reach 1/2 maximal ca2+ uptake was substantially reduced in
soleus muscles from bacteremic rats compared to control values.

These

results suggest that net ca2+ movement was increased across the
sarcolemmal membrane and/or intracellular organelles such as
sarcoplasmic reticulum (SR) in muscles from bacteremic rats.
Administration of the Ca 2+-channel antagonist diltiazem to bacteremic
animals reduced 45ca2+ uptake to control values in soleus muscles.
This dose of diltiazem had a lesser effect on ca2+ uptake in timematched control muscles.

In other experiments, high [K+] was added to

the incubation media to depolarize soleus muscles and stimulate the
release of SR ca2+ (307,395).

This ca2+ release presumably is

responsible for stimulation of 45ca2+ uptake (125,307,395), which was
larger in muscles from bacteremic rats than controls.

Together these

results suggest that ca 2+ movements are altered in soleus muscles from
12-hr bacteremic rats.

ca2+ movement through the voltage-sensitive
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channel in the sarcolemma and handling of ca2+ by the SR appear to be
affected in these muscles.
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C.

MECHANISMS OF ALTERED BASAL AND INSULIN-STIMULATED
3MG TRANSPORT IN BACTEREMIC RAT SOLEUS MUSCLES

In two subsequent studies, the hypothesis that altered Ca 2+
regulation may lead to changes in glucose transport was assessed using
ca2+_modifying agents.

Experiments tested whether incubation of

control muscles with these agents reproduced the increased basal and
attenuated insulin-mediated glucose transport observed in skeletal
muscles from 12-hr bacteremic rats.

Skeletal muscles from bacteremic

rats were also incubated with these agents to determine whether
additional changes could be induced in these muscles.

Agents used to

modify cellular ca2+ regulation included varying extracellular [ca2+]
([Ca2+] 0 ), ca2+ ionophores (A23187, ionomycin), 40 mM Na+ media,
ryanodine, and the ca2+ agonist Bay K 8644.
1)
transport.

Effect of Ca 2+-modifying agents on skeletal muscle 3MG
Increased [Ca 2+] 0 had little effect on basal and insulin-

mediated glucose transport in skeletal muscles from control and
bacteremic rats.

Reduction of [Ca2+] 0 to 'nominal' levels increased

basal and attenuated insulin-mediated 3MG transport in muscles from
control rats; however there was only a slight effect on transport in
skeletal muscles from bacteremic rats.

These results suggested that

reduction of [ca+] 0 below a certain range prevents the cell from
regulating basal and insulin-mediated glucose transport.

Addition of

the ca2+ ionophore A23187 attenuated insulin-mediated 3MG transport
but did not affect basal transport in control muscles.

However, there
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was increased basal glucose transport, along with the attenuated
insulin-mediated transport in control muscles when (Ca 2+J 0 was
increased in the presence of A23187.

This ionophore had no effect on

basal or insulin-mediated 3MG transport in soleus muscles from 12-hr
bacteremic rats.

It would appear that a specific range of (Ca 2+Ji is

required for optimal regulation of basal and insulin-mediated
transport.

"When (Ca 2+Ji is outside this range, basal and insulin-

mediated transport are not regulated and as a result, alterations
occur in both basal and insulin-mediated sugar transport.
The results obtained with ionomycin, 40 mM Na+ 0
supported this (Ca 2+Ji range hypothesis.

,

and ryanodine

Ionomycin produced

comparable increases in basal and decreases in insulin-mediated 3MG
transport in control and bacteremic rat muscles.

Low [Na+) 0 or

ryanodine produced effects similar to that of ionomycin and both
treatments also increased 45ca2+ uptake in similarly treated control
muscles.

In the presence of 40 mM Na+, basal transport was higher in

muscles from bacteremic rats compared to controls which indicated that
additional loss of regulation may have occurred in bacteremic rat
muscles.

These experiments show that cellular ca2+ modifications can

produce effects on skeletal muscle glucose transport that were
qualitatively similar to those observed in bacteremia.

However, in

muscles from bacteremic rats there was a greater increase in basal
along with a greater decrease in insulin-mediated transport with
ionomycin or 40 mM Na+ 0 than that observed with bacteremia alone.
Since the Ca 2+-modifying agents exaggerated the glucose transport
alterations in skeletal muscles from bacteremic rats, it appears that
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they may not quantitatively represent the mechanism(s) responsible for
the changes observed with bacteremia.
2)
transport.

Effect of ca2+ channel agonist on skeletal muscle 3MG
Muscles from control and bacteremic rats were incubated

with the ca2+ agonist Bay K 8644 to determine whether increased
movement of ca 2+ through voltage-sensitive channels could produce
altered glucose transport similar to that observed in bacteremia.

The

lowest [Bay K 8644) enhanced insulin-mediated 3MG transport but had no
effect on basal transport in control muscles.

Higher concentrations

of Bay K 8644 produced an increase in basal glucose transport in
control muscles and the higherst Bay K 8644 concentrations led to
attenuated insulin-mediated transport in these muscles.

The highest

[Bay K 8644] produced changes in basal and insulin-mediated transport
that were not different from values measured in bacteremic rat
muscles.

Bay K 8644 had no effect on basal or insulin-mediated

glucose transport in muscles from bacteremic rats.

It would appear

that increased movement of ca2+ through voltage-mediated ca2+ channels
led to the changes in basal and insulin-mediated glucose transport
observed in earlier experiments with bacteremic rats.

Muscles were

incubated with ca2+_channel antagonists in the presence of Bay K 8644
to ensure that the effects of Bay K 8644 were mediated through the
Ca 2+ channel.

Indeed, Bay K 8644 effects did appear to be mediated

via the ca2+ channel since both nifedipine and diltiazem prevented the
increased basal and attenuated insulin-mediated glucose transport
observed in the presence of Bay K 8644 alone.

An unexpected finding

of this study was that nifedipine alone appeared to have agonistic
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properties since it increased skeletal muscle ca 2+ uptake and altered
glucose transport.
3)

Effect of ca2+ antagonist administered during bacterernia on

skeletal muscle 3-0-rnethylglucose transport.

The final set of

experiments determined whether the ca2+ antagonist diltiazern could
prevent the changes in basal and insulin-mediated glucose transport
observed in soleus muscles from 12-hr bacterernic rats.

Diltiazern

added to the incubation media had no effect on basal or insulinmediated glucose transport in muscles from 12-hr bacteremic rats.
When diltiazem was given to the rat at the same time as bacteria
and/or 7.5 hr after bacteria, it was unable to prevent the increased
basal and attenuated insulin-mediated 3MG transport in 12-hr
bacteremic rats.

However, diltiazem administered 10 hrs after

bacterial injection restored basal and insulin-mediated glucose
transport to control values in soleus muscles from 12-hr bacteremic
rats.

The effect of diltiazern was dose-dependent with the highest

dose providing the greatest protection.

This diltiazem concentration

also prevented the altered skeletal muscle ca2+ regulation and
attenuated the hyperlactacidemia present in 12-hr bacterernic rats.
From this study, I concluded that alterations in ca2+ regulation
during bacterernia produced the observed changes in glucose transport.
When the altered ca2+ regulation was prevented in 12-hr bacteremic
rats, changes did not develop in skeletal muscle glucose transport.

CHAPTER IX
EPILOGUE
Figure 1 depicts the major findings and conclusions of this
study along with possible events that lead to alterations in skeletal
muscle ca2+ regulation and glucose transport.

A variety of cells

utilized for host defense are activated in response to sepsis,
including macrophages, polymorphonuclear leukocytes (PMNs) and
platelets (6,295,331).

Bacteria in the circulation are recognized and

digested by tissue macrophages (331).

Endotoxin released from

digested bacteria, as well as the bacteria themselves, stimulate the
production and release of monokines (e.g. IL-1, TNFa, colony
stimulating factor) from the macrophages (331).

Monokines released

into the circulation may directly or indirectly affect skeletal muscle
ion permeability.

Tracey et al. (385) showed that tumor necrosis

factor (TNF) added to hindlimb perfusates could cause the
depolarization of skeletal muscles which was previously observed in
bacteremic animals (387).

Depolarization occurs as a result of

altered ion permeability and ca2+ movements could be affected also.
These results suggest that monokines may directly affect cellular ion
permeability.
Alterations in the microcirculation also may contribute to the
altered ca2+ regulation observed in the present study.
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Platelet
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aggregation and PMN-derived chemotactic factors initiate blood
coagulation (6,437) and eventually may reduce skeletal muscle blood
flow and lead to tissue ischemia (349).

Mediators released from PMNs

as well as other leukocytes also may cause endothelial injury in
skeletal muscle (6).

The combination of ischemia and loss of

endothelial integrity may impair the delivery of nutrients to skeletal
muscle.

Decreased nutrient delivery may lead to altered ionic

regulation in skeletal muscle or affect neuro-humoral factors.
Monokines or alterations in the microvasculature may also
indirectly affect ion permeability by changing neural or hormonal
influences on skeletal muscle.

Increased levels of hormones which

regulate metabolism are observed during infection (103,222) and some
monokines have been shown to increase the release of insulin (434).
Both insulin and glucose increase [ca 2+Ji in adipocytes (117) and its
possible that elevated insulin and glucose may alter ion permeability
in muscle (156,344).

Monokines also stimulate the release of

epinephrine and norepinephrine (386), and

~-adrenergic

stimulation of

muscle enhances ca2+ influx via voltage-gated channels (9,100).

In

addition, monokines may alter neural input into skeletal muscle which
also could alter ca2+ movements although currently there is no direct
experimental evidence to support this hypothesis.

Ischemia increases

circulating levels of insulin and catecholamines (232,422), which have
been shown to influence ca2+ movements (84,118).

Ischemia also may

affect neural input into the muscle.
TNF or IL-1 do not appear to directly cause the alterations in
glucose transport (258).

Raymond et al. (324,327) indicated that
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ischemia also did not appear to play a direct role in causing
alterations in insulin-mediated glucose uptake.

Instead, the results

of the present study show that skeletal muscle carbohydrate metabolism
is affected by alterations in cellular ca2+ regulation.

The altered

ca2+ regulation and attenuated insulin-mediated glucose transport in
skeletal muscles from bacteremic rats supports the hypothesis recently
proposed by Draznin et al.

(118).

They postulated that [Ca 2 +Ji within

a specific range was required for optimal insulin-stimulation of
glucose transport.

In addition, it would appear that altered ca 2 +

regulation may produce increased basal glucose transport.

Although

increased glucose utilization is often viewed as a compensatory
mechanism to meet energy demands (336), it may signal a diminished
ability of the cell to regulate glucose transport and glucose
metabolism.

The importance of these alterations lies in the blunted

insulin responsiveness because this indicates that there is a
decreased capacity for the cell to stimulate glucose metabolism.
Meanwhile, reduced lipid utilization occurs during bacteremia due to
decreased lipoprotein lipase activity (12) and some investigators
suggest that skeletal muscle may increase its reliance on
carbohydrates to meet its energy demands (89,336).

A decreased

capacity to stimulate glucose transport coupled with increased
reliance on glucose for energy may eventually lead to a compromise in
the ability of skeletal muscle to meet energy demands via carbohydrate
metabolism.

The cell may resort to protein catabolism to meet energy

demands (89,336).

Reduced capacity of muscle to use carbohydrates

along with increased protein catabolism may lead to muscle cell injury
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and eventually to the muscle wasting characteristic
in humans (89,336).
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